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Abstract: Tightly-controlled cell division is of critical importance for multicellular organisms to be able
to grow and survive over long periods of time. The most demanding step in this process is the faithful
replication of the genome. If a cell fails to copy its DNA molecule in an error-free manner, the genetic
changes in the DNA can lead to cell death or, in the worst case, to uncontrolled cell division, resulting in
genome instability and cancer. The DNA is constantly challenged by exogenous and endogenous damaging
agents, such as UV irradiation, water or reactive oxygen species that threaten the integrity of DNA. The
resulting lesions are addressed by base excision repair (BER) and mismatch repair (MMR). The cell’s
repair pathways are, however, not only needed to correct damage in the DNA and mistakes arising during
replication, but they are also essential for many physiological processes. BER and MMR were shown to
play a role in antibody diversification during adaptive immune response and BER is implicated in DNA
methylation dynamics to control gene expression. In the first part of the thesis, we set out to investigate
the role of BER and MMR in class switch recombination (CSR), a process that enables B-cells to produce
antibodies with different effector functions. Using DNA substrates containing defined nicks and uracils,
we mimicked the intermediates arising during CSR by the action of activation induced cytidine deaminase
(AID). We found that the creation of DNA double strand breaks, a step that is essential for CSR, heavily
depends on the BER enzyme uracil DNA glycosylase (UNG) and on the MMR protein MutS￿. In the
second part of the thesis, I aimed to gain insights into the dynamic metabolism of DNA modifications
that control gene expression by investigating the chromatin dynamics at the vitellogenin (VTG) gene
regulatory region. The VTG gene represents a valuable model to study the events on chromatin leading
to expression of the gene, as it is well-characterized and inducible by estradiol treatment. Demethylation
events have been observed in the enhancer region in rooster DNA upon hormone treatment. In our cell
line system, we saw no demethylation, but an increase in 5-hydroxymethylation, a product of oxidation
mediated by the Ten-eleven Translocation proteins, implicated in DNA demethylation. In addition,
the estrogen receptor ￿ binding to its response element in the VTG enhancer was not altered by the
presence of 5mC or 5hmC, but a shift of a methylation-sensitive factor was observed in nuclear extracts.
In vitro methylation of a reporter plasmid under the control of the VTG regulatory region inhibited
transcription, confirming an important role of methylation dynamics in the control of VTG expression.
We found evidence that a CpG residing outside of the estrogen response element in an E-box in the
VTG promoter is responsible for the methylation-sensitivity. The data presented in this thesis illustrate
the diverse functions of eukaryotic repair pathways. They show the great potential of these versatile
mechanisms, but also point out the danger they pose to cells and multicellular organisms. If they are not
processed correctly, the DNA modifications and rearrangements can lead to tumorigenesis, highlighting
the importance of a deep understanding of the mechanisms involved.
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in	 antibody	 diversification	 during	 adaptive	 immune	 response	 and	 BER	 is	 implicated	 in	 DNA	
methylation	dynamics	to	control	gene	expression.	
In	 the	 first	 part	 of	 the	 thesis,	 we	 set	 out	 to	 investigate	 the	 role	 of	 BER	 and	MMR	 in	 class	 switch	





In	 the	 second	 part	 of	 the	 thesis,	 I	 aimed	 to	 gain	 insights	 into	 the	 dynamic	 metabolism	 of	 DNA	
modifications	 that	 control	 gene	 expression	 by	 investigating	 the	 chromatin	 dynamics	 at	 the	
vitellogenin	 (VTG)	 gene	 regulatory	 region.	The	VTG	 gene	 represents	a	valuable	model	 to	 study	 the	
events	on	chromatin	 leading	 to	expression	of	 the	gene,	as	 it	 is	well-characterized	and	 inducible	by	
estradiol	 treatment.	 Demethylation	 events	 have	 been	 observed	 in	 the	 enhancer	 region	 in	 rooster	
DNA	upon	hormone	treatment.	In	our	cell	line	system,	we	saw	no	demethylation,	but	an	increase	in	
5-hydroxymethylation,	 a	 product	 of	 oxidation	mediated	 by	 the	 Ten-eleven	 Translocation	 proteins,	
implicated	 in	 DNA	 demethylation.	 In	 addition,	 the	 estrogen	 receptor	 α	 binding	 to	 its	 response	
element	 in	 the	VTG	 enhancer	 was	 not	 altered	 by	 the	 presence	 of	 5mC	 or	 5hmC,	 but	 a	 shift	 of	 a	
methylation-sensitive	 factor	 was	 observed	 in	 nuclear	 extracts.	 In	 vitro	 methylation	 of	 a	 reporter	
plasmid	 under	 the	 control	 of	 the	 VTG	 regulatory	 region	 inhibited	 transcription,	 confirming	 an	
important	role	of	methylation	dynamics	in	the	control	of	VTG	expression.	We	found	evidence	that	a	
















UV-Strahlung,	Wasser	 oder	 reaktive	 Sauerstoffverbindungen,	 die	 die	 Integrität	 der	 DNS	 bedrohen.	








(CSR)	 untersuchen,	 einem	 Prozess,	 der	 es	 B-Zellen	 ermöglicht,	 Antikörper	 mit	 unterschiedlichen	
Effektor-Funktionen	zu	produzieren.	
Der	Einsatz	von	DNS-Substraten,	die	definierte	Strangbrüche	und	Uracil-Basen	enthalten	-	Läsionen,	
die	 von	der	 aktivierungsabhängigen	Cytidin-Deaminase	 (AID)	 erzeugt	werden	 -	 ermöglichte	es	uns,	
die	 Zwischenprodukte	 von	CSR	nachzuahmen.	Wir	haben	herausgefunden,	dass	die	 Erzeugung	 von	
DNS-Doppelstrangbrüchen,	 ein	 essentieller	 Schritt	 in	 CSR,	 vom	 BER-Enzym	 Uracil-DNS-Glykosylase	
(UNG)	und	vom	MMR	Protein	MutSα	abhängt.	
Im	zweiten	Teil	dieser	Arbeit	wollte	 ich	einen	Einblick	 in	den	dynamischen	Metabolismus	von	DNS-
Modifikationen	 in	 der	 Kontrolle	 von	Genexpression	 gewinnen,	 indem	 ich	die	 Chromatindynamik	 in	
der	 regulierenden	Region	des	Vitellogenin	 (VTG)-Gens	untersuchte.	Das	VTG	Gen	 ist	ein	wertvolles	
Modellsystem,	um	die	Ereignisse	am	Chromatin	zu	erforschen,	die	zur	Expression	des	Gens	 führen,	
da	 das	 System	 gut	 charakterisiert	 ist	 und	 ausserdem	mit	 Estradiol	 induzierbar	 ist.	 Demethylierung	
wurde	in	der	Enhancer	Region	in	der	DNS	von	Hähnen	nach	einer	Hormonbehandlung	beobachtet.	In	
unserer	 Zelllinie	 konnten	 wir	 keine	 Demethylierung	 sehen,	 aber	 einen	 Anstieg	 von	
Hydroxymethylierung,	 einem	 Produkt	 der	 Ten-eleven	 Translocation	 Proteine,	 die	 eine	 Rolle	 in	 der	
DNS-Demethylierung	spielen.	Zusätzlich	haben	wir	herausgefunden,	dass	der	Östrogenrezeptor	seine	
Bindungsstelle	im	Enhancer	des	VTG-Gens	unabhängig	von	Methylierung	oder	Hydroxymethylierung	
bindet,	 aber	wir	 fanden	 einen	methylierungsempfindlichen	 Faktor	 in	 nuklearen	 Extrakten.	 In-vitro-
Methylierung	 eines	 Reporter-Plasmids	 unter	 der	 Kontrolle	 der	 VTG-regulativen	 Region	 führte	 zur	
Verhinderung	 der	 Transkription,	was	 die	 Bedeutung	 von	Methylierungsdynamiken	 in	 der	 Kontrolle	
der	 VTG	 Expression	 hervorhebt.	 Wir	 fanden	 Hinweise,	 dass	 ein	 CpG,	 ausserhalb	 des	




Die	 in	 dieser	 These	 präsentierten	 Daten	 zeigen	 die	 verschiedenen	 Funktionen	 der	 eukaryotischen	
Reparaturwege.	 Sie	 zeigen	 das	 grosse	 Potenzial	 dieser	 vielseitigen	 Mechanismen,	 aber	 auch	 die	










































































































grow	 and	 survive	 over	 long	 periods	 of	 time.	 The	 most	 critical	 step	 in	 this	 process	 is	 the	 faithful	
replication	of	the	genome.	When	a	cell	 fails	 to	copy	 its	DNA	molecule	 in	an	error-free	manner,	the	
genetic	changes	in	the	DNA	sequence	can	lead,	in	the	best	case,	to	the	controlled	death	of	the	cell,	
called	 apoptosis,	 but	 they	 can	 also	 lead	 to	 uncontrolled	 division	 of	 the	 cell,	 resulting	 in	 genome	
instability	 and	 cancer	 [1-3].	 It	 is	 therefore	 of	 critical	 importance	 for	 the	 cell	 to	 ensure	 error-free	
replication	 of	 the	 genetic	 information	 and	 prevent	 any	 unintended	 changes	 in	 the	 DNA	molecule.	
Cells	possess	several	repair	pathways	that	ensure	the	stability	of	the	DNA	sequence	and	 its	 faithful	
duplication	and	propagation	to	the	following	generations,	some	of	which	will	be	discussed	below.		
Adding	 even	more	 complexity	 to	 the	metabolism	 of	 DNA,	 the	 cell's	 repair	 pathways	 are	 not	 only	
needed	 to	 correct	 damage	 in	 the	 DNA	 and	 mistakes	 arising	 during	 replication,	 but	 they	 are	 also	
essential	 for	many	physiological	processes	 in	 the	cell.	 It	 is	of	outmost	 importance	for	example	that	
the	DNA	molecule	 can	be	dynamically	modified	 for	 the	 regulation	and	 control	 of	 gene	expression.	
This	 occurs	 on	 an	 epigenetic	 level,	 meaning	 one	 level	 above	 the	 genetic	 code,	 but	 nevertheless	
involves	transient	modifications	of	the	DNA.	Even	more	striking,	 in	addition	to	modifications	of	the	
DNA	 necessary	 for	 epigenetic	 regulation	 of	 gene	 expression,	 there	 are	 some	 examples	where	 the	
DNA	 sequence	 itself	 is	 deliberately	 and	 irreversibly	 changed.	 In	 vertebrates	 for	 example,	DSBs	 are	











polymer.	 The	 polar	 amidino,	 guanidino	 and	 carbonyl	 groups	 of	 the	 complementary	 bases	 form	 a	
complex	network	consisting	of	hydrogen	bonds	with	neighboring	water	molecules.	Stability	depends	












The	 most	 important	 and	 most	 abundant	 ones	 are	 oxygen	 and	 water.	 Their	 contact	 with	 DNA	 is	
inevitable,	but	can	lead	to	modifications	that	threaten	the	integrity	of	the	DNA	and	the	genome.	
Molecular	oxygen	can	react	with	unpaired	electrons	that	escape	the	electron	transfer	chain,	leading	




oxidant	hydroxyl	 radical	 [10,	11].	ROS	 impose	an	 immense	 threat	 to	DNA,	because	 they	 react	with	
the	bases	and	 the	deoxyribosyl	backbone	causing	mutagenic	 lesions,	DNA	breaks	and	DNA-protein	
cross-links	[12,	13].	The	formation	of	7,8-dihydro-8-oxoguanine	(8-oxo-dG)	is	particularly	mutagenic	
in	 DNA,	 because	 its	 base	 pairing	 properties	 mimic	 those	 of	 a	 thymidine,	 causing	 the	 frequent	
misincorporation	of	adenine	into	the	opposite	strand	[14,	15].	This	leads	to	transversions	from	C/G	to	
A/T,	 which	 are	 among	 the	 predominant	 somatic	 mutations	 in	 lung,	 breast	 and	 colorectal	 cancers	
[16].	It	is	therefore	of	outmost	importance	for	the	cell	to	remove	8-oxo-dG	before	replication.	
	 	
Figure 1: Oxidation of guanosine by ROS leading to the formation of 8-oxo-dG.  
	
The	 other	 prevalent	 endogenous	 DNA	 damaging	 agent,	 water,	 also	 causes	 a	 variety	 of	mutagenic	
DNA	lesions.	It	hydrolyzes	cytosine	to	uracil	[17,	18]	and	5-methylcytosine	(mC)	to	thymine	[19-21].	
The	latter	reaction	causes	more	complex	problems,	as	the	product	is	a	bona	fide	DNA	base	and	not	
an	obvious	damage	product.	 In	addition,	adenine	can	be	hydrolyzed	 to	hypoxanthine,	causing	 it	 to	
mispair	with	 cytosine	 leading	 to	 A/T	 to	G/C	 transitions	 [22,	 23].	Water	 also	 causes	 protonation	 of	
guanine,	 eventually	 leading	 to	 its	 spontaneous	 loss	 through	 depurination	 [24]	 and,	 together	 with	
oxygen,	 it	can	generate	thymine	glycol	and	a	plethora	of	other,	minor,	aberrant	bases	that	need	to	
be	repaired	by	the	cell	to	ensure	the	stability	of	DNA.	
The	 third	 agent	 that	 spontaneously	 modifies	 DNA	 is	 S-adenosylmethionine	 (SAM);	 it	 acts	 as	 a	






Figure 2: Alkylated purines generated in DNA by aberrant methylation. From left to right: 3-N-
methyladenine, 7-N-methylguanine and 6-O-methylguanine. 
		
Apart	 from	arising	 through	endogenous	DNA	damaging	agents,	 cells	also	deliberately	modify	bases	
for	 regulatory	 purposes	 or	 to	 selectively	modify	 the	 genome	 in	 a	 highly	 controlled	manner.	 Some	
examples	relevant	for	this	work	are	mentioned	briefly	and	will	be	discusses	in	detail	later.	SAM	is	not	
only	 a	 mutagenic	 agent	 in	 cells,	 but	 is	 also	 used	 to	 attach	 methyl	 moieties	 to	 the	 5-position	 of	
cytosines,	 forming	 5-methylcytosine	 (5mC)	 [26].	 This	 so-called	 fifth	 base	 plays	 an	 essential	 role	 in	
many	 regulatory	 processes.	 In	 2009,	 a	 family	 of	 oxidases,	 the	 Ten-eleven	 Translocation	 (TET)	
enzymes	were	discovered	to	oxidize	5mC	to	5-hydroxymethylcytosine	(5hmC),	5-formylcytosine	(5fC)	
and	5-carboxycytosine	 (5caC)	 [27,	 28].	 The	exact	 role	of	 these	 additional	 cytosine	 species	 is	 under	
intense	investigation.		
	 	
Figure 3: Spontaneous or enzymatic (by AID/APOBEC) hydrolytic deamination of cytosine (top 
row) gives rise to uracil. 5-Methylcytosine can be either deaminated directly to thymine (middle row), 
or enzymatically converted in a stepwise manner to hydroxymethylcytosine, formylcytosine and 
carboxycytosine by TET dioxygenases. When opposite G in double-stranded DNA, T, fC and caC 
can be excised by thymine DNA glycosylase. 
Figure 1: Spontaneous hydrolytic deamination of cytosine (top row) gives rise to uracil. 5-
Methylcytosine can be either deaminated directly to thymine (middle row), or enzymatically 
co verted in stepwise manner to hydroxymethylcytosine, formylcytosine and carboxycytosine 
by TET dioxygenases. When opposite G in double-stranded DNA, T, fC and cC can be 
























































Another	 enzyme	 family	 shown	 to	 deaminate	 cytosines	 in	 DNA	 consists	 of	 the	 APOBEC1/AID	
deaminases.	Originally	described	 to	edit	RNA,	 they	were	 later	 shown	 to	also	modify	DNA	 [29,	 30].	
Activation-induced	cytidine	deaminase	(AID)	 is	used	by	the	cell	 to	deaminate	cytosines	to	uracils	 in	
the	 immunoglobulin	 locus	 in	activated	B-cells,	 to	facilitate	somatic	hypermutation	(SHM)	and	class-
switch	recombination	(CSR).		









Figure 4: Damage reversal by MGMT, restoring guanine from 6-O-methylguanine generated for 




very	 frequently,	 as	 it	 arises	 from	 spontaneous	 events	 caused	 by	 endogenous	 agents	 abundantly	







This	 lead	to	 the	discovery	of	many	other	damage-specific	glycosylases	 that	were	grouped	 into	 four	
structurally	 distinct	 superfamilies;	 the	 uracil	 DNA	 glycosylases	 (UDGs),	 the	 helix-hairpin-helix	
glycosylases	(HhH),	the	3-methyl-purine	glycosylases	and	the	endonuclease	VIII-like	glycosylases	[35].	






highly-specialized	 enzymes,	 many	 of	 the	 glycosylases	 have	 overlapping	 functions	 leading	 to	
redundancies,	as	indicated	by	the	mild	phenotypes	of	single	knockouts	of	the	different	glycosylases	
[37,	 38].	 The	 notable	 exception	 is	 thymine	 DNA	 glycosylase	 (TDG)	 that	 has	 been	 shown	 to	 be	
essential	for	embryonic	development	[39].	
The	minimal	BER	requires	a	monofunctional	DNA	glycosylase	or	a	bifunctional	DNA	glycosylase/lyase,	
an	 AP	 endonuclease,	 a	 DNA	 polymerase	 and	 a	 DNA	 ligase	 [38,	 40].	 First,	 the	 damaged	 base	 is	
recognized	and	removed	by	the	glycosylase,	leaving	behind	an	apurinic	or	apyrimidinic	(AP)	site,	or,	
in	 the	 case	 of	 a	 bifunctional	 glycosylase,	 a	 3'	 nicked	 AP	 site.	 The	 AP	 site	 is	 then	 processed	 by	 AP	
endonuclease	1	(APE1)	that	creates	a	single-stranded	DNA	nick	5'	to	the	AP	site	or	a	single	nucleotide	
gap	 when	 acting	 downstream	 from	 a	 glycosylase/lyase.	 Polymerase	 b	 then	 inserts	 the	 excised	
nucleotide.	 In	 the	 last	 step,	 the	 nick	 is	 sealed	 by	 XRCC1/ligaseIII	 [38].	 The	 basic	 repair	 pathway	 is	
shown	in	figure	5,	exemplified	on	UNG.	
The	 excised	 nucleotide	 can	 be	 replaced	 either	 by	 short-	 or	 long-patch	 base	 excision	 repair.	While	
short	 patch	 BER	 involves	 the	 replacement	 of	 a	 single	 nucleotide	 by	 polymerase	 b,	 followed	 by	
XRCC1/ligaseIII-dependent	ligation	of	the	nick,	long	patch	BER	is	slightly	more	complex	[41,	42].	It	has	
been	shown	to	additionally	depend	on	proliferating	cell	nuclear	antigen	(PCNA)	and	the	flap	structure	
specific	 endonuclease	 1	 (FEN1)	 [43,	 44],	 and	 involves	 the	 replacement	 of	 2-6	 nucleotides	 by	









Figure 5: The basic base excision repair pathway exemplified on 
uracil DNA glycosylase. In a first step, the lesion, here a uracil, is 
recognized by the glycosylase. The base is excised, leaving behind an 
AP site that is addressed by an AP endonuclease, nicking the AP 
site 5'. Polymerase b inserts the missing nucleotide and removes the 
deoxyribose 5-phosphate using its lyase activity. Ligase III seals the 







eukaryotes;	 the	 UNG	 subfamily,	 the	 mismatch-specific	 uracil	 DNA	 glycosylases	 (MUGs)	 and	 the	
single-strand-specific	 monofunctional	 uracil	 DNA	 glycosylases	 (SMUGs)	 [35,	 48].	 There	 are	 four	






the	 base	 opposite	 the	 uracil	 [33].	 UNG	 has	 an	 exceptionally	 high	 turnover	 rate	 of	 up	 to	 1000	 U	
excised	 per	 minute	 [51].	 It	 possesses	 a	 very	 narrow	 catalytic	 cavity	 that	 provides	 high	 specificity	





and	the	side	chain	of	a	 tyrosine	residue	blocks	 the	entry	of	 thymine.	Cytosine	can	enter	 the	active	
site,	but	is	not	processed	further	due	to	unfavorable	positioning	[55].	
There	are	two	UNG	isoforms	in	mammals,	the	mitochondrial	form	UNG1	and	the	nuclear	form	UNG2,	
arising	from	alternative	splicing	 [56].	UNG1	 is	highly	expressed	 in	mitochondria-rich	tissues	 like	the	
heart	or	 skeletal	muscle	 [57].	Considering	 that	most	ROS	arise	during	mitochondrial	metabolism,	 it	
makes	sense	for	the	cell	 to	have	a	specialized	glycosylase	 in	mitochondria.	The	nuclear	 form	UNG2	
has	been	more	extensively	studied.	Whereas	UNG1	is	ubiquitously	expressed,	UNG2	expression	is	cell	
cycle	regulated,	the	highest	levels	being	observed	in	late	G1/S.	It	has	additionally	been	shown	that	in	
B-cells,	UNG2	mRNA	 is	 only	 present	 after	 activation	 [58].	 The	differential	 expression	 levels	 can	be	








cell	 development.	 An	 altered	mutational	 pattern	 in	 somatic	 hypermutation	 (SHM)	was	 found.	 The	
ratio	 of	 nucleotide	 transition	 versus	 transversion	 at	 C/G	 sites	 was	 shifted	 significantly	 towards	
transition	 in	 the	absence	of	UNG,	whereas	 the	 ratio	at	A/T	sites	was	unchanged.	This	 is	 consistent	
with	the	fact	that	unrepaired	uracils	lead	to	transitions	from	C/G	to	T/A,	whereas	replication	through	





B-cells	deficient	of	UNG	showed	drastic	 reduction	 in	CSR	 [64].	Humans	with	mutations	 in	 the	UNG	
gene	 display	 the	 Hyper-IgM-syndrome	 (HIGM),	 characterized	 by	 increased	 serum	 IgM	 levels	
combined	 with	 low	 or	 absent	 serum	 IgG,	 IgA	 and	 IgE	 [58,	 65].	 HIGM	 is	 additionally	 linked	 to	
mutations	 in	 activation-induced	 cytidine	 deaminase	 [66],	 different	 cluster	 of	 differentiation	 (CD)	
genes	[67]	and	mismatch	repair	proteins.		
Both	SHM	and	CSR	are	 initiated	by	AID	that	 locus-specifically	deaminates	cytosines	 to	uracils.	UNG	
and	MMR	proteins	 seem	 to	be	 the	main	 repair	 factors	 involved	 in	 the	processing	of	 these	uracils.	




The	 correction	 of	 G/T	mismatches	 arising	 from	 deamination	 of	 5mC	 in	 the	 CpG	 context	 has	 been	
debated	[68-71].	Although	the	repair	seems	to	be	inefficient,	depicted	by	a	loss	of	CpG	dinucleotides	
in	evolution,	 it	was	clear	that	there	had	to	be	a	way	to	faithfully	repair	G/T	to	G/C.	Repair	activity,	
directed	 towards	 a	 bona	 fide	 deoxyribonucleotide	 uncoupled	 from	 replication	 however,	 demands	
careful	 regulation.	 A	 repair	 activity	 on	 G/T	 mismatches	 has	 first	 been	 described	 in	 simian	 cells	




glycosylase	 [75].	 TDG	 also	 catalyzes	 the	 removal	 of	 uracil	 in	 G/U	mismatches,	 supporting	 UNG	 in	
protecting	 the	DNA	 from	accumulating	 uracils	 [76,	 77].	Other	 than	UNG,	 TDG	 is	mismatch-specific	
and	therefore	does	not	address	A/U	pairs	arising	from	wrongly	incorporated	uracils,	but	only	uracils	
in	 the	G/U	 context,	 resulting	 from	deaminated	 cytosines.	 Its	mismatch	 specificity	 also	 implies	 that	
TDG	only	 acts	on	dsDNA,	 in	 contrast	 to	UNG	 that	processes	 also	 ssDNA	 substrates.	 The	enzymatic	
activities	of	UNG	and	TDG	can	be	readily	separated	by	the	use	of	UGI,	an	inhibitory	peptide	specific	
for	 UNG	 [78].	 Despite	 their	 overlapping	 substrate	 specificities,	 TDG	 was	 assigned	 into	 a	 new	
subfamily	of	UDGs,	the	MUGs.	
Unlike	UNG,	MUGs	have	 spacious,	 rather	non-discriminating	active	 site	pocket,	 allowing	a	broader	
range	 of	 substrates.	 TDG	 is	 able	 to	 excise	 a	wide	 variety	 of	modified	 and	 damaged	 bases	 (Fig.	 6),	




stabilizes	 the	 G	 in	 the	 opposite	 strand	 [82-84].	 An	 asparagine	 (Asn	 140	 in	 humans)	 acts	 as	 the	









Figure 6: TDG substrate spectrum. 
	




degraded	 during	 S-phase	 through	 a	 conserved	 PCNA-interacting	 peptide	 (PIP)-degron	 [89],	 first	
described	 in	 chromatin	 licensing	 and	 DNA	 replication	 factor	 1	 (CDT1).	 CDT1	 and	 other	 degron-
containing	proteins	are	marked	for	degradation	by	the	E3	ubiquitin	 ligase	CRL4Cdt2	upon	interaction	
with	PCNA.	This	depicts	an	efficient	way	to	couple	DNA	synthesis	and	proteolysis,	thereby	preventing	
re-replication	 [90,	 91]	or	 in	 the	 case	of	 TDG,	 erroneous	 repair	 of	G/T	mismatches	 arising	 from	Gs,	
incorporated	opposite	Ts.	
Aside	from	its	important	role	in	DNA	repair,	TDG	has	been	repeatedly	linked	to	gene	regulation	and	
DNA	demethylation	 [92,	 93],	 especially	 since	 the	discovery	of	 the	TET	proteins	 and	 their	oxidation	
activity	towards	5mC.	TDG	displayed	glycosylase	activity	towards	the	TET	products	5fC	and	5caC	[27,	
94-97].	 Interestingly,	 TDG	 is	 the	 only	 glycosylase	 with	 a	 lethal	 phenotype	 in	 KO	 mice	 that	 is	
dependent	on	its	catalytic	activity,	but	not	linked	to	canonical	base	damage.	This	affirms	an	essential	







MBD4	was	discovered	 in	a	database	 search	 for	proteins	with	a	methyl-CpG-binding	domain	 (MBD)	
resembling	MeCP1	 (=MBD1)	and	2,	 together	with	MBD2	and	3	 [99].	All	 of	 the	mentioned	proteins	













































































preferably	 double-stranded,	 symmetrically	 methylated	 DNA.	 Reduced	 binding	 of	 MBD4	 to	
hemimethylated	 oligonucleotides	 was	 observed.	 The	 binding	 of	 MBD3	 to	 methylated	
oligonucleotides	was	shown	to	be	unspecific.	MBD3	was	found	to	lack	a	functional	MBD,	but	it	is	an	





addition	 to	 the	 N-terminal	 MBD.	 This	 C-terminal	 domain	 was	 described	 to	 be	 homologous	 to	
bacterial	 DNA	 repair	 enzymes,	 linking	 DNA	 repair	 and	 methylation	 [99].	 Subsequently	 MBD4	 was	
shown	to	efficiently	excise	thymine	and	uracil	from	mismatches,	similar	to	TDG.	Despite	the	similar	
substrate	specificities,	TDG	and	MBD4	show	no	amino-acid	sequence	homology,	 indicating	that	the	
proteins	 evolved	 from	 two	 different	 ancestors.	 MBD4	 shows	 preference	 for	 the	 binding	 of	








MMR	 is	 a	 highly-conserved	 bidirectional	 process	 that	 repairs	 nucleotide	 incorporation	 errors	 and	
insertion-deletion	 loops	(IDLs)	occurring	during	DNA	replication.	MMR	improves	the	fidelity	of	DNA	
replication	 by	 several	 orders	 of	 magnitude	 [106].	 Cells	 deficient	 in	 MMR	 display	 greatly	 elevated	
mutation	rates	and	microsatellite	repeat	instability,	a	hallmark	of	MMR	deficient	cancers	(reviewed	




only	 transiently	 in	 the	 DNA.	 In	 case	 the	 mismatches	 are	 not	 repaired	 before	 the	 next	 round	 of	
replication,	half	of	the	newly-synthesized	strands	will	acquire	a	mutation	that	is	no	longer	recognized	
as	a	lesion.	It	is	therefore	of	great	importance	that	MMR	acts	fast	and	that	it	is	directed	to	the	newly-
synthesized	 strand	 to	 avoid	 mutagenesis.	 Apart	 from	 correcting	 nucleotide	 incorporation	 errors,	
MMR	 also	 has	 an	 important	 role	 in	 the	 protection	 against	 oxidative	 stress	 [110]	 and	
chemotherapeutics	 [111].	 Moreover,	 it	 prevents	 aberrant	 recombination	 between	 non-identical	
sequences	during	meiotic	recombination	and	in	double-strand	break	repair	(DSBR),	as	indicated	by	a	










Eukaryotic	 replicative	polymerases	display	an	error	 rate	of	about	10-4-10-5.	The	 fidelity	 is	enhanced	
about	 100-fold	 by	 the	 3'-exonuclease	 proofreading	 activity	 of	 the	 polymerases.	 MMR	 further	
increases	 replication	 fidelity	 by	 additional	 two	 to	 three	 orders	 of	 magnitude	 [106],	 resulting	 in	 a	
highly	 accurate	 process.	 IDLs,	 however,	 generated	 preferentially	 at	 repetitive	 microsatellite	
sequences,	 rely	 entirely	 on	MMR,	 as	 they	 are	 not	 recognized	 by	 the	 proofreading	 activity	 of	 the	
polymerases.	This	translates	 into	high	microsatellite	 instability	 in	the	absence	of	MMR,	the	primary	
phenotype	of	MMR-deficient	cells	[119,	120].	
MMR	 proteins	 are	 highly-conserved	 from	 bacteria	 to	 humans.	 They	 were	 first	 detected	 in	 E.	 coli	
[121],	 where	 the	 mechanism	 shows	 clear	 parallels	 to	 eukaryotic	 MMR,	 but	 also	 important	
differences.	The	first	human	MMR	protein	to	be	purified	was	MutSa.	 It	was	found	in	an	attempt	to	




MutSß,	 consisting	 of	 MSH3	 and	 MSH2,	 recognizes	 larger	 IDLs.	 Upon	 mismatch	 binding,	 MutSa	
changes	 its	 conformation	 into	 a	 sliding-clamp,	 dependent	 on	 Mg2+-	 and	 ATP	 [125].	 MutSa	 then	
recruits	MutLa,	a	heterodimer	of	MLH1	and	PMS2	with	endonucleolytic	activity.	This	complex	then	
moves	along	the	DNA	in	search	of	a	strand-discrimination	signal.	This	step	is	essential	for	successful	
MMR	 and	 has	 long	 posed	 an	 enigma,	 as	 eukaryotes	 lack	 a	MutH	 homologue,	 responsible	 for	 the	
strand	 discrimination	 in	 bacteria.	 To	 date,	 the	 signals	 directing	 MMR	 to	 the	 nascent	 strand	 are	
believed	to	be	the	5'	and	3'	termini	of	Okazaki	fragments	and	the	3'	end	of	the	leading	strand	[126-
128].	 There	 is	 recent	 evidence	 that	 nicks	 resulting	 from	 processed	 ribonucleotides,	 uracils	 and	
oxidized	 bases	 in	 the	 DNA	 act	 as	 supportive	 strand-discrimination	 signals	 [118,	 129,	 130].	 These	
additional	signals	carry	a	 threat	however,	as	 they	may	direct	MMR	to	the	wrong	strand	 if	 they	are	
generated	 in	 the	 DNA	 rather	 than	 being	 mis-incorporated	 during	 replication.	 One	 well-studied	
example	 is	 6-O-methylguanine	 that	 arises	 from	 methylation	 of	 the	 DNA.	 Upon	 encounter	 with	
replication	before	being	 repaired	by	MGMT,	 this	 lesion	either	pairs	with	cytosine	or	 thymine.	Both	




and	 MutSa	 [135],	 further	 incising	 the	 nick-containing	 strand	 [136].	 As	 a	 last	 step,	 exonuclease	 1	










MMR	 acting	 outside	 of	 S-phase	 are,	 similar	 to	 BER,	 damaged	 or	 modified	 bases	 that	 cause	
mismatched	 structures.	 However,	 non-canonical	 MMR	 does	 not	 specifically	 excise	 the	 damaged	
base,	 but	 excises	 a	 long	 stretch	 of	 DNA	 on	 the	 strand	 it	 has	 been	 directed	 to	 by	 a	 nick	 in	 close	
proximity.	 It	 is	 therefore	 difficult	 to	 imagine	 a	 scenario	 where	 MMR	 outside	 of	 S-phase	 would	
efficiently	prevent	mutations.	Due	to	the	fact	that	high-fidelity	replicative	polymerases	able	to	fill	the	
gap	are	scarce	and	dNTP	pools	suboptimal,	 it	 is	 in	fact	much	more	 likely	that	MMR	is	mutagenic	 in	
this	context.		
Genetic	 studies	 implicated	 MMR,	 as	 well	 as	 monoubiquitylated	 PCNA	 (Ub-PCNA)	 and	 DNA	
polymerase	eta	 (pol	η),	 in	 the	mutagenic	processes	somatic	hypermutation	 (SHM)	and	class-switch	
recombination	 (CSR)	 during	 antibody	 diversification	 [137-143].	 This	 non-canonical	MMR,	 linked	 to	
PCNA	 monoubiquitylation	 was	 shown	 to	 be	 activated	 upon	 encounter	 with	 uracils	 or	 alkylation	
damage	 in	 B-cell	 extracts	 as	 well	 as	 in	 human	 embryonic	 kidney	 cells	 [117].	 Ub-PCNA	 led	 to	 the	
recruitment	of	pol	η,	as	shown	in	human	cells	[144].	
SHM	 and	 CSR	 are	 both	 initiated	 by	 activation-induced	 cytidine	 deaminase	 (AID),	 which	 converts	
cytidines	 in	 immunoglobulin	 loci	 to	 uracils	 [145,	 146].	 Those	 uracil-guanine	 mismatches	 are	
substrates	for	BER	and	MMR	and	both	seem	to	play	a	role	in	antibody	diversification,	as	deficiencies	
of	either	process	lead	to	impaired	SHM	and	CSR	[147].	The	involvement	of	an	error-prone	translesion	
polymerase	 in	 combination	 with	 MMR	 acting	 randomly	 on	 both	 DNA	 strands	 represents	 a	 nice	
system	 for	 introduction	 of	 somatic	 mutations	 [148-150].	 Consistent	 with	 this	 it	 was	 found	 that	
mutations	at	A:T	sites	depend	on	MMR	[138]	and	on	pol	η	[151].	However,	the	interplay	of	BER	and	




Spontaneous	 base	 loss	 (primarily	 depurination)	 or	 incomplete	 BER	 can	 give	 rise	 to	 single-strand	




Detection	 of	 the	 lesion	 is	 carried	 out	 primarily	 by	 poly	 (ADP-ribose)	 polymerase-1	 (PARP1).	 Upon	
binding	to	DNA,	PARP1	activity	is	stimulated	and	catalyzes	the	generation	of	poly	(ADP)	ribose	chains	
on	 itself	and	other	acceptor	proteins	 in	close	proximity.	This	 first	 recognition	and	activation	step	 is	
fast	 and	 PARP1	 is	 recycled	 to	 its	 de-ribosylated	 state	 by	 poly	 (ADP-ribose)	 glycohydrolase	 (PARG)	
[154,	 155].	 The	 PARylation	 of	 accessory	 proteins	 then	 aids	 in	 recruiting	 further	 factors,	 like	 the	






can	 be	 repaired	 by	 polynucleotide	 kinase/phosphatase	 (PNKP)	 and	 APE1,	 whereas	 termini	 arising	
from	 incomplete	 BER	 typically	 need	 the	 lyase	 activity	 of	 polymerase	 b	 and	 flap	 endonuclease-1	
(FEN1)	in	case	of	a	modified	5'-end	that	the	polymerase	cannot	remove	[156].	Another	type	of	lesion	













major	 pathways	 to	 deal	 with	 these	 dangerous	 lesions;	 homologous	 recombination	 (HR)	 and	 non-
homologous	end-joining	(NHEJ).	 In	the	absence	of	 factors	needed	for	the	canonical	pathways	NHEJ	
and	HR,	 cells	 can	 choose	 alternative	 repair	mechanisms.	 Single-strand	annealing	 (SSA)	depends	on	
RAD52	and	involves	annealing	at	 long	homologies,	resulting	in	extensive	deletions.	Alternative	end-







Figure 7 DNA double strand break repair pathways. Depending on the nature of the break and the 
cell cycle phase, the cells repairs DNA DSBs via canonical NHEJ (A), or it resects the DNA at the 
breaks, channeling the repair into HR (B), SSA (C) or Alt-EJ (D). From [160]. 
	
Homologous	recombination		




template.	This	ensures	a	 faithful	and	error-free	correction	of	 the	 lesion,	but	 it	also	 largely	 restricts	









for	the	Ku	proteins,	 the	 initiating	enzymes	 in	NHEJ.	Cells	are	therefore	restricted	to	continue	along	
the	HR-	or	other	homology-mediated	repair	pathways,	such	as	SSA	or	Alt-EJ	[166].	
The	 3'	 single-stranded	 tail	 is	 first	 coated	 by	 replication	 protein	A	 (RPA),	which	 has	 been	 shown	 to	
have	 a	 positive	 as	well	 as	 an	 inhibitory	 effect	 on	HR.	 It	 helps	 to	 stabilize	 ssDNA	 generated	 during	
resection	[167],	but	then	suppresses	the	ATPase	and	recombinase	activities	of	RAD51	if	not	removed	
[168,	169].	Therefore,	RPA	is	replaced	by	RAD51	with	the	help	of	Breast	Cancer	type	2	susceptibility	








by	 disengagement	 of	 the	 two	 strands.	 This	 process,	 called	 synthesis-dependent	 strand	 annealing	





double-helix	 by	 directly	 re-joining	 the	 two	 ends.	 Due	 to	 its	 applicability	 throughout	 the	 cell	 cycle,	
NHEJ	is	the	more	common	pathway	of	choice	in	higher	eukaryotes,	even	though	it	is	error-prone	and	
can	result	 in	genomic	translocations.	 In	 fact,	most	of	 the	genomic	rearrangements	occurring	 in	our	
genome	and	eventually	causing	cancer	are	induced	by	NHEJ	[176].	Apart	from	fixing	pathogenic	DSBs,	
NHEJ	 is	 important	 for	 the	 processing	 of	 physiologically-induced	 DSB,	 for	 example	 during	 antibody	
diversification	[177].	Patients	lacking	NHEJ	do	not	only	show	sensitivity	to	ionizing	radiation,	but	they	
also	 suffer	 from	 a	 human	 severe	 combined	 immunodeficiency	 (SCID)	 [178,	 179].	 SCID	 is	 an	
autosomal-recessive	disease,	characterized	by	absence	of	circulating	T	and	B	lymphocytes,	indicating	
a	defect	in	V(D)J	recombination	[178,	179].	About	15%	of	SCID	cases	originate	from	defects	in	NHEJ,	




bind	 to	 free,	 unresected	DNA	 ends,	marked	 by	 γ-H2AX	 [182].	 The	 ends	 are	 thusly	 protected	 from	
degradation	and	the	Ku	proteins	act	as	a	recruiting	platform	for	Artemis	and	DNA-dependent	protein	
kinase	catalytic	subunit	(DNA-PKcs)	[183].	Artemis	has	a	nuclease	activity	and	its	recruitment	leads	to	
resection	 of	 the	 different	 DNA	 end	 configurations.	 The	 DNA-PKcs-Artemis	 complex	 has	 5'	 -and	 3-	
endonuclease,	 as	 well	 as	 hairpin	 opening	 and	 5'	 exonuclease	 activity	 [181,	 184].	 The	 short-range	
resection	of	 the	ends	 is	 followed	by	binding	of	DNA	polymerases	µ	or	l	 that	 repair	 the	ends.	 The	
polymerases	 may	 generate	 small	 deletions	 and	 insertions,	 introducing	 further	 inaccuracy.	
Subsequently,	 the	 XLF/XRCC4/DNA	 ligase	 IV	 complex	 is	 recruited,	 which	 is	 able	 to	 ligate	 also	












Ku-independent	 NHEJ	 or	 DNA-PKcs-independent	 NHEJ	 [184].	 It	 is	 also	 frequently	 called	
microhomology-mediated	 end	 joining	 (MMEJ),	 as	 short	 homologous	 sequences	 are	 used	 to	 tether	
the	ends	together	in	most	of	these	sub-pathways.	It	is	discriminated	from	SSA,	which	involves	longer	







For	 ligation,	 the	 MMEJ	 mechanism	 seems	 to	 rely	 more	 on	 DNA	 ligase	 I	 or	 the	 XRCC1/ligase	 III	
complex,	 in	contrast	to	XRCC4/ligase	 IV	acting	 in	NHEJ	[192].	Altered	patterns	of	CSR	bearing	more	
microhomologies	were	observed	 in	human	patients	with	DNA	 ligase	 IV	mutations	 [193].	A	 role	 for	





Our	 immune	 system	 is	 steadily	 challenged	 by	 a	 variety	 of	 constantly-evolving	 pathogens.	 The	 vast	
majority	of	 intruders	is	detained	by	the	innate	immune	system.	This	system	is	however	not	specific	
and	cannot	ensure	long-lasting	protective	immunity	to	the	host,	like	the	adaptive	immune	response	
does.	 The	 production	 of	 newly-recombined	 immunoglobulins	 (Igs)	 is	 therefore	 necessary	 for	 an	
efficient	host	defense.		
The	 main	 players	 in	 the	 adaptive	 immune	 system	 are	 T-	 and	 B-lymphocytes	 that	 recognize	 the	
infecting	 pathogens	 in	 a	 highly	 specific	 manner.	 They	 accomplish	 their	 task	 with	 the	 help	 of	
membrane	 receptors	 in	 the	 case	 of	 T-cells	 (cellular	 response)	 or	 with	 soluble	 antibodies	 called	
immunoglobulins	 (Igs)	 in	 the	case	of	B-cells	 (humoral	 response).	This	work	 is	 focused	on	B-cells,	as	
they	are	the	only	cells	making	use	of	SHM	and	CSR	to	increase	the	diversity	of	their	antibodies.	
Each	immunoglobulin	produced	by	B-cells	comprises	two	light	and	two	heavy	chains,	all	four	of	which	
have	a	variable	and	a	constant	 region	 (Fig.	8).	The	variable	 regions,	 containing	 the	antigen-binding	
sites,	 are	 generated	 by	 recombination	 of	 the	 variable	 (V)-,	 diversity	 (D)-	 and	 the	 joining	 (J)-region	
(V(D)J	recombination)	in	progenitor	lymphocytes	of	the	bone	marrow.	The	two	types	of	light	chains	
(λ	 and	κ)	harbor	 several	different	 variable	 regions	 in	 their	 genomic	 locus,	 4,	 respectively	5,	 joining	
regions	 and	 no	 diversity	 regions,	whereas	 the	 heavy	 chains	 are	 assembled	 from	 a	 choice	 of	many	
variable	regions,	6	joining	regions	and	25	diversity	regions.	In	the	case	of	the	heavy	chain,	a	DH	region	
is	 first	 joined	 to	 a	 JH,	 before	 a	 VH	 is	 juxtaposed	 to	 a	 DHJH	 segment.	 The	 recombination	 events	 are	
initiated	by	 the	recombination	activating	genes	1	and	2	 (RAG1	and	RAG2),	expressed	exclusively	 in	










Figure 8: Structure of an antibody with two light and two 
heavy chains, each comprising a variable and a constant 
region. From [201]. 
	
The	choices	of	V,	D	and	 J	 segments	and	combinations	of	different	 light	and	heavy	chains,	 together	
with	small	 insertions	and	deletions	occurring	during	the	NHEJ-mediated	repair	of	 the	DSBs,	creates	
the	first	 layer	of	diversity.	The	antibodies	expressed	at	this	stage	do	not	yet	have	very	high	affinity	
towards	 antigens,	 but	 it	 is	 high	 enough	 for	 the	 immune	 system	 to	 flexibly	 interact	 with	 many	
different	antigens.	To	neutralize	 the	antigens,	however,	 very	high	affinity	 interactions	are	 required	
[202].	This	 is	achieved	by	SHM	and	CSR,	processes	 that	 follow	V(D)J	 recombination	 in	B-cells,	once	
they	leave	the	bone	marrow	and	migrate	to	peripheral	lymphoid	organs,	where	they	form	germinal	










the	 type	 of	 antibody	 the	 cell	 switches	 to.	 Like	 V(D)J	 recombination,	 CSR	 involves	 the	 deliberate	
formation	of	DSBs.	The	mechanism	 in	CSR	 is	 less	precise,	but	accordingly	more	 flexible.	 It	 involves	







Figure 9 Mechanisms of immunoglobulin diversification schematically represented on the mouse IgH 
locus. One segment of each variable (V), diversity (D) and joining (J) are combined in a process called 
V(D)J recombination. Subsequently, upon activation of the B-cell, AID initiates somatic 
hypermutation of the newly recombined variable region and class switch recombination of the heavy 
chain constant region. From [206]. 
	Activation-induced	Cytidine	Deaminase	
AID	plays	an	essential	 role	 in	adaptive	 immunity	by	 initiating	both	SHM	and	CSR.	 It	 is	a	member	of	
the	 AID/APOBEC	 family	 of	 Zn-dependent	 cytosine	 deaminase-related	 enzymes,	most	 of	 which	 are	




target	 sequences	 by	 transcription,	 which	 generates	 transient	 ssDNA	 in	 the	 so-called	 transcription	








Interestingly,	 mutational	 studies	 functionally	 uncoupled	 the	 roles	 of	 AID	 in	 SHM	 and	 CSR.	 It	 was	
shown	that	while	the	catalytic	function	is	essential	for	both	processes,	the	C-terminus	is	additionally	
required	 for	 CSR	 [218,	 219],	 whereas	 the	 N-terminus	 is	 necessary	 for	 SHM	 [220].	 These	 findings	








Figure 10: AID functional domains showing the naturally occurring mutations in the AID gene that 
are responsible for the autosomal recessive disorder HIGM. These mutations, depending on the 
domain they affect, cause defects in CSR and/or SHM. From [221]. 
 
Loss	of	 function	mutations	 in	AID	abrogate	SHM	and	CSR,	 leading	to	the	HIGM	syndrome	[66,	146,	





formed	 as	 CSR	 intermediates.	 Translocations	 involving	 the	 Ig	 locus,	 such	 as	 the	well	 characterized	
IgH-cMyc	 translocation,	were	 found	 	 to	be	a	hallmark	of	Burkitt's	 lymphoma	[223].	But	also	non-Ig	
genes	can	be	targets	of	aberrant	AID	activity	[224].	Elevated	levels	of	AID	were	linked	to	autoimmune	
diseases,	 for	 example	 [225].	 Interestingly,	 ubiquitous	 transgenic	 overexpression	 of	 AID	 has	 more	
severe	 effects	 on	 T-cells	 and	 other	 tissues	 than	 on	 B-cells,	 suggesting	 that	 B-cells	 have	 evolved	
protective	mechanisms	[226].		
The	sensitive	balance	of	AID	 levels	 in	B-cells	has	 likely	evolved	as	a	 trade-off	between	an	effective	
and	 highly	 adaptive	 immune	 response	 and	 the	 risk	 of	 cancer	 or	 autoimmune	 diseases	 [202].	 The	




transported	 into	 the	nucleus	 [228-230],	AID	 is	 constantly	 targeted	 to	 the	proteasome.	 In	 addition,	
AID	 is	 regulated	 through	phosphorylation	on	 five	 residues	 that	 affects	 its	 localization	 and	 catalytic	
activity	[231-234].	
AID	is	a	B-cell	specific	enzyme	and	therefore	only	B-cells	and	not	T-cells	are	able	to	undergo	SHM	and	
CSR.	 Nevertheless,	 low	 levels	 of	 AID	 have	 been	 reported	 in	 the	 ovary,	 heart,	 prostate,	 lung	 and	
primordial	germ	cells,	where	the	function	of	AID	remains	unclear	[202].		
Apart	from	converting	cytosine	to	uracil,	AID	is	also	able	to	deaminate	5-methylcytosine	to	thymine,	























AID	 [49,	 239].	 This	 contributes	 to	 an	 accumulation	 of	 uracils	 in	 the	 S	 regions,	 whose	 processing	
results	in	DSBs.	The	DNA	fragment	between	two	breaks	is	spliced	out	as	an	extrachromosomal	circle	
(Fig.	11).	The	exposed	CH	terminus	is	then	joined	to	the	VDJ	region,	preferentially	by	NHEJ,	but	if	need	
be	 also	 by	 the	 poorly-characterized	 alternative-NHEJ	 pathway	 that	 depends	 on	 microhomologies	
[240-242].	
After	successful	class	switching,	the	mono-	or	dimeric	IgE,	IgG	and	IgA	are	distributed	systemically	to	
tissues,	 where	 they	mediate	 different	 biological	 effector	 functions	 [243].	 The	 effectiveness	 of	 the	






Figure 11: CSR from IgM- to IgA-expression. A promoter upstream of the VDJ region initiates 
transcription of the IgH locus yielding IgM (or IgD if alternativley spliced) antibodies before CSR 
had occurred. To enable CSR in activated B-cells, two DSBs have to be introduced with the help of 
AID; one in the very first S region (Cµ) and one in the specific S region the cell switches to (here Cα). 
The DNA in between is spliced out as a circular DNA fragment and the new immunoglobulin isotype 
can be transcribed. From [49]. 
 
The	factors	and	pathways	involved	in	CSR	are	well	defined,	being	AID	[66],	BER	with	UNG	[64,	244],	
MMR	 with	 MutSα	 [137,	 139,	 140,	 142],	 and	 to	 a	 lower	 extent	 MutLα	 [245],	 and	 NHEJ	 factors,	
although	 the	 latter	 are	not	 essential	 [4,	 246].	 Still,	 the	exact	mechanism	of	DSB	 induction	and	 the	
specificity	 towards	 S	 regions	 in	 B-cells	 remain	 enigmatic.	 The	 current	model	 postulates	 that	MMR	
helps	 create	DSBs	when	 the	uracils	 are	 less	dense,	by	EXO1-mediated	degradation	of	DNA	 regions	






addition	 to,	 around)	 to	 the	 base	 sequence	 and	 chromatin	 structure,	 leading	 to	 transient	 or	 stable	
changes	in	gene	expression.		
In	addition	to	the	direct	modification	of	DNA	with	covalently-attached	methyl	groups	on	cytosines	(or	
adenines),	 also	 the	 building	 blocks	 of	 nucleosomes,	 the	 histones,	 can	 become	 altered	 by	 a	 large	
variety	 of	 post-translational	 modifications	 (PTMs).	 DNA-	 and	 histone	 modifications	 affect	 the	






evidence	 points	 towards	 a	 complex	 interplay	 that	 depends	 on	 the	 stimulus	 and	 the	 type	 and	
developmental	stage	of	the	cell.	
In	 eukaryotes,	 genomes	 are	 packaged	 into	 two	 main	 types	 of	 chromatin:	 the	 relaxed	 or	 "open"	
euchromatin	 and	 the	 densely-packed	 heterochromatin.	 The	 differences	 are	 established	 by	 a	
combination	of	DNA	methylation	and	the	type	and	modifications	of	the	associated	proteins.	Actively-
transcribed	 genes	 are	 generally	 located	 in	 euchromatic	 regions,	 whereas	 other	 genomic	 regions,	
containing	mostly	 inactive	 genes,	 are	 packed	 into	 heterochromatin.	 The	 latter	 can	 be	 divided	 into	
two	different	 types:	 facultative	 and	 constitutive.	An	example	of	 facultative	heterochromatin	 is	 the	
inactive	X-chromosome,	marked	extensively	with	histone	H3	trimethylated	on	lysine	27	(H3K27me3)	
and	 the	 Polycomb	 Repressor	 Complex	 (PRC),	 responsible	 for	 transcriptional	 silencing	 during	
development	 [248].	 Constitutive	 heterochromatin	 contains	 permanently-silenced	 genes.	 Examples	
are	chromatin	of	 the	centromeres	or	 telomeres	 that	are	characterized	by	high	abundance	of	H3K9	
trimethylation	 and	 binding	 of	 heterochromatin	 protein	 1	 (HP1)	 that	 recruit	 other	 chromatin	
remodeling	proteins	and	DNA	methyltransferases,	leading	to	DNA	compaction	[249].	









and	 arginines	 on	 the	 histone	 N-terminal	 tails.	 Acetylation	 of	 lysines	 has	 a	 positive	 effect	 on	 RNA	
synthesis	 [255]	 by	 largely	 neutralizing	 the	 positive	 charge	 of	 the	 histone,	 thereby	 weakening	 the	
interaction	 with	 the	 negatively-charged	 DNA.	 The	 resulting	 less-tightly	 packed	 chromatin	 is	 more	
accessible	 to	 the	 transcription	 machinery.	 Histone	 acetylation	 is	 regulated	 by	 histone	
acetyltransferases	(HATs)	and	deacetylases	(HDACs).	Acetylated	lysines	are	bound	by	bromodomains,	
often	found	in	chromatin-remodeling	complexes	that	function	to	open	the	chromatin	structure	[256].		





associated	 factors	 can	 bind	 methylated	 lysines,	 among	 others	 zinc	 finger	 plant	 homeodomains	










1	 (CHD1),	 an	 ATP-dependent	 remodeling	 enzyme	 capable	 of	 repositioning	 nucleosomes	 [261].	 In	
addition,	 H3K4me3	 prevents	 binding	 of	 the	 nucleosome	 remodeling	 and	 deacetylase	 (NuRD)	








of	heterochromatin	 [265,	266].	HP1	has	also	been	 shown	 to	 recruit	 the	DNA	methyltransferase	3B	
(DNMT3B),	thereby	linking	histone	and	DNA	methylation	[267].	DNA	methylation	in	contrast	can	also	
inhibit	 protein	 binding	 to	 specific	 histone	 modifications.	 An	 example	 is	 lysine	 demethylase	 2A	
(KDM2A)	 that	 is	 only	 able	 to	 bind	 nucleosomes	 bearing	H3K9me3	when	 the	DNA	 is	 unmethylated	
[268].	
The	 two	 methylation	 systems	 interact	 to	 form	 stable	 heterochromatic	 subdomains	 and	 thereby	
protect	genome	integrity.	
To	 make	 the	 story	 even	 more	 complex,	 histones	 can	 also	 be	 ADP	 ribosylated,	 phosphorylated,	
ubiquitylated,	 or	 SUMOylated,	 enabling	 the	 recruitment	 of	 a	 large	 variety	 of	 modulating	 proteins	
(reviewed	in	[269,	270]).	
	DNA	methylation	
The	 modification	 of	 adenines	 and	 cytosines	 with	 a	 covalently-attached	 methyl	 group	 can	 alter	
protein/DNA	 interactions.	 In	 bacteria,	 this	 forms	 the	 basis	 of	 restriction/modification	 systems;	 a	
primitive	 immune	system	 in	which	 invading	DNA	molecules	 (e.g.	phage	genomes)	are	degraded	by	
nucleases	that	cleave	unmethylated	DNA.	
This	 phenomenon	 was	 first	 reported	 by	 Werner	 Arber	 in	 the	 early	 1960s.	 He	 hypothesized	 that	
enzymes	 in	bacteria	 cut	 foreign	DNA	 into	pieces	at	defined	 sequences	and	 that	 this	 is	 impeded	by	
methylases	 of	 the	 host	 [271-277].	 Confirmation	 of	 this	 process	 came	 from	 Hamilton	 Smith,	 who	
discovered	 the	 endonuclease	 HindII	 in	 1969.	 He	 showed	 that	 cleavage	 depended	 on	 a	 specific	




enzymes	 to	 create	 a	 map	 of	 simian	 virus	 40	 (SV40),	 by	 cutting	 it	 into	 defined	 pieces,	 applying	





overexpressing	 the	 Dam	 methylase	 responsible	 for	 post-replicative	 methylation	 of	 GATC	 motifs	
exhibit	a	hypermutator	phenotype	[288,	290-293],	similar	to	MMR	mutants	[294,	295].	
DNA	methylase	activity	 is	 also	present	 in	mammals	 [296,	297],	where	 it	 serves	different	purposes.	
While	the	main	modified	bases	in	bacteria	are	both,	6-methyladenine	and	5-methylcytosine,	only	the	
latter	plays	a	role	in	higher	eukaryotes.	In	plants	and	vertebrates,	DNA	methylation	of	cytosines	plays	




Nearest-neighbor	 sequencing	 studies	 revealed	 many	 years	 ago	 that	 the	 frequency	 of	 CpG	
dinucleotides	in	DNA	is	much	lower	than	expected	from	random	distribution	[302].	This	phenomenon	
was	 suggested	 to	 be	 linked	 to	DNA	methylation,	 as	 there	was	 a	 correlation	between	deficiency	 in	
CpGs	and	high	methylation	 levels	 in	different	 species.	An	explanation	came	 from	studies	 in	E.	 coli,	
where	 sites	 of	 cytosine	 methylation	 were	 shown	 to	 be	 hotspots	 of	 C	 to	 T	 transition	 mutations,	
believed	to	be	associated	with	spontaneous	deaminations	of	5mC	to	T	that	are	not	repaired	[303].	To	






phenomenon	 be	 just	 a	 way	 to	 increase	 mutation	 rate	 beneficial	 for	 evolution?	 Or	 is	 there	 an	
important	function	of	5mC,	outweighing	the	disadvantage	of	high	mutability?		
In	an	attempt	to	identify	repair	pathways	acting	on	5mC	deamination	that	results	in	G:T	mismatches,	














CpGs.	 In	 vitro	 methylation	 caused	 the	 silencing	 of	 the	 genes,	 directly	 linking	methylation	 to	 gene	
expression	 [310].	 Similar	 findings	 were	 obtained	 from	 a	 study	 on	 human	 gamma-globin	 gene	
expression	[311].	Further	evidence	for	the	inhibitory	effect	of	methylation	at	CpG-islands	came	from	
studies	 of	 the	 hypoxanthine	 phosphoribosyltransferase	 (HPRT)	 gene	 on	 the	 X	 chromosome.	 It	was	
found	to	be	inactive	when	methylated	and	could	be	induced	with	5-azacytidine,	a	cytosine	analogue	
whose	incorporation	into	DNA	leads	to	demethylation	[312-314]. 
In	 the	 following	 years,	 more	 examples	 of	 primarily	 housekeeping	 genes	 with	 unmethylated	 CpG	
islands	 in	 the	 5'	 region	were	 found	 [315,	 316].	 The	 generally	 unmethylated	 state	 of	 these	 regions	
explains	the	accumulation	of	CpGs,	as	unmethylated	cytosines	are	more	resistant	to	deamination	and	
if	still	deaminated,	extremely	efficiently	repaired	by	BER,	which	prevents	their	loss	from	DNA.	
Studies	on	 the	X	chromosome	[317]	and	on	 imprinted	genes	 [318,	319]	showed	however	 that	CpG	
islands	 are	 not	 inherently	 resistant	 to	 methylation.	 Moreover,	 many	 cancers	 exhibit	 CpG	
hypermethylation	 of	 tumor	 suppressor	 genes	 [320,	 321].	 One	 prominent	 example	 is	 aberrant	
methylation	 of	 the	 MLH1	 promoter,	 leading	 to	 inactivation	 of	 the	 gene	 and	 tumorigenesis	 in	
endometrium	and	colon	[322-325].	It	is	therefore	of	interest	to	investigate	the	mechanism	by	which	
CpG	 islands	 are	 selectively	 kept	 free	 of	methylation.	 Several	 hypotheses	 are	 under	 consideration.	
There	 is	 evidence	 that	 the	 de	 novo	 methylation	 capacity	 of	 adult	 tissues	 is	 very	 weak	 [326].	 This	
would	 guarantee	 the	 maintenance	 of	 unmethylated	 sites	 after	 methylation	 patterns	 have	 been	
established	 during	 development.	 Another	 idea	 is	 that	methylation	 is	 a	 secondary	 consequence	 of	
gene	inactivity.	As	long	as	a	gene	is	active,	its	CpG	island	might	be	bound	by	transcription	factors	or	
other	 accessory	 proteins,	 preventing	 access	 for	 methylases.	 There	 is	 accumulating	 evidence	 for	
proteins	 binding	 unmethylated	 CpG	 islands,	 therefore	 protecting	 them	 from	methylation	 or	 even	
constantly	 demethylating	 them.	 Accordingly,	 the	 TET1	 protein	 has	 been	 shown	 to	 localise	 to	 CpG	
islands	via	its	CXXC	domain	[327,	328]	and	depletion	of	TET1	resulted	in	increased	CpG	methylation	
[329].	In	addition,	experiments	in	TDG	knockout	mice	suggested	that	the	glycosylase	may	play	a	role	
in	 protecting	 CpG	 islands	 from	de	 novo	methylation	 [39,	 98].	 These	 pathways	will	 be	 discussed	 in	
more	detail	later.	
The	study	of	CpG	islands	received	a	great	deal	of	attention,	but	also	single	CpGs	have	been	linked	to	






interactions	 leading	 to	 changes	 in	 chromatin	 structure	 as	 mentioned	 already	 in	 'histone	
modifications'.	Studies	using	DNaseI	and	micrococcal	nuclease	 (MNase)	 showed	that	unmethylated	




rendering	 the	 sequence	 DNase	 I-insensitive.	 These	 findings	 led	 to	 the	 conclusion	 that	 DNA	
methylation	modifies	 specific,	as	well	as	nonspecific	 interactions	between	DNA	and	proteins	 [333].	
Support	for	these	findings	came	from	studies	of	an	upstream	region	of	the	tyrosine	aminotransferase	
(TAT)	 gene,	 where	methylation	 prevented	 specific	 factor	 binding	 in	 cells	 that	 do	 not	 express	 TAT	
[334].	 Another	 example	 is	 the	 methylation	 of	 the	 cAMP-responsive	 element	 that	 was	 shown	 to	
suffice	 to	 abolish	 transcriptional	 activation	 by	 inhibiting	 transcription	 factor	 binding	 [335].	 In	 the	
following	 years,	 many	 transcription	 factors	 were	 found	 to	 be	 prevented	 from	 binding	 DNA	 when	
their	 recognition	site	was	methylated	[336-341].	Specific	 transcription	 factor	binding	often	 initiates	
the	 changes	 in	 chromatin	 leading	 to	 the	 establishment	 of	 a	 transcription-friendly	 environment.	




domain	 (MBD)	 protein	 discovered	was	MeCP1	 [342].	 It	was	 shown	 to	 bind	DNA	 stretches	with	 an	
accumulation	of	symmetrically-methylated	CpGs,	leading	to	inhibition	of	transcription	[343].	MeCP2,	
detected	shortly	thereafter,	displayed	similar	properties,	but	was	able	to	bind	a	single	5mCpG	pair	in	
vitro	 [344].	 In	 vivo	 it	 was	 shown	 to	 localize	 to	 centromeric	 heterochromatin	 in	 a	 methylation-
dependent	manner	[345].	It	has	an	important	role	in	embryonic	development,	but	was	dispensable	in	
embryonic	stem	cells	(ESCs)	[346].	MeCP2	binding	leads	to	repression	of	transcription	in	vitro	as	well	
as	 in	 vivo,	 displaying	 a	 direct	 correlation	 with	 the	 density	 of	 5mCpGs	 [347].	 Three	 additional	
members	of	 the	MBD	 family	were	 found	 in	a	database	 search	 for	proteins	with	an	MBD	similar	 to	





and	 cause	 Rett	 Syndrome,	 a	 neurological	 disorder,	 in	 females	 [352-354].	 Rett	 syndrome	 is	 not	 a	
neurodegenerative	disorder,	accordingly,	symptoms	have	been	successfully	reversed	in	mutant	mice	
by	re-expression	of	the	protein	[355].	
DNA	methylation	 acts	 through	 recruitment	 of	 a	 combination	 of	 unspecific	 and	 specific	 interacting	
proteins.	MBD	proteins	play	a	major	role	in	silencing	regions	with	a	high	density	of	methylated	CpGs,	
such	as	methylated	CpG	islands.	Cell	type-specific	genes,	however,	often	have	only	few	CpGs	in	their	
regulatory	 regions.	 In	 that	 case,	 specific	 transcription	 factor	binding	 seems	 to	be	 inhibited	by	DNA	
methylation.	These	events	often	occur	in	enhancers	instead	of	promoters,	complicating	the	analysis.	
	Chromatin	and	transcription	
The	 compaction	 of	 DNA	 into	 chromatin,	 guided	 by	 histone	 and	 DNA	 modifications	 as	 mentioned	












and	 therefore	 'open'	 chromatin,	 whereas	 only	 around	 half	 of	 tissue-specific	 genes	 display	 this	
feature.	 A	 ubiquitous	 TF	 that	 binds	 the	 consensus	 sequence	 GGGCGG	 (or	 CCGCCC),	 a	 sequence	
prominent	 in	 CpG	 islands,	 is	 Specificity	 Protein	 1	 (SP1).	 Most,	 but	 not	 all	 promoters	 additionally	
possess	a	TATA-box	~30	nt	upstream	of	the	TSS	that	is	bound	by	a	TATA-box	binding	(TBP)	protein.	
Transcription	factors	are	responsible	for	communicating	the	gene-specific	DNA	sequence	information	
to	 the	 transcription	 machinery.	 They	 consist	 of	 two	 main	 domains:	 a	 DNA	 binding	 domain	 that	
"reads"	 the	 binding	 site	 sequence,	 and	 a	 transactivation	 domain.	 The	 DNA	 binding	 domain	 can	




ion	 to	 stabilize	 their	 structure	 [356].	 Leucine	 zippers	 constitute	 a	 special	 case	 of	 DNA	 binding	
domains,	 as	 they	 mediate	 -	 in	 addition	 to	 DNA	 binding	 -	 also	 protein-protein	 interactions	 via	
extended	 contacts	 along	 their	 α-helices	 [357,	 358].	 A	 related	 DNA-binding	motif	 is	 the	 helix-loop-
helix	 (HLH)	 structure.	 It	 also	 mediates	 dimerization	 in	 addition	 to	 DNA	 binding.	 A	 HLH	 motif	 is	
composed	of	a	short	α-helix	connected	to	a	longer	one	via	a	flexible	loop	[359].		
The	 different	 TF	 motifs	 “read”	 specific	 nucleotide	 sequences,	 primarily	 through	 hydrophobic	
interactions	in	the	major	grove	of	DNA,	but	also	with	the	help	of	base-specific	interactions	defined	by	
combinations	 of	 hydrogen	 bond	 donor	 and	 acceptor	 sites.	 Some	 TF	 recognize	 their	 cognate	 DNA	
sequences	with	the	help	of	other	characteristics,	such	as	base-stacking	or	helical	twist.	Depending	on	
the	 flexibility	of	 the	DNA	stretch,	DNA	binding	proteins	can	cause	distortions	of	 the	helix,	enabling	
them	better	access.	Some	TFs	show	moreover	sensitivity	to	cytosine	methylation	in	their	recognition	
sites,	 as	 mentioned	 above,	 while	 other	 DNA	 binding	 factors,	 containing	 MDB	 domains,	 bind	
specifically	to	methylated	DNA	as	transcriptional	repressors	[360-363].	
The	 other	 domain	 defining	 a	 transcription	 factor	 can	 also	 assume	 different	 forms.	 Generally	
speaking,	 the	 activation	 domain	 mediates	 the	 effector	 function	 of	 the	 TF.	 This	 happens	 via	
interactions	with	other	proteins,	for	example	RNA	polymerase	II.	This	represents	the	most	direct	way	
of	activating	transcription.	Many	TF	also	act	via	chromatin	remodeling	interactors,	thereby	preparing	
the	 chromatin	 environment	 for	 gene	 expression.	 There	 are	 three	main	motifs	 characteristic	 of	 TF	
activation	domains:	acidic-,	 glutamine-rich-	and	proline-rich	motifs.	Acidic	activation	domains	were	
shown	 to	 assemble	 in	 an	 amphipathic	 helical	 structure,	 where	 one	 side	 contains	 the	 acidic,	
hydrophilic	 residues,	 whereas	 the	 other	 side	 is	 hydrophobic	 [364].	 Glutamine-rich	 domains	 have	
been	most	 extensively	 studied	 in	 SP1,	where	 they	mediate	 the	 interaction	with	 TBP,	 a	 subunit	 of	





Eukaryotes	 possess	 three	 different	 nuclear	 RNA	 polymerases	 that	 are	 responsible	 for	 the	
transcription	of	distinct	 classes	of	 genes	 [368].	 The	most	 extensively-studied	 is	RNA	polymerase	 II,	
which	transcribes	all	protein-coding	genes	into	messenger	RNAs	(mRNAs)	and	a	variety	of	non-coding	







of	protein-coding	genes	by	 the	eukaryotic	RNA	polymerase	 II.	 The	 first	 step	 is	 the	binding	of	TFIID	
(containing	TBP)	to	the	TATA-box.	TBP	was	shown	to	have	a	relatively	broad	sequence	specificity	and	
binds	also	to	promoters	lacking	a	TATA-box.	TBP	then	binds	TFIIB	and	together	they	recruit	TFIIF	and	
RNA	polymerase	 II.	 Then,	 TFIIE	 and	H,	 important	 for	 initiation	of	 transcription,	 can	bind.	 TFIIH	 is	 a	
multi-subunit	 protein	 with	 several	 enzymatic	 activities.	 It	 comprises	 helicases	 to	 open	 DNA	 for	
transcription	 and	 a	 kinase	 that	 phosphorylates	 the	 C-terminal	 domain	 (CTD)	 of	 the	 largest	 RNA	
polymerase	 subunit	 [370].	 	 The	 CTD	 has	 many	 essential	 functions	 in	 transcription,	 not	 only	 in	
initiation,	 but	 also	 in	 elongation,	 processing	 of	mRNAs	 and	 in	 termination.	 It	 consists	 of	 up	 to	 52	
copies	 of	 the	 heptad	 repeat	 Tyr-Ser-Pro-Thr-Ser-Pro-Ser.	 Phosphorylation	 of	 CTD	 by	 the	 kinase	
subunit	of	TFIIH	helps	to	release	the	polymerase	from	the	transcription	initiation	complex,	enabling	it	
to	start	elongating	the	RNA.	A	complex	interplay	of	different	kinases	and	phosphatases	modifies	the	
CTD	 while	 it	 travels	 along	 the	 gene,	 enabling	 efficient	 transcription,	 as	 well	 as	 orchestrating	 5'-
capping,	splicing	and	3'-polyadenylation	[371].	
This	 complex	general	mechanism	of	gene	expression	 is	 further	modulated	and	 fine-tuned	by	many	
additional	 factors,	especially	 in	 the	case	of	 tissue-specific	genes,	but	also	 in	ubiquitously	expressed	
housekeeping	genes.	
To	account	for	the	different	tissue-	and	developmental	stage-specific	expression	patterns	in	the	cells	
of	 higher	 eukaryotes,	 a	 wide	 array	 of	 additional	 TFs	 is	 needed.	 Gene-specific	 transcriptional	
regulation	 is	 generally	 governed	 by	 the	 binding	 of	 transcriptional	 activators	 or	 repressors	 to	
upstream	regulatory	sequences,	the	so-called	enhancers.	They	recruit	chromatin-modifying	enzymes,	
preparing	a	transcription-permissive	environment	for	the	general	TFs	and	the	RNA	polymerase	[372].	
Often,	 these	 tissue-specific	 transcription	 factors	 react	 to	 intra-	 or	 extracellular	 stimuli,	 such	 as	
cellular	metabolites,	 interleukins	or	hormones.	They	are	thereby	able	to	merge	a	variety	of	signals,	
translating	 them	 into	 cell	 type-specific	 gene	 expression.	 Hormone-dependent	 transcription	 factors	
belonging	to	the	superfamily	of	nuclear	receptors,	will	be	discussed	in	more	detail	below.	
	DNA	methyltransferases	
DNA	methyltransferases	 (DNMTs)	 are	 a	 highly	 conserved	 family	 of	 proteins.	 In	 jawed	 vertebrates,	





of	 the	 family,	DNMT3L	 [374],	 has	 no	 enzymatic	 activity,	 but	was	 shown	 to	 increase	 activity	 of	 the	
other	DNMT3s	[375,	376].	
The	C-terminal	catalytic	domain	of	the	DNMTs	consists	of	10	conserved	amino	acids	forming	a	prolyl-
cysteinyl	 active	 site	 that	 catalyzes	 the	 attachment	 of	 a	methyl	 group	 to	 the	 5-position	 of	 cytosine	
through	 a	 complex	 process	 first	 described	 in	 bacterial	 homologs	 of	 the	 DNMTs	 [377-379].	 A	
conserved	cysteine	residue	 initiates	the	reaction	by	attacking	the	carbon	at	the	6-position,	 forming	
an	covalent	 intermediate	between	 the	cytosine	and	 the	enzyme	 (Fig	12).	 This	produces	a	negative	
charge	 at	 position	 5	 and	 activates	 the	 usually	 inert	 carbon	 that	 can	 now	 interact	with	 the	methyl	
donor	 S-adenosyl	methionine	 (SAM).	 The	product,	 S-adenosyl-homocysteine	 (SAH),	 is	 released	and	







Figure 12 Mechanism of cytosine methylation in DNA, catalyzed by DNA methyltransferases. 
	
The	first	mammalian	relative	of	bacterial	restriction	methyltransferases,	DNMT1,	was	cloned	in	1988	
[383].	 It	 was	 shown	 to	 have	 5-	 to	 30-fold	 preference	 for	 hemimethylated	 substrates,	 strongly	
implicating	 it	 in	maintenance	of	methylation	during	DNA	replication	 [384].	 It	 shares	 the	C-terminal	
catalytic	domain	with	DNMT3A	and	B,	but	has	an	additional,	large	N-terminal	domain,	implicated	in	
regulation	and	 targeting.	 The	 interaction	with	Ubiquitin	 Like	With	PHD	And	Ring	Finger	Domains	1	
(UHRF1,	also	nuclear	protein	95)	mediates	the	selectivity	for	hemimethylated	site	recognition,	via	the	
SRA	(SET	and	RING	finger	associated)	domain	of	UHRF1	[385-387].	In	addition,	DNMT1	contains	a	zinc	
finger	 CXXC	 domain	 that	 is	 characteristic	 of	 proteins	 binding	 unmethylated	 CpGs.	 Other	 proteins	
containing	 this	domain	 include	the	 lysine	demethylases	KDM2A/B	and	the	 ten-eleven-translocation	
(TET)	proteins	1	and	3.	DNMT1	also	possesses	a	PCNA	interacting	peptide	(PIP)	module	responsible	

















































methylation	 [393],	 pointing	 towards	 a	 backup	 system	 for	 methylation	 of	 cytosine.	 Dnmt1-/-	 ESCs	
undergo	apoptosis	when	induced	to	differentiate	however,	leading	to	the	conclusion	that	the	backup	




DNMT3B	 is	 barely	 detectable.	 They	 show	 robust	 methyltransferase	 activity	 on	 hemi-	 as	 well	 as	
unmethylated	DNA,	assigning	them	a	role	as	de	novo	DNA	methyltransferases	[395].	
While	DNMT1	is	uniformly	expressed	in	all	cell	types	and	developmental	stages,	DNMT3A	and	B	show	
distinct	 cellular	 localizations	 during	 embryogenesis	 hinting	 towards	 separate	 roles.	 Like	 DNMT1,	





of	 the	 ICF	 (immunodeficiency,	 centromeric	 region	 instability,	 and	 facial	 anomalies)	 syndrome	 in	
humans	[397-400].	Consistent	with	the	fact	that	DNMT3B	loss	is	embryonic	lethal,	it	was	found	that	
at	least	one	mutation	in	ICF	patients	has	residual	catalytic	activity	[401].	One	hallmark	of	this	genetic	
disorder	 are	 low	 methylation	 levels	 in	 pericentromeric	 satellite	 regions	 [402]	 and	 the	 disease	
translates	into	genomic	instability	and	fatal	immunodeficiency.	
Deregulation	of	all	major	DNMTs	is	associated	with	cancer	development	[403,	404],	assigning	them	a	
role	 as	 potential	 anti-cancer	 targets.	 Methyltransferase	 inhibitors	 that	 competitively	 bind	 to	 the	
catalytic	 site	 of	 DNMT	 have	 been	 used	 in	 clinical	 trials	 to	 treat	 different	 kinds	 of	 hematopoietic	
malignancies.	 5-AzaC	 (Decitabine,	 trade	 name:	 Dacogen)	 is	 approved	 for	 the	 treatment	 of	
myelodysplasic	 syndromes,	 including	 different	 kinds	 of	 anemias	 and	 chronic	 myelomonocytic	
leukemia	[405-408].	
	DNA	demethylation	
DNA	 demethylation	 can	 be	 divided	 into	 two	major	 mechanisms:	 passive	 demethylation,	 involving	
replication-dependent	 dilution	 of	 the	 methyl	 marks,	 and	 active	 demethylation	 that	 is	 replication-





CpG-rich	 regions,	 such	 as	 CpG	 islands.	 The	 sensitivity	 of	 the	 applied	 methods	 does	 not	 allow	
conclusions	on	specific	single	CpGs.	As	mentioned	earlier,	however,	demethylation	of	single	CpGs	can	
also	have	a	profound	effect	on	expression	of	certain	genes	in	somatic	cells.	The	proteins	involved	in	







been	 shown	 to	 occur	 during	 the	 repair	 of	 6-O-methylguanine	where	MGMT	 removes	 the	O-linked	
methylation	on	damaged	DNA,	 thereby	 irreversibly	 inactivating	 itself.	 But,	 in	 contrast	 to	 the	 latter	




silencing	 1	 (ROS1)	 family	 of	 glycosylase/lyases	 can	 initiate	 the	 active	 demethylation	 process	 by	




model,	 because	 -	 as	 already	 described	 -	 there	 are	 several	 possibilities	 to	 repair	 the	 resulting	 G:T	
mismatches,	leading	to	demethylation.	The	main	player	described	for	this	pathway	is	AID.	Although	
mainly	 expressed	 in	 activated	 B-cells,	 low	 levels	 of	 AID	 have	 been	 detected	 among	 others	 in	
primordial	 germ	 cells	 [202],	 which	 undergo	 a	 wave	 of	 rapid,	 active	 demethylation.	 The	 cytidine	
deaminase	displays	activity	on	5mC,	albeit	much	weaker	than	on	unmethylated	cytosine	[235,	236].	
This	 raises	 the	 question	 of	 how	 the	 cell	would	 protect	 the	 cytosines	 in	 an	 environment	with	 high	
levels	 of	 AID	 activity.	 Despite	 this	 caveat,	 genome-wide	 studies	 found	 a	 correlation	 between	 AID	
activity	and	demethylation	in	PGCs	[237,	238,	416]	and	in	embryogenesis	[98,	104,	417].	






Ten-eleven	 translocation	 (TET)	 proteins	 constitute	 a	 new	 family	 of	 Fe2+	 and	 2-oxoglutarate	 (2OG)	
dependent	dioxygenases.	Their	existence	was	 first	mentioned	 in	2002,	when	a	 translocation	of	 the	
H3K4	 methyltransferase	 mixed	 lineage	 leukemia	 (MLL)	 gene	 on	 chromosome	 11	 to	 a	 gene	 on	
chromosome	10	 encoding	 a	 protein	with	 a	CXXC	domain	was	observed	 in	 acute	myeloid	 leukemia	
(AML)	[418,	419].	
It	was	only	several	years	 later	 that	the	enzyme	was	purified	and	characterized.	 It	was	shown	to	be	
one	of	three	enzymes	in	mammals	that	catalyze	the	oxidation	of	5mC	to	5hmC	[28]	and	further	to	5-
formylcytosine	 (5fC)	 and	 5-carboxylcytosine	 (5caC)	 [27]	 in	 vitro	 and	 in	 cells.	 5fC	 and	 5caC	 are	















Figure 13 Schematic representation of the three TET proteins present in jawed vertebrates. They 
share a highly conserved catalytic region at their C-terminus. The TET2 locus underwent inversion, 
resulting in the detachment of the DNA binding domain CXXC. From [424]. 
	
The	 core	 catalytic	 domain	 of	 the	 TET	 enzymes	 forms	 a	 double-stranded	 β-helix	 (DSBH)	 fold,	
characteristic	of	Fe2+	-and	2OG-dependent	dioxygenases.	It	contains	a	triad	of	two	histidines	and	one	
aspartate	 or	 glutamate	 that	 cooperate	 to	 bind	 Fe2+.	 The	 iron	 center	 then	 binds	 oxygen	 and	 2OG,	





Studies	 on	 a	 Naegleria	 TET-like	 dioxygenase	 (NgTET1)	 reveal	 that	 5mC	 is	 strongly	 preferred	 as	
substrate	 over	 5hmC	 and	 5fC.	 It	 was	 further	 shown	 that	more	 5caC	 was	 formed	when	 the	 initial	
substrate	was	5mC,	then	when	the	reaction	was	started	with	DNA	containing	5hmC	or	5fC.	This	led	
the	authors	to	the	conclusion	that	the	three	oxidation	steps	might	be	carried	out	processively	by	TET,	
without	 releasing	 the	 DNA	 [432,	 433].	 After	 every	 oxidation	 step,	 however,	 succinate	 has	 to	 be	
released	to	make	space	for	a	new	2OG.	Structural	studies	on	human	TET2	revealed	that	the	hydrogen	
abstraction	 leading	 to	 the	 oxidation	 of	 the	 cytosine	 species	 is	 likely	 to	 be	 inefficient	 from	 the	










target	 recognition.	Crystal	 structure	of	a	TET2	complex	with	methylated	DNA	showed	that	 the	cys-
rich	 domain	 wraps	 around	 the	 DSBH	 and	 together	 they	 coordinate	 3	 zinc	 ions	 thus	 stabilizing	
important	structures	for	catalysis	and	DNA	binding	[437].	
The	different	TETs	 in	 jawed	vertebrates	carry	out	 the	same	catalytic	 reaction,	but	are	expressed	 in	
different	tissues	and	developmental	stages.	
TET1	levels	are	barely	detectable	in	early	zygotic	stages,	but	increase	at	later	pre-implantation	stages	
and	are	high	 in	ESCs,	 together	with	TET2	 [438,	439].	There	 is	 limited	expression	of	TET1	 in	 several	
adult	 tissues	 [418].	 TET1	 localizes	 predominantly	 to	 CpG	 islands,	 keeping	 them	 methylation-free,	
presumably	by	 inhibiting	de	novo	methylation	by	DNMTs	or	by	 active	demethylation.	Depletion	of	
TET1	 leads	 to	 increased	 levels	 of	 5mC	 at	 many	 TET1-enriched	 regions.	 	 These	 experiments	 also	
revealed	a	dual	 role	of	TET1	 in	gene	 regulation,	as	 similar	number	of	genes	were	upregulated	and	
downregulated	in	the	absence	of	TET1.	This	points	towards	a	complex	 interplay	of	different	factors	
and	complicates	the	analysis	on	a	genome-wide	scale	[329,	440,	441].	
Tet1	 knockout	mESCs	 show	a	decrease	 in	5hmC	 levels	of	 approximately	35%,	but	maintain	normal	
morphology	 and	 support	 embryonic	 development.	 Tet1-null	 mice	 are	 viable,	 but	 the	 number	 of	
progenies	 is	 reduced	 indicating	 that	 either	 a	 fraction	 of	 embryos	 die	 or	 germ	 cell	 development	 is	
impaired	[442].	Tet1-	and	-2	double	knockout	mice	are	also	viable	and	develop	all	three	germ	layers,	
indicating	that	the	two	TETs	have	modulatory,	but	not	essential	functions	in	development	[443].	
TET1	 and	 2	 have	 been	 implicated	 in	 the	 rapid	 demethylation	 event	 occurring	 in	 PGCs.	 The	
demethylation	is	accompanied	by	conversion	of	5mC	to	5hmC	[444,	445].	Kinetics	of	removal	of	5mC	
and	5hmC	indicate	a	passive	mechanism	involving	DNA	replication,	after	rapid	conversion	of	most	of	
the	 methylation	 to	 hydroxymethylation.	 TET1	 and	 TET2	 therefore	 seem	 to	 enhance	 passive	
demethylation,	but	they	are	not	the	only	factors	responsible,	 in	agreement	with	the	 largely	normal	
phenotypes	of	the	surviving	progenies	from	Tet1-/-	Tet2-/-	mice	[443].	
TET2	 levels	 are,	 similarly	 to	 TET1,	 high	 in	 later	 stage	 embryos	 and	 in	 ESCs.	 TET2	 is	 additionally	
ubiquitously	expressed	in	adult	tissues	[418],	including	high	levels	in	hematopoietic	stem	cells	(HSCs).	
Accordingly,	 loss	 of	 TET2	 was	 observed	 to	 promote	 HSC	 self-renewal,	 proliferation,	 and	
differentiation,	 leading	 to	 a	 number	 of	 hematopoietic	 malignancies	 [446-449].	 TET2	 displays	
haploinsufficieny,	 as	 already	 TET2-/+	 HSCs	 show	 a	 growth	 advantage	 for	 populating	 hematopoietic	
lineages	 [450].	 Although	 there	 are	 also	 low	 levels	 of	 TET1-	 and-	 3	 expressed	 in	 the	 hematopoietic	
system,	loss	of	TET2	alone	causes	significant	loss	of	5hmC	and	results	in	tumorigenesis,	assigning	it	a	







5hmC	 coincides	with	 the	 disappearance	 of	 5mC	 from	 the	 paternal	 pronucleus.	 [439],	 where	 TET3	
appears	 to	 be	 specifically	 enriched	 [452].	 Further	 evidence	 for	 this	 pathway	 was	 provided	 by	
knockdown	studies	showing	impeded	conversion	of	5mC	to	5hmC	in	the	absence	of	TET3	[439].	In	a	
recent	 study,	 however,	 it	 was	 found	 that	 the	 initial	 loss	 of	 paternal	 5mC	 does	 not	 require	 TET3-
dependent	 5hmC	 formation	 [453],	 pointing	 towards	 a	 more	 complex	 mechanism	 likely	 involving	
other,	 yet	 unknown,	 factors.	 In	 addition,	 the	 observation	 was	 made	 that	 5hmC	 and,	 to	 a	 lesser	





Apart	 from	 the	 role	 of	 the	 TET	 enzymes	 in	 active	 DNA	 demethylation,	 its	 oxidized	 products	
themselves	 might	 also	 play	 important	 roles	 in	 DNA.	 One	 well-established	 example	 concerns	
maintenance	methylation.	DNMT1	strongly	prefers	hemi-methylated-	over	hemi-hydroxymethylated	
sites	 [456].	 This	 results	 in	 passive,	 replication-coupled	 demethylation,	 following	 a	 first	 active	
enzymatic	step.	Also	the	MBD	proteins	were	shown	to	have	reduced	binding	affinity	towards	5hmC,	
as	compared	to	5mC	[457].	The	binding	properties	of	specific	transcription	factors,	such	as	hormone	








The	 first	 evidence	 that	 TDG	 might	 play	 a	 role	 in	 DNA	 demethylation	 was	 obtained	 when	 it	 was	
purified	 from	a	 chicken	 'demethylation	 complex'	 and	 shown	 to	have	5mC	glycosylase	 activity	 [93].	
This	 activity	 was	 however	 extremely	 low	 compared	 to	 the	 activity	 against	 G/T	 mismatches	 and	




reporter	 gene	 that	 was	 necessary	 for	 its	 expression	 [460].	 TDG	 was	 also	 linked	 to	 myoblast	
differentiation	 that	 was	 accompanied	 by	 genome-wide	 DNA	 demethylation	 [464].	 In	 a	 functional	
genomics	screen	aimed	to	identify	proteins	involved	in	demethylation	of	a	reporter	gene,	the	SUMO-
dependent	 ubiquitin	 E3-ligase	 RING	 finger	 protein	 4	 (RNF4)	 was	 found	 [465].	 RNF4	 deficiency	 is	
embryonic	lethal	and	Rnf4-/-	mouse	embryonic	fibroblasts	(MEFs)	present	higher	levels	of	5mC.	RNF4	










Tdg-/-	 MEFs	 display	 hypermethylation	 at	 regions	 normally	 unmethylated	 and	 bound	 by	 TDG	 [39].	
Another	 group	 that	 also	 established	 a	 TDG	 knockout	 model	 showed	 that	 two	 site-specific	
demethylation	events	described	earlier	[467,	468]	are	dependent	on	TDG.	They	proposed	a	pathway	
involving	AID	and	GADD45a	 (Growth	Arrest	and	DNA	Damage-inducible	45)	 [98],	based	on	the	 fact	
that	AID	 interacts	with	TDG	and	GADD45a.	 The	 involvement	of	GADD45a	 in	DNA	demethylation	 is	
controversial.	Some	groups	support	its	role	[104,	469],	whereas	others	do	not	[470].	
With	the	discovery	of	the	TET	enzymes	and	the	ability	of	TDG	to	excise	their	oxidation	products,	the	
connection	 between	 TDG	 and	DNA	demethylation	was	 further	 strengthened	 [27,	 28,	 97,	 420].	 5fC	
and	 5caC	 accumulate	 in	 proximal	 and	 distal	 regulatory	 elements	 in	mESCs	 upon	 depletion	 of	 TDG	







A	potential	 site-specific,	active	DNA	demethylation	machinery	must	be	 targeted	 reliably	 to	defined	
CpGs	 in	 regulatory	 sequences.	 In	 the	 case	 of	 hormone-induced	 demethylation	 events,	 a	 likely	





RXR	 heterodimers	 (class	 II),	 homodimeric	 orphan	 receptors	 (class	 III)	 and	 monomeric	 orphan	
receptors	 (class	 IV).	 Nuclear	 hormone	 receptors	 consist	 of	 three	 main	 domains;	 a	 central	 DNA	
binding	 domain	 (DBD),	 a	 C-terminal	 ligand	 binding	 domain	 (LBD)	 and	 a	 variable	 transactivation	
domain.	
The	DBD	of	nuclear	receptors	consists	of	two	highly	conserved	zinc	fingers	[477,	478].	Since	they	act	
as	 transcription	 factors,	 nuclear	 receptors	 rely	 on	 specific	 sequence	motifs	 for	 binding,	 known	 as	
hormone	response	elements.	Except	for	the	monomeric	orphan	receptors,	they	bind	as	dimers	to	a	







The	 LBD	 works	 as	 a	 switch,	 changing	 the	 conformation	 and	 the	 properties	 of	 the	 receptor	 upon	
ligand	binding,	 thereby	 activating	 the	 transcription	 factor	 [481,	 482].	 The	majority	 of	NRs	 has	 two	








Figure 14 Structure of a typical nuclear receptor with the two activation domains (AF-1 and AF-2), 
the DNA binding domain (DBD) and the ligand binding domain (LBD). Below the general principle 
of activation of class I and class II NRs; lipophilic hormones pass the lipid bilayer of the cell and bind 
to their cognate receptors, causing their dissociation from heat shock proteins (HSPs) in the 
cytoplasm, in the case of NRs from class I. The receptors dimerize and translocated into the nucleus 
to exert their effector functions on target genes. In the case of NRs from class II (and III/IV), the 
hormones bind their receptors directly in the nucleus (class II, III, IV). From [486]. 	Estrogen	receptors	










response	element	 (ERE)	GGTCANNNTGACC	 [489].	They	are	59%	homologous	 in	 the	LBD,	explaining	
the	similar	affinities	to	E2	and	other	ligands	[490].	However,	ligands	with	distinct	affinities	and	ligand	
binding	 characteristics	 for	 the	 two	 receptors	 have	 been	 described	 [491,	 492].	 	 One	 prominent	
example	is	the	chemotherapeutic	Tamoxifen.	It	acts	as	a	selective,	partial	agonist/antagonist	of	ERα,	
but	has	a	pure	antagonistic	effect	when	binding	 to	ERβ	 [493].	 The	 two	ERs	display	different	 tissue	





ERα	 to	 DNA	 also	 depends	 on	 the	 chromatin	 context.	 Similarly	 to	 other	 transcription	 factors,	 it	
preferably	 binds	 to	 open	 chromatin	 regions	 [498].	 It	 was	 shown	 that	 ERα	 is	 recruited	 mostly	 to	
regulatory	 elements	 distant	 from	 promoters	 and	 mediates	 loop	 formation	 to	 interact	 with	





tissue.	 ERα-positive	 breast	 cancers	 are	 treatable	 with	 hormonal	 therapy,	 such	 as	 the	 selective	
estrogen	 receptor	 modulator	 (SERM)	 Tamoxifen.	 ERα	 overexpression	 therefore	 correlates	 with	 a	






lipovitellin	 and	 phosvitin	 that	 serve	 as	 nutritional	 reserves	 in	 the	 egg.	 There	 are	 two	 minor	
vitellogenin	genes	and	one	major	vitellogenin	gene,	vitellogenin	II.	
The	chicken	vitellogenin	II	(VTG)	gene	is	ideally	suited	to	study	the	connection	between	methylation,	
chromatin	 dynamics	 and	 gene	 activity,	 because	 it	 is	 rapidly	 induced	upon	β-estradiol	 treatment	 in	
terminally-differentiated	 hepatocytes,	 concomitantly	 with	 chromatin	 rearrangements.	 It	 is	 well	
studied	 and	 several	 sites	 in	 the	 proximal	 enhancer	 and	 promoter	 that	 play	 a	 role	 in	 the	
transcriptional	control	are	described.		
A	 site-specific	 DNA	 demethylation	 event	 was	 observed,	 as	 assessed	 by	 digests	 with	 HpaII,	 a	
methylation-sensitive	 restriction	enzyme	 [503].	 The	hormone-dependent	demethylation	 took	place	
in	 hepatocytes	 that	 express	 ERα	 and	 also	 in	 the	 oviduct	 that	 expresses	 ERα,	 but	 no	 VTG.	 In	 ERα-
negative	 erythrocytes,	 there	 was	 no	 demethylation	 of	 the	 specific	 site.	 The	 responsible	 factor	





cell	 division	 [504].	 The	 next	 observation	made	was	 the	 appearance	 of	 DNaseI	 hypersensitive	 sites	
with	different	 characteristics.	Two	sites	 close	 to	 the	TSS	were	 stable,	while	one	was	only	 transient	
and	 disappeared	 after	 hormone	 removal	 [505].	 Further	 studies	 confirmed	 the	 independence	 from	
DNA	synthesis	by	using	arabinose	and	hydroxyurea	(HU)	and	showed	15%	undermethylation	of	the	
HpaII	 site	 after	 24h	 treatment.	 The	 same	 group	 showed	 in	 addition	 a	 relatively	 uniform	 VTG	
expression	 in	 the	 cells	 analyzed,	 excluding	 that	 the	 effect	 came	 from	 only	 a	 few	 cells	 within	 the	
population	[506].	
The	DNA	sequencing	protocol	developed	by	Maxam	and	Gilbert	 [507]	and	modified	by	Church	and	
Gilbert	 [508]	opened	new	possibilities	 to	 also	 analyze	CpGs	methylation	 status	outside	of	HpaII	 or	
other	 methylation-sensitive	 restriction	 enzyme	 recognition	 sites.	 Additionally,	 it	 was	 only	 now	
possible	to	distinguish	hemimethylated	sites	from	fully-methylated	ones.	
A	 key	 study	 in	 1986	 made	 use	 of	 this	 method	 and	 observed	 the	 site-	 and	 strand-specific	
demethylation	 of	 four	 CpGs	 in	 the	VTG	 enhancer	 in	 liver	 nuclei	 of	 immature	 chickens.	 The	 coding	
(upper)	strand	became	demethylated	with	kinetics	parallel	to	those	of	mRNA	synthesis,	whereas	the	
lower	 strand	 followed	 only	 after	 24	 h	 of	 hormone	 treatment.	 This	 re-opened	 the	 possibility	 that	
demethylation	 preceded	 transcription,	 which	 was	 disputed	 earlier	 because	 HpaII	 cleaves	 DNA	
unmethylated	 on	 both	 strands.	 Another	 interesting	 observation	 concerned	 a	 CpG	 lying	 in	 a	
glucocorticoid	response	element.	 It	was	found	to	be	unmethylated	in	the	upper	strand	in	the	basal	
state,	 but	 50%	methylated	 in	 the	 lower	 strand.	 Stable	 presence	 of	 hemimethylated	 CpGs	was	 not	
considered	possible,	because	of	the	maintenance	methyltransferase	DNMT1.	The	same	behavior	of	
the	 gene	 in	 oviduct	 cells	 and	 erythrocytes,	 already	 described	 by	Wilks	 et	 al.,	 1982,	 was	 observed	





binding	 of	 two	 non-histone	 proteins	 (NHP1	 and	 2)	 to	 the	 estrogen-responsive	 element	 (ERE)	 that	
were	different	from	ERα	and	seemed	to	increase	its	binding	efficiency	to	the	ERE	[509].	Another	ERE	













balance	 readily	 lead	 to	 uncontrolled	 cell	 division,	 enhanced	 apoptosis	 or	 altered	 behavior	 of	 cells,	
resulting	in	cancer,	degenerative-	or	autoimmune	diseases,	respectively.	The	detailed	understanding	




undoubtedly	 important	 for	 the	 survival	 of	 higher	 eukaryotes.	 This	 is	 exemplified	 by	 a	 variety	 of	
diseases	 caused	 by	 mutations	 in	 key	 DNA	 repair	 proteins	 [511,	 512].	 However,	 in	 addition	 to	
repairing	damage	arising	 in	DNA,	cells	sometimes	use	the	same	pathways	to	generate	physiological	












has	 a	 very	 important	 role	 in	 the	 control	 of	 gene	 expression	 in	 development,	 as	well	 as	 in	 somatic	
cells.	Methylation	patterns	are	highly	deregulated	in	most	cancers,	further	stressing	their	importance	
in	genomic	stability.	To	find	new	interventions	for	cancer	therapy	without	causing	side	effects,	it	is	of	
great	 importance	 to	 understand	 how	 cells	 maintain	 the	 sensitive	 balance	 between	 maintaining	
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ABSTRACT
During class switch recombination (CSR), antigen-
stimulated B-cells rearrange their immunoglobulin
constant heavy chain (CH) loci to generate antibodies
with different effector functions. CSR is initiated by
activation-induced deaminase (AID), which converts
cytosines in switch (S) regions, repetitive sequences
flanking the CH loci, to uracils. Although U/G mi-
spairs arising in this way are generally efficiently
repaired to C/Gs by uracil DNA glycosylase (UNG)-
initiated base excision repair (BER), uracil process-
ing in S-regions of activated B-cells occasionally
gives rise to double strand breaks (DSBs), which trig-
ger CSR. Surprisingly, genetic experiments revealed
that CSR is dependent not only on AID and UNG,
but also on mismatch repair (MMR). To elucidate the
role of MMR in CSR, we studied the processing of
uracil-containing DNA substrates in extracts of MMR-
proficient and –deficient human cells, as well as in
a system reconstituted from recombinant BER and
MMR proteins. Here, we show that the interplay of
these repair systems gives rise to DSBs in vitro and
to genomic deletions and mutations in vivo, partic-
ularly in an S-region sequence. Our findings further
suggest that MMR affects pathway choice in DSB re-
pair. Given its amenability to manipulation, our sys-
tem represents a powerful tool for the molecular dis-
section of CSR.
INTRODUCTION
Antigen-dependent antibody diversification occurs in two
stages: somatic hypermutation (SHM) and class switch
recombination (CSR) (1,2). During SHM, antibody-
expressing B cell clones that bind antigens are stimulated to
proliferate and the variable regions of their immunoglobulin
(Ig) genes acquire a large number of mutations. Cell clones
expressing mutated immunoglobulins with higher affini-
ties for the antigen undergo positive selection and further
rounds of maturation. In contrast to SHM, which yields
antibodies with higher affinity through altering the variable
region, CSR gives rise to antibodies of a different isotype
through an irreversible rearrangement of the heavy chain
(CH) locus. The human CH locus consists of several genes
(C!, C", C# 3, C# 1, C$1, C# 2, C# 4, C% and C$2), but ma-
ture B cells express on their surface initially only IgM or
IgD (the latter arising through alternative splicing). During
CSR, the antigen/cytokine combination in the environment
of the B cell activates transcription of specific switch (S) re-
gions, highly-repetitive sequences flanking the 5′ termini of
the CH genes. Transcription then triggers a recombination
process during which the Ig variable region is joined to one
of the downstream constant genes with a concomitant loss
of the intervening DNA. In this way, the B-cell switches
from expressing the high-avidity IgM to producing high-
affinity IgG, IgA or IgE with different biological effector
functions (3).
SHM and CSR are initiated by activation-induced cy-
tidine deaminase (AID), a protein expressed in antigen-
activated B cells (4,5). AID converts numerous cytidines
within the Ig locus to uracils, in a reaction that is depen-
dent on transcription (6). In the absence of AID, both SHM
and CSR are abrogated (7,8). In humans, CSR malfunc-
tion causesHyper-IgM syndrome, characterized by elevated
IgM levels and a concomitant decrease or complete absence
of IgG, IgA and IgE (9).
That SHM and CSR depend not only on the genera-
tion of uracils but also on their metabolism was demon-
strated by the finding that ageing mice lacking uracil-DNA
N-glycosylase (UNG), an enzyme that excises uracil from
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DNA (10), develop B-cell lymphomas (11) and that SHM
and CSR are severely attenuated in these animals (12). In
humans, recessive mutations in theUNG gene cause Hyper-
IgM syndrome (13).
Genetic evidence implicated also the mismatch repair
(MMR) pathway in these processes: disruption of the
mouse MMR genes Msh2, Msh6, Mlh1, Pms2 or Exo1 led
to altered SHMand to a reduction in CSR that ranged from
2- to 7-fold, depending on the gene and the Ig serotype (14–
21). Similarly, patients lacking PMS2 or MSH6 were di-
agnosed with a profound CSR defect (22,23). These find-
ings were unexpected. Deamination of deoxycytidine, both
AID-catalyzed and spontaneous (24), gives rise to U/G
mispairs in DNA, however, even though these structures
are recognized and bound by the human mismatch bind-
ing factor MutS! (heterodimer of MSH2 and MSH6) (25),
they should not be addressed by MMR. Postreplicative
MMR has evolved to remove mispaired nucleotides from
the newly-synthesized strand during replication. To achieve
this goal, MMR proteins need not only detect the mis-
pair, but also direct its repair to the nascent strand. In eu-
karyotes, this strand is distinguished from the template by
pre-existing termini, such as gaps between Okazaki frag-
ments, where EXO1 initiates the degradation of the error-
containing nascent strand up to and ∼150 nucleotides past
the mispair (26). Because AID-induced U/Gmispairs arise
in G1 phase of the cell cycle, i.e. in DNA devoid of EXO1
loading sites, they should not trigger MMR. Instead, they
should be repaired to C/G by base excision repair (BER)
(27).
In all organisms, short-patch BER of uracil is initiated
by the removal of this aberrant base, catalyzed primar-
ily by UNG (10), although mammalian cells encode also
the uracil-processing enzymes TDG (28), SMUG1 (29) and
MBD4 (30). The resulting apyrimidinic (AP) site is then in-
cised at its 5′ phosphate by an AP-endonuclease (APE1 in
humans), which thus provides an entry site for polymerase-
" (pol-") that extends the 3′-OH terminus of the break by a
single dCMP and concurrently removes the baseless sugar-
phosphate residue by "-elimination. The remaining nick is
then sealed byDNALigase III/XRCC1.Uracils can also be
addressed by long-patch BER, which differs from the short-
patch process in that the repair synthesis catalyzed by pol-
", pol-# or pol-$ generates repair tracts of 2–6 nucleotides
through stand displacement. This process requires, in addi-
tion to the BER enzymes, also the replication factors RFC,
PCNA and FEN1 (31–33). BER-mediated repair of uracils
is generally extremely efficient, possibly also due to the re-
dundancy betweenUNG,TDG, SMUG1 andMBD4, how-
ever, only UNG has to date been implicated in SHM/CSR.
BER and MMR are highly-effective guardians of ge-
nomic integrity. So why are these processes linked to mu-
tagenesis and chromosomal deletions at the Ig locus? One
possible reason could be the high density of uracils gener-
ated byAID at its preferred target sequencesWRCY (where
the underlined C is the target of deamination and W = A
or T; R = A or G; Y = C or T) in the regions undergoing
SHM and CSR. In an earlier study, we were able to demon-
strate that MMR can interfere with BER-mediated uracil
repair on substrates containing a U/G and a G/T mispair
in close proximity (34). We could also show that processing
of substrates containing two U/G mispairs in close prox-
imity activated PCNAmonoubiquitylation and recruitment
to chromatin of the error-prone DNA pol-% (35), events re-
quired for SHM (36–38). It was proposed that a similar in-
terference between BER and MMR might give rise to the
double-strand breaks (DSBs) that arise in the switch regions
during the G1 phase of the cell cycle and that are necessary
for CSR (39,40), but experimental evidence supporting this
hypothesis is not available to date.
In an attempt to gain novel insights into the CSR pro-
cess, wemade use of a series of circular phagemid substrates
containing uracil residues in one strand and a nick at a de-
fined site in the other strand, the latter representing an inter-
mediate of BER-catalyzed uracil repair and an entry point
for MMR. We then studied the appearance and location
of DSBs upon incubation of these molecules with MMR-
proficient or -deficient extracts of human cells, as well as
with purified recombinant BER and MMR proteins. We
now show that DSBs can arise through processing of a com-
bination of uracils and nicks situated on opposite strands.
We also show that DSB induction is absolutely dependent
on UNG, but that the dependence on MutS! is limited to
substrates in which the uracils and the nick are separated
by more than∼50 nucleotides. MutL! was required only in
a subset of events and this function required its endonucle-
olytic activity. We also provide evidence that processing of
these substrates in vivo gives rise to deletions delineated by
the uracil and/or strand break sites, and that this process is
not limited to B-cells.
MATERIALS AND METHODS
Antibodies and reagents
The rabbit polyclonal anti-TDG antibody was a generous
gift of Primo Scha¨r, MSH2 antibody was from Calbiochem
and the MSH6 and Lamin B antibodies were from Abcam.
Restriction enzymes (NotI, XmnI, AclI and Nt.BstNBI),
UDG, APE1 and the UDG inhibitor Ugi were obtained
from New England Biolabs and the Protein A Dynabeads
were obtained from Dynal Biotech. The purified recombi-
nantMutL!D699N protein was a generous gift of Farid A.
Kadyrov; additionally, MutL! and MutS! wt and MutS!
KR (41), RPA and EXO1 were purified in our laboratory.
Cell culture
Burkitt lymphoma cells (BL2) were cultured in RPMI
medium 1640 (GIBCO) with 10% fetal calf serum
(GIBCO), 10 000 U/ml penicillin and 10 mg/ml strep-
tomycin (Gibco-BRL). LoVo cells were grown in 50%
DMEM (GIBCO), 50% F12 (GIBCO) supplemented with
10% fetal calf serum and penicillin-streptomycin, 293T
L! were cultured in DMEM supplemented with 10% Tet
System-approved fetal calf serum (Clontech), 300 &g/ml
hygromycin B (Roche) and 100 &g/ml zeocin (InvivoGen).
To abrogateMutL! expression, 50 ng/ml doxycyclin (Clon-
tech) was added to the media. siRNA transfections were
carried out using the calcium phosphate transfection. Syn-
thetic siRNA oligonucleotides sequences (all 5′ to 3′) were
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GATT, siMSH2 UCCAGGCAUGCUUGUGUUGAATT
and MSH6 CGCCATTGTTCGAGATTTA (Microsynth).
DNA substrates and DSB/mismatch repair assays
Isolation of the supercoiled homo- and heteroduplex sub-
strates and the MMR assays were carried out as previously
described (42). A heteroduplex DNA substrate (referred
to as ‘304’, Figures 1A, and 3A) containing a U/G-U/G
mismatch (one within an AclI restriction site) in the 89-bp
polylinker of a pGEM13Zf(+) derivative pRichi was con-




In this substrate, the distance between the nick and the
closest uracil was 304 nucleotides. In order to create a
substrate with a distance of 58 nucleotides between the
nicking site and the closest uracil in the top strand (referred




To assess the impact of sequence context, a 95-mer
oligonucleotide containing nucleotides 267–344 sequence
of the human S! region (GenBank/EMBL/DDBJ
accession no. X54713) was cloned into the PshAI
site of the polylinker of plasmid pRichi. The S!
substrate was then generated by primer extension




region sequence is shown in italics.) In this substrate, the
Us are mispaired with Gs in the complementary strand.
To generate substrates with abasic sites, the following
primers were used: U/G-ab: CCA GTG AAT TGT AAT
AUG AAC ACT ATA GGG CGA ATT GGC GGC CGC
GAT CTG ATC AGA TCC AGA CGT CTG TCA AXG
TTG GGA AGC TTG AG and ab-U/G: CCA GTG AAT
TGT AAT AXG AAC ACT ATA GGG CGA ATT GGC
GGC CGC GAT CTG ATC AGA TCC AGA CGT CTG
TCA AUG TTG GGA AGC TTG AG. In all sequences,
uracils are shown in bold. X represents the abasic site ana-
log inserted with using dSpacer CE phosphoramidite (Glen
Research, 10–1914–90). The desired supercoiled substrates
were purified on a CsCl gradient by standard methods. The
nick was introduced by incubation with Nt.BstNBI.
TheDSB assays were carried out using 100 ng (47.5 fmol)
heteroduplexDNA substrate and 100!g of nuclear extracts
from BL2, 293TL"+ (MLH1+), 293TL"− (MLH1−) or
LoVo cells in a total volume of 25 !l in a buffer contain-
ing 20 mM Tris HCl pH 7.6, 110 mM KCl, 5 mM MgCl2,
1 mM glutathione, 1.5 mM ATP, 50 !g/ml BSA. The re-
actions were incubated for 25 min at 30◦C, followed by 60
min incubation with a stop solution (final concentrations:
0.5 mmol/l EDTA, 1.5% SDS, 2.5 mg/ml proteinase K).
The DNA was purified using Qiagen MinElute Reaction
Cleanup Kit followed by digestion with XmnI and treat-
ment with 200 !g/ml RNase A (Sigma-Aldrich, Germany).
MMR efficiency was estimated as described previously
(34), by digestion of the recovered DNAwith AclI. In order
to be able to visualize the repair tracts, the nuclear extracts
were supplemented with ["-32P]dATP. The DNA fragments
were then separated on 1% agarose gels containing GelRed
and visualized on a UV trans-illuminator. The gels were
then dried and exposed to PhosphoImager screens or X-ray
films.
UDG inhibition and immunodepletions
Where indicated, UDG was inhibited by the addition of
Ugi peptide (4.8 units) per 100 !g nuclear extract and pre-
incubation for 10 min at 37◦C. Immunodepletions were car-
ried out as described previously (34).
Primer extension reactions
Phagemid DNA recovered from the DSB assay was
subjected to primer extension reactions, using the 5′-
labeled ‘Blue’ GCCTCCCTCGCGCCATCAGCTTAAT-
GCGCCGCTACAGGG or ‘Red’ CTCATTAGGCACC-
CCAGGC primers (Figure 5). The reactions were per-
formed by adding 0.2 !M5′-labelled primer to 50 ng DNA,
1 mM dNTPs, 1x thermobuffer and 0.3 !l Taq polymerase.
The following parameters were used for the annealing and
extension reactions: 15 min at 95◦C, 15 min at 50◦C and 35
min at 72◦C. The reaction products were admixed with an
equal volume of formamide and separated on 5% denatur-
ing polyacrylamide gels. The gels were fixed in 50% EtOH,
40% H2O and 10% acetic acid, dried and exposed to Phos-
phoImager screens.
Transfection/transformation experiments
HEK 293 cells were grown to 60% confluence and trans-
fected with 1 !g U/G-U/G or C/G-C/G (ccc or nicked 5′
from the mispaired Us) plasmids (Amp resistant) and 500
ng of a control plasmid (Kan resistant) using calcium phos-
phate transfection. Twenty four hours post transfection,
the plasmids were recovered using a DNA extraction kit
(Qiagen). As DSB generation and religation was expected
to be rare, we used positive selection. Half of the recov-
ered plasmid DNAwas digested with PshAI, the restriction
site of which is situated in the vicinity of the uracils. Dele-
tions were expected to eliminate this cleavage site and hence
render the plasmid refractory to cleavage, while making it
also unable to form colonies. DH10B bacteria were trans-
formed with the digested or undigested plasmid DNA and
plated on kanamycin or ampicillin plates. Single ampicillin-
resistant colonies were picked and taken forward to colony
hybridization.
Colony hybridization
The colony hybridizations were performed essentially as de-
scribed (43). The colonies picked from the agar plate (see
above) were streaked on a fresh plate as shown in Figure 6B.
The bacteria were then transferred to a nitrocellulose mem-
brane by placing the membrane on top of the agar plate for
30 s. The membrane was then denatured and fixed as de-
scribed (43). The bacterial plate was kept at 4◦C. The clones
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Figure 1. Processing of the U/G-U/G substrate in vitro gives rise to DSBs. (A) Schematic representation of the circular heteroduplex substrates carrying
two U/Gmispairs, one located in the recognition site of AclI endonuclease at nucleotide 47 and the other at position 3182. The positions of the Nt.BstNBI
sites at nucleotide 351 (5′ substrate) or 2865 (3′ substrate), where a nick can be introduced selectively into the inner strand, and the position of the XmnI
cleavage site are indicated. Digestion of the phagemid DNA with XmnI resulted in its linearization (3194 bp). Upon incubation of the substrates (either
covalently-closed or nicked as shown in the respective figures) with the nuclear extracts, recovery and enzymatic digestion, appearance of DSBs in the
vicinity of the uracils (mimicked here by additional restriction with NotI that cuts between the two uracils) gave rise to two smaller fragments of about
1900 bp and 1300 bp. The efficiency of DSB induction was estimated by ImageQuant from scans of GelRed-stained agarose gels. (B) Minimal requirements
for DSB induction, analyzed by incubation of substrates containing two uracils in one strand and, where indicated, a nick either 3′ or 5′ from the mispaired
Gs with BL2 nuclear extracts (NE). The upper panel shows UV shadowing of an agarose gel stained with GelRed. Black arrows indicate the fragments
arising due to the presence ofDSBs. (C) DSBs arising in theU/G-U/Gsubstrate nicked 3′ from themispairedGs upon incubationwith extracts of BL2 cells,
LoVo extracts supplemented with recombinant MutS! or HEK 293TL!+ (MMR-proficient) extracts. Quantifications of three independent experiments
are shown in the lower panels. Error bars show mean +/− S.D. (n = 3).
Reconstituted DSB assay
For the in vitro DSB-assay, the reaction contained 100 ng
of the substrate, 375 fmol human MutS!, 460 fmol human
MutL!, 478 fmol human RPA, 26 fmol human EXOI, 1.2
fmol bacterial Uracil-DNA glycosylase and 0.378 fmol hu-
man AP Endonuclease. Briefly, the substrates were incu-
bated with the indicated proteins in the presence of 20 mM
Tris-HCl (pH 7.6), 3 mM ATP, 1 mM glutathione, 5 mM
MgCl2, 0.05 mg/ml BSA and 100 mM KCl. After incuba-
tion at 37◦C for 20 min, the samples were heat-inactivated
for 10 min at 80◦C, digested with XmnI and analyzed on a
1% agarose gel containing GelRed.
RESULTS
U/G processing in B-cell extracts promotes DSB formation
AID was reported to act in a processive manner (44) and
to target both strands in switch regions, albeit with dif-
ferent efficiencies (45). In an attempt to mimic the sub-
strates that might arise in vivo in our in vitro assays, we
set out to generate circular plasmids containing uracils in
bothDNA strands.However,U/Gmispairs arising through
AID-catalyzed deamination of cytosines are substrates for
both BER and MMR and processing of substrates carry-
ing several such mispairs could therefore potentially initiate
at any uracil residue, which would complicate the analysis
of the products. In order to simplify the situation, we gen-
erated substrates containing two U/G lesions in the same
strand, representing the processive action of AID, and a
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or 5′ from the uracils (Figure 1A, left panel), representing
a cleaved abasic site generated upon removal of a uracil by
UNG and hydrolysis by APE1 that would provide an entry
site for MMR as shown in our earlier work (34). Restric-
tion digest of these substrates with XmnI gives rise to the
linearized full-length plasmid molecule of 3193 bp (Figure
1A, top right panel), but a DSB arising in the vicinity of
the uracils would give rise to fragments migrating close to
the 1923 and 1270 bp fragments generated by XmnI/NotI
cleavage (Figure 1A, bottom right panel). When we in-
cubated the closed-circular U/G-U/G substrates (which
should be addressed by BER but not by MMR due to the
absence of a pre-existing nick) with nuclear extracts (NE) of
BL2 (human Burkitt lymphoma) B cells and subjected the
recovered DNA to XmnI digest, only the full-length frag-
ment was detectable (Figure 1B, lane 1). Introduction of
a single nick (MMR entry site) in the opposite strand ei-
ther 5′ or 3′ from the U/G mispairs prior to incubation of
the substrates with the extracts yielded ∼10% of molecules
cleaved by XmnI into two fragments of ∼2000 and ∼1200
bp in size, indicative of the presence of DSBs in the vicinity
of the uracil residues (Figure 1B lane 1 versus lanes 2, 3).
Induction of DSBs in the nicked U/G-U/G substrate is not
limited to B-cell extracts
In order to learn whether theDSBs arising as a consequence
of uracil processing require B-cell specific factors, we com-
pared the processing of the above substrates in B-cell ex-
tracts to that in extracts of LoVo and HEK293T-L! cells.
The former is a MMR-deficient human colon cancer cell
linemutated inMSH2, but the extracts can bemadeMMR-
proficient by complementation with purified recombinant
MutS!. The latter cells are of human embryonic kidney ori-
gin. The MLH1 MMR gene is silenced by methylation in
these cells, but we have modified them to express exogenous
MLH1 upon treatment with doxycycline (46). As shown
in Figure 1C, DSBs were generated in nuclear extracts de-
rived from BL2 cells as shown previously (lane 1), and even
somewhat more efficiently in the MMR-proficient extracts
of LoVo cells supplemented with recombinantMutS! (lane
2) or in HEK293T-L!+ extracts expressing MLH1 (lane 3).
This finding demonstrates that DSB generation in this sys-
tem is not limited to B-cell extracts.
UNG and MutS! play key roles in DSB induction
As mentioned above, genetic evidence showed that both
BER and MMR participate in CSR. We therefore wanted
to test whether the induction of DSBs in our system was de-
pendent on these repair pathways. MMR-deficient extracts
of LoVo cells generated noDSBs in theU/G-U/Gsubstrate
containing a single nick in the G strand 5′ from the mispairs
(Figure 2A, lane 1) and addition of the uracil DNA glycosy-
lase inhibitor Ugi did not alter the situation (lane 2). When
the MMR defect in these extracts was complemented with
MutS!, DSBs were formed (lane 3), but their formation
was effectively inhibited by Ugi (lane 4). This showed that
the breaks were generated by a process requiring uracil ex-
cision. Similar observations were made when the substrate
contained a nick in the G strand 3′ from the mispairs (Fig-
ure 2A, lanes 5–8). In order to test whether DSB induction
required enzymatically-activeMutS!, we supplemented the
LoVo extract with the MutS! KR variant, which is mu-
tated in the ATP binding motifs of bothMSH2 andMSH6.
This variant is unable to undergo the ATP-driven transition
to a sliding clamp and hence remains bound at the mis-
match (47). Unlike the wild type protein (Figure 2A, lane
7), MutS!KR failed to restore DSB induction in LoVo ex-
tracts (lane 9). The generation of DSBs thus requires not
only the binding of MutS! to DNA, but also its ATPase
activity.
We next studied the requirement for MutL! (a het-
erodimer of MLH1 and PMS2). When the nick was posi-
tioned 5′ from the mispaired guanines, DSBs were induced
independently of MutL! (Figure 2B, lanes 1 and 3). As
above, their formation was inhibited by Ugi (lanes 2 and
4). In contrast, MutL! was indispensable for the induction
of DSBs in a substrate containing the nick 3′ from the mis-
paired guanines (Figure 2B, lane 9). No DSBs were formed
when the extracts were supplemented with aMutL! variant
lacking endonuclease activity (lane 7). These results con-
form to our understanding of MMR mechanism (see also
Discussion), in which excision initiated at a 3′ nick displays
an absolute requirement forMutL!, whereas excision start-
ing at a 5′ nick does not (48). The requirement for UNG
showed that DSB formation in these substrates required
an intermediate of uracil processing, most likely a strand
break arising through APE1-mediated cleavage of the aba-
sic site generated by the UNG-catalyzed removal of one of
the uracils. DSBs might then arise through the collision of a
U/G-activatedMMR-catalyzed excision tract in the nicked
strand with a cleaved abasic site in the other strand.
The requirement for MMR in DSB formation is dependent
on the distance between the nick and the U/G mispairs
In the Ig loci of activated B-cells, AID carries out multi-
ple deaminations (44) in both strands (45). In an attempt
to gain further insight into the criteria necessary to give
rise to BER- and MMR-dependent DSBs in vivo, we var-
ied the distance between the uracils and the nick in the op-
posite strand. By using uracil-containing oligonucleotides
in the primer extension reaction that annealed closer to
the Nt.BstNBI site, we were able to generate an additional
substrate (Figure 3B), in which the nicking site was 58 nu-
cleotides 5′ from the G of the nearest U/G mispair rather
than 304 (Figure 3A). When the nick was 58 nucleotides
away, the DSBs were formed with similar efficiency as in the
substrate where it was 304 nucleotides away (Figure 3C).
[NB: In the ‘58’ substrate, a DSB generated close to the
uracils and XmnI cleavage generate two fragments of simi-
lar size, hence only a single band is seen in the agarose gel,
as opposed to two different size bands generated from the
‘304’ substrate.]
Because CSR efficiency is only decreased and not abol-
ished in MMR-deficient cells, we wanted to test whether
the DSBs generated in the ‘58’ substrate were MMR-
dependent, like those detected in the ‘304’ substrate (Fig-
ure 2). As shown in Figure 3D, incubation of the former
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Figure 2. UNG and MutS! play key roles in DSB induction. (A) Lanes 1–4: DSB formation in a U/G-U/G substrate, nicked 5′ from the mispaired Gs,
upon incubation with NE of LoVo cells supplemented with recombinant MutS! and pretreated with Ugi where indicated. Lanes 5–10: Incubation of the
U/G-U/G substrate, nicked 3′ from the mispaired Gs, with LoVo extracts supplemented either with wild type MutS! or the ATPase-dead KR mutant,
and pretreated with Ugi where indicated. (B) Lanes 1–4: DSB formation in a U/G-U/G substrate, nicked 5′ from the mispaired Gs, upon incubation with
MMR-proficient (HEK 293T-L!+) and -deficient (HEK 293T-L!-) extracts. UNG was inhibited by the addition of Ugi where indicated. Lanes 5–10:
DSB formation in a U/G-U/G substrate, nicked 3′ from the mispaired Gs, upon incubation with MMR-proficient (HEK 293T-L!+) or -deficient (HEK
293T-L!−) extracts. The MMR-deficient extracts were supplemented with either wild type MutL! or its endonuclease-deficient mutant (DN). Extracts
were pretreated with Ugi where indicated. Quantifications of three independent experiments are shown in the lower panels. Error bars show mean +/−
S.D. (n = 3).
sulted in the generation of DSBs when the extract was sup-
plemented with purified recombinant MutS! (lane 3), but
were detectable, albeit only weakly, even in the unsupple-
mented extract (lane 1). Because DSB formation was still
absolutely dependent on UNG (lanes 2,4), we postulated
that they must have arisen byMMR-independent exonucle-
olytic degradation between the nick and the cleaved abasic
site(s) in the opposite strand. This was substantiated by the
finding that no DSBs were detected upon incubation of this
substrate with extracts of EXO1-deficient cells (Supplemen-
tary Figure S1).
The DSB formation is dependent on sequence context
As mentioned in the Introduction, deletions occurring at
the Ig locus during CSR initiate and terminate at the in-
tergenic S regions. In order to learn whether these repet-
itive sequence elements affect the efficiency of DSB for-
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Figure 3. Lesion density and sequence context affect DSB induction. Schematic representation of the circular heteroduplex substrates 304 (A) and 58
(B) carrying two U/G mispairs and a Nt.BstNBI site 58 or 304 nucleotides 5′ from the nearest mispaired G. (C) The Nt.BstNBI-nicked ‘58’ or ‘304’
substrates were incubated with BL2 extracts pretreated with Ugi where indicated. (D) The Nt.BstNBI-nicked ‘58’ substrate was incubated with LoVo
extracts pretreated where indicated with Ugi and supplemented or not with recombinant MutS!. (E) The presence of uracils and a nick located within a
sequence fragment from an Ig switch region renders the phagemid more prone to DSB induction in a time course experiment. (F) Same as in C, but the
experiment was performed with ‘304’ substrates containing an abasic site, a U/Gmispair and a nick in the G-strand 3′ from the U/Gmispairs as indicated.
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phagemid and positioned the U/G mispairs 52 nucleotides
apart within this sequence (see Materials and Methods).
As shown in Figure 3E, DSB induction in the switch re-
gion sequence context was more efficient than in the orig-
inal phagemid (compare lanes 1,3,5,7 with lanes 2,4,6,8).
This result suggested that the S regions might be highly
recombinogenic in vivo not only because they contain nu-
merousAID consensus sequences, but possibly also because
the highly-repetitive sequences might form secondary struc-
tures upon degradation of one strand. This would hinder re-
pair synthesis and thus increase the time window for a col-
lision of the MMR and or BER degradation tracts, which
could result in DSB formation.
MMR involvement in DSB generation requires U/Gmispairs
Exonucleolytic degradation of the error-containing strand
during postreplicative MMR is initiated by loading of
EXO1 at the nick by mismatch-activated MutS!. We
wanted to confirm that the MMR-dependent DSB forma-
tion observed in our assays was indeed triggered by MutS!
binding to the U/G mispairs. We also wondered whether
the low efficiency of DSB formation was linked to the rapid
removal of the uracils by UNG, which would convert our
U/G-U/G substrate into a DNA molecule carrying two
abasic sites, which are not substrates for MutS!. We there-
fore generated a substrate carrying only a single U/G mis-
pair and a synthetic abasic site (a tetrahydrofuran ring) in
place of the second uracil. This substrate mimics the U/G-
U/G substrate from which one uracil had been removed
by UNG. When a nick was introduced 3′ or 5′ from the
mispair into the unmodified G strand, DSBs arose only in
the MMR-proficient extract and upon inhibition of UNG
with Ugi (Figure 3F, lanes 4,8). This suggested that UNG-
catalysed removal of the uracil was more rapid than recog-
nition of the U/G mispair by MutS!. Once the uracil was
removed, the substrate contained either two abasic sites (in-
tact or cleaved), or two C/G pairs generated by success-
ful BER (see next section). As neither abasic sites nor C/G
pairs are substrates for MMR, the strand degradation pro-
cess was not activated.
U/G mispairs are processed by BER more rapidly than by
MMR
We could test the above hypothesis directly. The 3′ uracil in
the U/G-U/G substrate is situated in an AclI site such that
it renders the substrate refractory to cleavage by this enzyme
(Figure 4A). Correction to C/G, which can be mediated ei-
ther by BER or by MMR directed to the uracil-containing
strand, restores the AclI site (35). Because the repaired plas-
mid contains three AclI sites as opposed to only two in the
U/G-U/G substrate, digestion of the repaired plasmid with
AclI gives rise to three fragments of 1515, 1305 and 373 bp,
whereas the unrepaired plasmid is cleaved into only two, of
2820 and 373 bp. As shown in Figure 4B (lane 1), incubation
of the U/G-U/Gplasmid nicked in the G strand 5′ from the
mismatch in the AclI site with MMR-proficient extracts of
HEK293TL!+ cells resulted in ∼60% repair to C/G. Im-
portantly, much of this repair was mediated by BER, as its
efficiency was reduced by maximally 50% (lanes 2,3) in the
– 60 600 – 60 600 





































































Figure 4. Both BER and MMR are activated on the nicked U/G-U/G
substrate. (A) Schematic representation of the circular heteroduplexMMR
substrate carrying two U/Gmispairs, one located in the recognition site of
AclI endonuclease at nucleotide 47 and the other at position 3182. The po-
sitions of the Nt.BstNBI site, where a nick can be introduced selectively
into the inner strand 5′ from the mispaired Gs, and the position of the
other two AclI cleavage sites are indicated. (B) U/G to C/G mismatch re-
pair efficiency estimated by conversion ofAclI-resistant toAclI-susceptible
substrate (34). Aph, aphidicolin. The panel shows a representative image of
a 0.8% agarose gel stained with GelRed. (C) Autoradiograph of the dried
0.8% agarose gel shown in panel B above. Bar graphs in panels B and C
show quantifications of three independent experiments. Error bars show
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presence of aphidicolin, an inhibitor of DNA polymerase
! that carries out repair synthesis in the in vitro MMR re-
action (26). Moreover, the MMR-mediated events were di-
rected into the U-containing strand, most likely through re-
pair tracts initiating at the cleaved abasic site generated by
BER at the 5′ uracil (34), because only U/G to C/G repair
restores the AclI site. This was further confirmed by the in-
corporation of ["-32P]dAMP into the 1515 and 1305 bpAclI
fragments that only arise upon U/G to C/G repair (Figure
4C, lane 1).
In contrast, inhibition of UNG with Ugi inhibited AclI
cleavage almost completely (Figure 4B, lanes 4–6). Impor-
tantly, MMR was activated on this substrate more effi-
ciently than in the absence of Ugi, as witnessed by the
greater incorporation of ["-32P]dAMP into the phagemid
molecules (Figure 4C, lane 4). Moreover, this process was
mostly directed to the G-strand, given that the labeled
molecules were refractory to AclI cleavage. This is indica-
tive of U/G-activated MMR repair tracts initiating at the
Nt.BstNBI nicking site, which would convert the U/G mi-
spairs into U/A pairs.
Taken together, the latter evidence helps explainwhyDSB
incidence in our system is relatively low. First, to generate
a DSB, the MMR repair tract must collide with a BER
intermediate in the opposite strand. Second, in order for
MMR to be activated, some U/G mispairs must remain in
theDNA, which is likely to occur only rarely due to the high
efficiency of BER.
In vitro-generated DSBs cluster mostly in the proximity of
the uracil sites
Using primer extension assays, we mapped the position of
the DSBs arising in the U/G-U/G substrate nicked 3′ from
the mispairs in the G-strand upon incubation with extracts
of MMR-proficient HEK 293TL"+ cells. The most promi-
nent breakpoint in the G-strand (mapped with the ‘blue’
primer) was located in close proximity of the AclI site con-
taining the distal (3′) uracil residue (Figure 5A, lane 1).
Upon inhibition of UNG with Ugi (lane 2), several weaker
bands were detected, which were most likely generated by
the MutL" heterodimer (49) upon MMR activation by the
U/G mismatch.
The major breakpoint in the uracil-containing strand,
mapped by extension of the ‘red’ primer, also resided at or
close to the uracil within the AclI site (Figure 5B, lane 1). As
addition of Ugi to the extract substantially reduced the in-
cidence of this breakpoint (lane 2), we propose that it arose
through APE1-catalyzed cleavage of the abasic site gener-
ated byUNG.Under the latter conditions, a second, slightly
shorter, product was also detected. This fragment might
represent an intermediate of uracil processing by long-patch
BER initiated by other glycosylases present in the extracts
(MBD4, SMUG1 or undepleted TDG).
DSBs in the U/G-U/G substrate are induced also in vivo
The sizes of the plasmid fragments generated from the
U/G-U/G substrates in our in vitro assay indicated that the
DSBs were occurring in close proximity to the uracils. We
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Figure 5. Breakpoints in the U/G-U/G substrate are at or near the uracil
residues. U/G-U/G substrate nicked 5′ from the mispaired Gs was incu-
batedwithHEK293T-L"+/− extracts pretreatedwithUgiwhere indicated.
The DNA was recovered and subjected to primer extension using 5′ la-
beled primers ‘blue’ and ‘red’ (see Materials and Methods). The reaction
products were separated on 5% denaturing polyacrylamide gels. Markers
were products of primer extensions on plasmids digested with AclI (A) or
NotI (N). The ‘blue’ primer was complementary to the G strand (A), the
‘red’ primer was complementary to the uracil-bearing strand (B) as shown
schematically between the panels. The figure shows representative autora-
diographs from four independent experiments.
ing of these substrates in vivo. DSBs arising upon transfec-
tion of the U/G-U/G plasmids into human cells should be
repaired by non-homologous end-joining (NHEJ), a pro-
cess that generally leads to a small loss of genetic informa-
tion at the break (50,51). We therefore designed a proto-
col that enabled us to identify the mutated plasmids among
the large excess of molecules that were corrected by BER
to C/G-C/G without mutations. We carried out these ex-
periments in human kidney 293 (HEK 293) cells, because
they can be transfected with very high efficiency. Moreover,
we showed above that DSBs form in uracil-containing sub-
strates also in non-B cell types, and ectopic expression of
AID in non-B cells was shown to trigger both SHM and
CSR (52–54), suggesting that AID is the only B-cell-specific
factor required for these processes.
We transfected the U/G-U/G or the control C/G-C/G
substrate into the HEK293 cells, either wild-type or de-
pleted of MutS" with siRNAs targeting MSH2 and MSH6
(Figure 6A), recovered the plasmid DNA 24 h later and
used it to transform competent E. coli after digestion with
PshAI. The cleavage site of this enzyme is situated in close
proximity of the uracils and it was therefore anticipated that
all plasmid molecules carrying the wild-type sequence at
this site would be linearized and thus made transformation-
incompetent. [NB: The enrichment for mutant molecules
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Figure 6. In vivo repair ofDSBs in theU/G-U/Gsubstrate leads tomutations and deletions. (A)Western blot of extracts ofHEK293 cells showing efficiency
of knock-down of MSH2 and MSH6 with siRNA. (B) Autoradiograph of a representative filter carrying plasmid DNA recovered from transfections of
HEK 293 cells with the U/G-U/G substrate nicked 5′ from the mispaired Gs, hybridized with a radiolabeled oligonucleotide complementary to the wild
type (unmodified) plasmid sequence flanking the uracil residues. (C) Mutated and deleted plasmids recovered from multiple transfections of HEK 293
cells with the listed substrates. (D) As in C, but the substrates were transfected into HEK 293 cells depleted of MutS!. (E) As in C, but the substrates were
transfected intoHEC59+ chr2 cells (MMR-proficient). (F) As inC, but the substrates were transfected intoHEC59 cells. (G) Incidence ofmicrohomologies
in plasmids recovered from transfections of the indicated substrates into HEK 293 cells depleted or not of MutS!. (H) Incidence of microhomologies in
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by digestion with PshAI was necessary, because the forma-
tion of DSBs and/or uracil misrepair in vivo are extremely
rare.] In six independent experiments, we generally obtained
∼20 times more colonies from transformations with the re-
covered PshAI-digested U/G-U/G plasmid than with the
C/G-C/G homoduplex control (data not shown). How-
ever, DNA sequencing revealed that the majority of these
molecules in both populations were devoid of mutations,
which implied that the PshAI digest was not quantitative.
We therefore introduced a second screening step for the
mutants: colony hybridization with a radiolabeled oligonu-
cleotide complementary to the sequence flanking the PshAI
site. We then sequenced only those colonies that indicated
the presence of point mutations or deletions (Figure 6B).
As shown in Figure 6C and Supplementary Figure S2A,
of 326 sequenced colonies from control transformations
of HEK 293 cells with the covalently-closed circular (ccc)
C/G-C/Gplasmid, 7 (2.1%) contained pointmutations and
7 (2.1%) contained deletions. Because the mutants were se-
lected with a probe located between the two uracil residues,
all examined deletion mutants lost this site. DNA sequenc-
ing revealed that these very rare deletions in the unnicked
C/G-C/G substrate were several hundred base pairs long
and did not share their end points. The presence of a nick
in the G strand of this substrate trebled the occurrence of
these large deletions to 6.3% and, as anticipated, one end
point of these deletions was often (∼30%) close to the posi-
tion of the nick. Transfection of the cccU/G-U/Gsubstrate
yielded both mutations (8.5%) and deletions (7%), which
were generally short, mostly <200 bp. Transfection of the
nicked U/G-U/G substrate yielded plasmids containing a
similar amount of mutations (8.7%), but substantially more
deletions (16%), largely spanning the distance between the
position of the uracils and the Nt.BstNBI nick. Most of the
end-joining events occurred at sequences with no apparent
homologies. This resembled analysis of hybrid S-S junctions
in immunoglobulin switch regions, which showed that the
sequences were fused at or very close to AID hotspots (40).
We also detected several translocation events between the
U/G-U/G plasmid substrate and genomic DNA (Supple-
mentary Figure S2A, yellow lines). This finding shows that
DSBs arising through the interplay ofMMR and BER dur-
ing the processing of proximal uracil residues in our sub-
strate are recombinogenic and provides independent sup-
port for the hypothesis that chromosomal translocations
arising in activated B cells (55) might have arisen through
a similar mechanism.
We next wanted to study the effect of the MMR sys-
tem on the above events. To this end, we treated the HEK
293 cells with siRNA targeting MSH2 and MSH6 to de-
plete MutS! (Figure 6A). Transfections of the above sub-
strates into these cells yielded some unanticipated results
(Figure 6D, Supplementary Figure S2B), inasmuch as the
proportion of deletions was similar in all four substrates
(8% for ccc C/G-C/G, 9.5% for nicked C/G-C/G, 5.3% for
ccc U/G-U/G and 9.3% for nicked U/G-U/G), but––most
remarkably––the number of point mutants was substan-
tially reduced (0.8% for ccc C/G-C/G, 1% for nicked C/G-
C/G, 1.9% for ccc U/G-U/G and 2.7% for nicked U/G-
U/G). In all these mutants, the deletions were large and the
influence of the nick was much less pronounced, which con-
firms that the nick is a specific signal for MMR-catalyzed
strand degradation events.
We then transfected these substrates into the MMR-
deficient human endometrial cancer cell lineHEC 59, which
is mutated in MSH2, or HEC 59 + chr2 cells, in which
the MMR defect was corrected by transfer of chromosome
2 that carries the wild type MSH2 gene. Unexpectedly,
the number of point mutants identified in both cell lines
was very low, but the number of deletions in the MMR-
proficient cells (Figure 6E, Supplementary FIgure S2C) was
more than 2.5-fold higher than in the MMR-deficient line
(Figure 6F, Supplementary FIgure S2D), particularly in the
nicked U/G-U/G substrate. Their size and end-points re-
flected those observed in HEK 293 cells. Interestingly, se-
quence analysis of the clones revealed an increase in the
number of microhomologies around the break points in the
plasmids recovered from MMR-deficient MutS!-depleted
HEK 293 (Figure 6G) andHEC 59 cells (Figure 6H), which
suggests that the molecular mechanism of DSB repair is af-
fected by theMMRstatus of the cells. [N.B.: The sequencing
data are not shown due to space limitations, but are avail-
able upon request.]
DSBs arise in the nicked U/G-UG substrate in a system re-
constituted from purified proteins
Based on the results of the above experiments and on pub-
lished biochemical (34,35) and genetic (40,56,57) data, we
postulated that the DSBs in the nicked U/G-U/G substrate
might arise by a mechanism outlined in Figure 7. To sub-
stantiate that the DSBs in our system arose by this mech-
anism and that the process did not involve additional, as
yet unidentified, factor(s) present in human cell extracts,
we reconstituted the repair process from purified recombi-
nant UNG, APE1, MutS!, MutL!, RPA (required to sta-
bilize the single-stranded DNA gap) and EXO1. As shown
in Figure 8, DSB generation in the substrate nicked in the
G-strand 5′ from the mispairs was rather efficient.
DISCUSSION
Antigen-induced B cell activation leads to the expression of
AID, which is targeted to the Ig loci, where it deaminates
a subset of cytosines in its preferred recognition sequences
to uracils. Metabolism of the AID-generated uracils then
triggers SHM, during which the rearranged VDJ regions
undergo extensive mutagenesis, and CSR that affects the
switch regions between the constant genes. Here, uracil pro-
cessing results in the generation of not only mutations, but
also DSBs that trigger non-homologous end-joining and
cause an irreversible loss of the interveningDNA sequences.
Genetic evidence implicated BER and, to a lesser extent,
alsoMMR in both these processes, even though the absence
of UNG resulted in a substantially more severe phenotype
thanMMRdeficiency. However, the absence of bothMMR
and BER abolishes CSR completely (58,59).What is the na-
ture of themolecular transactions that allowSHMandCSR
to subvert antimutator DNA repair processes such as BER
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Figure 7. Putative scheme of BER- and MMR-dependent DSB induction in Ig loci. The first step of CSR is the active recruitment to the Ig locus of AID,
which deaminates several cytosines in both DNA strands. The U/Gmispairs generated at these sites are substrates for both BER andMMR. In a scenario
explored in the present study, removal of a uracil in the bottom strand by UNG followed by APE1-mediated cleavage of the abasic site would generate
the substrate shown in (A). Recognition of one of the remaining U/G mispairs by MutS!/MutL! causes activation of the complex and its translocation
along the DNA contour. Interaction with PCNA loaded at the cleaved abasic site (B) activates the endonuclease activity of MutL!, which, upon complex
formation with PCNA, introduces additional nicks into the discontinuous (bottom) strand (C). One of these is used as an entry site for EXO1, which
commences to degrade the DNA in a 5′ to 3′ direction (D). If the remaining Us in the upper strand were in the meantime addressed by UNG (E), APE1
will cleave the abasic sites (F). Collision of the EXO1-catalyzed excision tract in the lower strand with the APE1-induced break in the upper strand will give
rise to a DSB and EXO1 dissociation (G). [N.B. In this scenario, DSB formation is absolutely dependent on MutL!, which has to introduce additional
nicks into the bottom strand, some of which must be situated 5′ from the mispaired Gs. Only then will EXO1 be able to degrade this strand toward the U/G
mispairs. Had the process been initiated by the removal of a uracil residue 5′ from the two mispaired Gs, the process would have been largely independent
of MutL!.]
We argued that one answer to this question might lie in
the processive action of AID. Because this enzyme is tar-
geted to the variable and switch regions of the Ig locus (60),
uracils arise at these sites frequently and are clustered to-
gether, rather than being dispersed and rare, as is the case
when they arise through spontaneous hydrolytic deamina-
tion. This unique situation provides both BER and MMR
with substrates in the same region of DNA and, because
the two repair systems do not normally encounter each
other, it is likely that there are no evolutionary safeguards
in place that prevent them from interfering with one an-
other. Our experiments suggest that the incidence of DSBs
arising through BER and MMR interference is rather low,
even in our system that was designed to increase the likeli-
hood of their detection. In vivo, the mutagenic events trig-
gering SHM/CSR also occur rather infrequently, but they
are detectable due to a process of positive selection of the
mutated and/or rearranged clones. Moreover, CSR can be
triggered by only a few breaks, providing that they occur at
sites conducive to recombination, such as the Ig switch re-
gions. Experimental evidence in support of the hypothesis
that strategically-placed DSBs are sufficient for CSR was
provided by replacement of the switch regions with yeast
I-SceI endonuclease cleavage sites (61).
The finding that CSR-associated DSBs arise outside of
S-phase (40) rules out the possibility that these DSBs are
generated when replication forks encounter single-strand
breaks arising through APE1-mediated cleavage of abasic
sites left behind after uracil removal. In this study, we pro-
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Figure 8. Reconstitution of the minimal BER/MMR interference system.
The minimal mismatch repairosome was assembled from purified recom-
binant MutS!, MutL!, RPA, EXO1, RFC and PCNA. Uracil process-
ing was mediated by purified recombinant UNG and APE1. Following
incubation of the U/G-U/G and nicked U/G-U/G substrates with the
indicated protein combinations, the recovered plasmids were subjected to
electrophoresis on 0.8% agarose gels. The panel shows an image of a repre-
sentative gel stained with GelRed. Bar graph shows quantification of three
independent experiments. Error bars show mean +/− S.D. (n = 3).
DSBs arising in our in vitro assay arise in DNA molecules
that do not replicate and that therefore lack strand dis-
crimination signals (such as Okazaki fragment termini) that
MMR uses to direct excision to the nascent DNA strand.
Indeed, no DSBs were generated in the covalently-closed
U/G-U/G substrate even when BER was active (Figure 1),
nor were they formed in the same substrate when BER was
blocked by the addition of Ugi, even though a nick was
present in the G-strand (Figures 2–4). In contrast, when
BERwas active, DSBs were readily detected, providing that
the substrate was nicked and that MMR was also active.
This shows that the breaks in our system were generated
by interplay of the two pathways, where MMR-dependent
strand excision initiated at the nick in one strand collided
with a cleaved abasic site arising after uracil removal and
in the opposite strand. This hypothesis is experimentally
substantiated by our break- and deletion-mapping exper-
iments, which showed that the DSBs were predominantly
positioned at or close to one of the uracils (Figure 5) and
that the deletions most often spanned the distance between
the nick and the closest uracil (Supplementary Figure S2).
It should be remembered that the nick in our model sub-
strates acts as a surrogate for an APE1-cleaved abasic site
arising through UNG-catalyzed uracil removal, which we
could show previously to act as a loading site for MMR-
activated EXO1 (34).
During processive AID-catalyzed cytosine deamination
of the Ig loci, uracil residues would be generated in both
strands in close proximity. Although BER is normally ex-
tremely efficient, uracil repair in antigen-activated B cells
appears to be sluggish. This leads on the one hand to muta-
tions caused probably to Rev1/pol-" -catalyzed error-prone
by-pass of a subset of abasic sites arising at the sites of
deamination upon uracil removal by UNG and, on the
other hand, to strand breaks generated by APE1-catalyzed
cleavage of another subset of these abasic sites. Thus, AID-
deaminated S region might contain intact U/G and G/U
mispairs, as well as incised and intact abasic sites. The intact
mispairs would activate MMR, which would load EXO1 at
the strand discontinuities to generate a single-stranded ex-
cision tract that could be up to a kilobase long. If this tract
were to collide with a cleaved abasic site or indeed with a
MMR-activated EXO1-catalyzed excision tract in the op-
posite strand, a DSB would arise.
Our transfection experiments yielded also an unexpected
finding, in that the frequency of microhomologies was
higher in MMR-deficient cells compared to the MMR-
proficient controls (Figure 6). The requirement for MMR
in the control of HR fidelity has long been known (62), but
its involvement in NHEJ or microhomology-mediated end-
joining (MMEJ) has to our knowledge not been reported to
date in recombination-proficient cells.
DSBs are a frequent cause of chromosomal rearrange-
ments that play a key role in cancer, particularly in in-
stances where recombination is disrupted, such as in case
of BRCA1/2 mutations that cause breast cancer predispo-
sition (63). In B-cells, deregulation of AID expression and
its aberrant targeting induces translocations and results in
lymphomagenesis (64), and it would appear highly likely
that the latter chromosomal rearrangements are triggered
by DSBs arising through MMR- and BER-mediated pro-
cessing of AID-generated uracils. As shown above, the in-
terference of MMR and BER is neither specific to B-cells,
nor to U/G processing. We therefore posit that this phe-
nomenon could come into play in instances where DNA
modifications, such as U/G mispairs, addressed by both
systems are generated at high density. One analogous ex-
ample is methylation damage induced by SN1 type methy-
lating agents, such as the cancer therapeutics temozolo-
mide, dacarbazine or streptozotocin, which generate sub-
strates for both BER andMMR and which are highly toxic
to MMR-proficient, but not –deficient cells (46). It is also
possible that the interference of MMR and BER may be
the cause of the MMR-dependent DNA damage-induced
chromosomal instability in colon cancer cells (65). Indeed,
MMR-deficient colon cancer cell lines are generally diploid,
in contrast to MMR-proficient cells, which are frequently
aneuploid (8).
DNA repair processes are generally thought of as
guardians of our genome. In this work we demon-
strate that their canonical roles can––under certain
circumstances––cause genomic instability. In this particu-
lar case, mutagenesis and genetic deletions that accompany
SHM/CSR are beneficial to the organism, given that they
protect it from infections. Moreover, these processes affect
B cells that are programmed to die, which minimizes the
possibility of deleterious side effects. Thus, even though
aberrant recombination linked to antibody diversification
may in rare instances cause cancer, the benefits offered
by SHM/CSR in evolutionary terms far outweigh the
drawbacks. It is our hope that an understanding of the
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find the Achilles heel of cells in which antibody diversi-
fication went awry and, in the long run, identify ways of
eliminating them.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
ACKNOWLEDGEMENTS
We are grateful to AnneDurandy for helpful advice and nu-
merous stimulating discussions, to Anja Saxer andKalpana
Surendranath for expressing and purifying the recombinant
MutS! and MutL!, and to Stefano Ferrari and Pavel Jan-
scak for the gift of the EXO1 and RPA expression vectors,
respectively.
FUNDING
Swiss National Science Foundation [310030B-133123 and
31003A-149989]; European Research Council [‘MIRIAM’
294537 to J.J.]. Funding for open access charge: University
of Zurich.
Conflict of interest statement.None declared.
REFERENCES
1. Vaidyanathan,B., Yen,W.F., Pucella,J.N. and Chaudhuri,J. (2014)
AIDing chromatin and transcription-coupled orchestration of
immunoglobulin class-switch recombination. Front. Immunol., 5, 120.
2. Saribasak,H. and Gearhart,P.J. (2012) Does DNA repair occur
during somatic hypermutation? Semin. Immunol., 24, 287–292.
3. Manis,J.P., Tian,M. and Alt,F.W. (2002) Mechanism and control of
class-switch recombination. Trends Immunol., 23, 31–39.
4. Muramatsu,M., Kinoshita,K., Fagarasan,S., Yamada,S., Shinkai,Y.
and Honjo,T. (2000) Class switch recombination and hypermutation
require activation-induced cytidine deaminase (AID), a potential
RNA editing enzyme. Cell, 102, 553–563.
5. Muramatsu,M., Sankaranand,V.S., Anant,S., Sugai,M.,
Kinoshita,K., Davidson,N.O. and Honjo,T. (1999) Specific
expression of activation-induced cytidine deaminase (AID), a novel
member of the RNA-editing deaminase family in germinal center B
cells. J. Biol. Chem., 274, 18470–18476.
6. Chaudhuri,J. and Alt,F.W. (2004) Class-switch recombination:
interplay of transcription, DNA deamination and DNA repair. Nat.
Rev. Immunol., 4, 541–552.
7. Revy,P., Muto,T., Levy,Y., Geissmann,F., Plebani,A., Sanal,O.,
Catalan,N., Forveille,M., Dufourcq-Labelouse,R., Gennery,A. et al.
(2000) Activation-induced cytidine deaminase (AID) deficiency
causes the autosomal recessive form of the Hyper-IgM syndrome
(HIGM2). Cell, 102, 565–575.
8. Lengauer,C., Kinzler,K.W. and Vogelstein,B. (1997) Genetic
instability in colorectal cancers. Nature, 386, 623–627.
9. Durandy,A., Revy,P., Imai,K. and Fischer,A. (2005)
Hyper-immunoglobulin M syndromes caused by intrinsic
B-lymphocyte defects. Immunol. Rev., 203, 67–79.
10. Lindahl,T. (1974) An N-glycosidase from Escherichia coli that
releases free uracil from DNA containing deaminated cytosine
residues. Proc. Natl. Acad. Sci. U.S.A., 71, 3649–3653.
11. Nilsen,H., Stamp,G., Andersen,S., Hrivnak,G., Krokan,H.E.,
Lindahl,T. and Barnes,D.E. (2003) Gene-targeted mice lacking the
Ung uracil-DNA glycosylase develop B-cell lymphomas. Oncogene,
22, 5381–5386.
12. Rada,C., Williams,G.T., Nilsen,H., Barnes,D.E., Lindahl,T. and
Neuberger,M.S. (2002) Immunoglobulin isotype switching is
inhibited and somatic hypermutation perturbed in UNG-deficient
mice. Curr. Biol., 12, 1748–1755.
13. Imai,K., Slupphaug,G., Lee,W.I., Revy,P., Nonoyama,S., Catalan,N.,
Yel,L., Forveille,M., Kavli,B., Krokan,H.E. et al. (2003) Human
uracil-DNA glycosylase deficiency associated with profoundly
impaired immunoglobulin class-switch recombination. Nat.
Immunol., 4, 1023–1028.
14. van Oers,J.M., Roa,S., Werling,U., Liu,Y., Genschel,J., Hou,H. Jr,
Sellers,R.S., Modrich,P., Scharff,M.D. and Edelmann,W. (2010)
PMS2 endonuclease activity has distinct biological functions and is
essential for genome maintenance. Proc. Natl. Acad. Sci. U.S.A., 107,
13384–13389.
15. Martomo,S.A., Yang,W.W. and Gearhart,P.J. (2004) A role for Msh6
but not Msh3 in somatic hypermutation and class switch
recombination. J. Exp. Med., 200, 61–68.
16. Rada,C., Ehrenstein,M.R., Neuberger,M.S. and Milstein,C. (1998)
Hot spot focusing of somatic hypermutation in MSH2-deficient mice
suggests two stages of mutational targeting. Immunity, 9, 135–141.
17. Neuberger,M.S., Lanoue,A., Ehrenstein,M.R., Batista,F.D., Sale,J.E.
and Williams,G.T. (1999) Antibody diversification and selection in
the mature B-cell compartment. Cold Spring Harb. Symp. Quant.
Biol., 64, 211–216.
18. Ehrenstein,M.R. and Neuberger,M.S. (1999) Deficiency in Msh2
affects the efficiency and local sequence specificity of immunoglobulin
class-switch recombination: parallels with somatic hypermutation.
EMBO J., 18, 3484–3490.
19. Schrader,C.E., Edelmann,W., Kucherlapati,R. and Stavnezer,J.
(1999) Reduced isotype switching in splenic B cells from mice
deficient in mismatch repair enzymes. J. Exp. Med., 190, 323–330.
20. Li,Z., Scherer,S.J., Ronai,D., Iglesias-Ussel,M.D., Peled,J.U.,
Bardwell,P.D., Zhuang,M., Lee,K., Martin,A., Edelmann,W. et al.
(2004) Examination of Msh6- and Msh3-deficient mice in class
switching reveals overlapping and distinct roles of MutS homologues
in antibody diversification. J. Exp. Med., 200, 47–59.
21. Bardwell,P.D., Woo,C.J., Wei,K., Li,Z., Martin,A., Sack,S.Z.,
Parris,T., Edelmann,W. and Scharff,M.D. (2004) Altered somatic
hypermutation and reduced class-switch recombination in
exonuclease 1-mutant mice. Nat. Immunol., 5, 224–229.
22. Peron,S., Metin,A., Gardes,P., Alyanakian,M.A., Sheridan,E.,
Kratz,C.P., Fischer,A. and Durandy,A. (2008) Human PMS2
deficiency is associated with impaired immunoglobulin class switch
recombination. J. Exp. Med., 205, 2465–2472.
23. Gardes,P., Forveille,M., Alyanakian,M.A., Aucouturier,P.,
Ilencikova,D., Leroux,D., Rahner,N., Mazerolles,F., Fischer,A.,
Kracker,S. et al. (2012) Human MSH6 deficiency is associated with
impaired antibody maturation. J. Immunol., 188, 2023–2029.
24. Lindahl,T. (1982) DNA repair enzymes. Annu. Rev. Biochem., 51,
61–87.
25. Hughes,M.J. and Jiricny,J. (1992) The purification of a human
mismatch-binding protein and identification of its associated ATPase
and helicase activities. J. Biol. Chem., 267, 23876–23882.
26. Jiricny,J. (2006) The multifaceted mismatch-repair system. Nat. Rev.
Mol. Cell Biol., 7, 335–346.
27. Krokan,H.E. and Bjoras,M. (2013) Base excision repair. Cold Spring
Harb. Perspect. Biol., 5, a012583.
28. Neddermann,P. and Jiricny,J. (1994) Efficient removal of uracil from
G.U mispairs by the mismatch-specific thymine DNA glycosylase
from HeLa cells. Proc. Natl. Acad. Sci. U.S.A., 91, 1642–1646.
29. Nilsen,H., Haushalter,K.A., Robins,P., Barnes,D.E., Verdine,G.L.
and Lindahl,T. (2001) Excision of deaminated cytosine from the
vertebrate genome: role of the SMUG1 uracil-DNA glycosylase.
EMBO J., 20, 4278–4286.
30. Hendrich,B., Hardeland,U., Ng,H.H., Jiricny,J. and Bird,A. (1999)
The thymine glycosylase MBD4 can bind to the product of
deamination at methylated CpG sites. Nature, 401, 301–304.
31. Visnes,T., Doseth,B., Pettersen,H.S., Hagen,L., Sousa,M.M.,
Akbari,M., Otterlei,M., Kavli,B., Slupphaug,G. and Krokan,H.E.
(2009) Uracil in DNA and its processing by different DNA
glycosylases. Philos. Trans. R Soc. Lond. B Biol. Sci., 364, 563–568.
32. Robertson,A.B., Klungland,A., Rognes,T. and Leiros,I. (2009) DNA
repair in mammalian cells: Base excision repair: the long and short of
it. Cell. Mol. Life. Sci., 66, 981–993.
33. Frosina,G., Fortini,P., Rossi,O., Carrozzino,F., Raspaglio,G.,
Cox,L.S., Lane,D.P., Abbondandolo,A. and Dogliotti,E. (1996) Two






Nucleic Acids Research, 2016, Vol. 44, No. 6 2705
34. Schanz,S., Castor,D., Fischer,F. and Jiricny,J. (2009) Interference of
mismatch and base excision repair during the processing of adjacent
U/G mispairs may play a key role in somatic hypermutation. Proc.
Natl. Acad. Sci. U.S.A., 106, 5593–5598.
35. Pena-Diaz,J., Bregenhorn,S., Ghodgaonkar,M., Follonier,C.,
Artola-Boran,M., Castor,D., Lopes,M., Sartori,A.A. and Jiricny,J.
(2012) Noncanonical mismatch repair as a source of genomic
instability in human cells.Mol. Cell, 47, 669–680.
36. Langerak,P., Nygren,A.O., Krijger,P.H., van den Berk,P.C. and
Jacobs,H. (2007) A/T mutagenesis in hypermutated immunoglobulin
genes strongly depends on PCNAK164 modification. J. Exp. Med.,
204, 1989–1998.
37. Delbos,F., De Smet,A., Faili,A., Aoufouchi,S., Weill,J.C. and
Reynaud,C.A. (2005) Contribution of DNA polymerase eta to
immunoglobulin gene hypermutation in the mouse. J. Exp. Med., 201,
1191–1196.
38. Mayorov,V.I., Rogozin,I.B., Adkison,L.R. and Gearhart,P.J. (2005)
DNA polymerase eta contributes to strand bias of mutations of A
versus T in immunoglobulin genes. J. Immunol., 174, 7781–7786.
39. Stavnezer,J. and Schrader,C.E. (2006) Mismatch repair converts
AID-instigated nicks to double-strand breaks for antibody
class-switch recombination. Trends Genet., 22, 23–28.
40. Schrader,C.E., Guikema,J.E., Linehan,E.K., Selsing,E. and
Stavnezer,J. (2007) Activation-induced cytidine deaminase-dependent
DNA breaks in class switch recombination occur during G1 phase of
the cell cycle and depend upon mismatch repair. J. Immunol., 179,
6064–6071.
41. Raschle,M., Dufner,P., Marra,G. and Jiricny,J. (2002) Mutations
within the hMLH1 and hPMS2 subunits of the human MutLalpha
mismatch repair factor affect its ATPase activity, but not its ability to
interact with hMutSalpha. J. Biol. Chem., 277, 21810–21820.
42. Fischer,F., Baerenfaller,K. and Jiricny,J. (2007) 5-Fluorouracil is
efficiently removed from DNA by the base excision and mismatch
repair systems. Gastroenterology, 133, 1858–1868.
43. Grunstein,M. and Hogness,D.S. (1975) Colony hybridization: a
method for the isolation of cloned DNAs that contain a specific gene.
Proc. Natl. Acad. Sci. U.S.A., 72, 3961–3965.
44. Pham,P., Bransteitter,R., Petruska,J. and Goodman,M.F. (2003)
Processive AID-catalysed cytosine deamination on single-stranded
DNA simulates somatic hypermutation. Nature, 424, 103–107.
45. Shen,H.M. and Storb,U. (2004) Activation-induced cytidine
deaminase (AID) can target both DNA strands when the DNA is
supercoiled. Proc. Natl. Acad. Sci. U.S.A., 101, 12997–13002.
46. Cejka,P., Stojic,L., Mojas,N., Russell,A.M., Heinimann,K.,
Cannavo,E., di Pietro,M., Marra,G. and Jiricny,J. (2003)
Methylation-induced G(2)/M arrest requires a full complement of the
mismatch repair protein hMLH1. EMBO J., 22, 2245–2254.
47. Iaccarino,I., Marra,G., Dufner,P. and Jiricny,J. (2000) Mutation in
the magnesium binding site of hMSH6 disables the hMutSalpha
sliding clamp from translocating along DNA. J. Biol. Chem., 275,
2080–2086.
48. Kadyrov,F.A., Dzantiev,L., Constantin,N. and Modrich,P. (2006)
Endonucleolytic function of MutLalpha in human mismatch repair.
Cell, 126, 297–308.
49. Pluciennik,A., Dzantiev,L., Iyer,R.R., Constantin,N., Kadyrov,F.A.
and Modrich,P. (2010) PCNA function in the activation and strand
direction of MutLalpha endonuclease in mismatch repair. Proc. Natl.
Acad. Sci. U.S.A., 107, 16066–16071.
50. Casellas,R., Nussenzweig,A., Wuerffel,R., Pelanda,R., Reichlin,A.,
Suh,H., Qin,X.F., Besmer,E., Kenter,A., Rajewsky,K. et al. (1998)
Ku80 is required for immunoglobulin isotype switching. EMBO J.,
17, 2404–2411.
51. Manis,J.P., Gu,Y., Lansford,R., Sonoda,E., Ferrini,R., Davidson,L.,
Rajewsky,K. and Alt,F.W. (1998) Ku70 is required for late B cell
development and immunoglobulin heavy chain class switching. J.
Exp. Med., 187, 2081–2089.
52. Yoshikawa,K., Okazaki,I.M., Eto,T., Kinoshita,K., Muramatsu,M.,
Nagaoka,H. and Honjo,T. (2002) AID enzyme-induced
hypermutation in an actively transcribed gene in fibroblasts. Science,
296, 2033–2036.
53. Okazaki,I.M., Kinoshita,K., Muramatsu,M., Yoshikawa,K. and
Honjo,T. (2002) The AID enzyme induces class switch recombination
in fibroblasts. Nature, 416, 340–345.
54. Bowers,P.M., Horlick,R.A., Neben,T.Y., Toobian,R.M.,
Tomlinson,G.L., Dalton,J.L., Jones,H.A., Chen,A., Altobell,L. 3rd,
Zhang,X. et al. (2011) Coupling mammalian cell surface display with
somatic hypermutation for the discovery and maturation of human
antibodies. Proc. Natl. Acad. Sci. U.S.A., 108, 20455–20460.
55. Greisman,H.A., Lu,Z., Tsai,A.G., Greiner,T.C., Yi,H.S. and
Lieber,M.R. (2012) IgH partner breakpoint sequences provide
evidence that AID initiates t(11;14) and t(8;14) chromosomal breaks
in mantle cell and Burkitt lymphomas. Blood, 120, 2864–2867.
56. Schrader,C.E., Linehan,E.K., Mochegova,S.N., Woodland,R.T. and
Stavnezer,J. (2005) Inducible DNA breaks in Ig S regions are
dependent on AID and UNG. J. Exp. Med., 202, 561–568.
57. Schrader,C.E., Guikema,J.E., Wu,X. and Stavnezer,J. (2009) The
roles of APE1, APE2, DNA polymerase beta and mismatch repair in
creating S region DNA breaks during antibody class switch. Philos.
Trans. R Soc. Lond. B Biol. Sci., 364, 645–652.
58. Rada,C., Di Noia,J.M. and Neuberger,M.S. (2004) Mismatch
recognition and uracil excision provide complementary paths to both
Ig switching and the A/T-focused phase of somatic mutation.Mol.
Cell, 16, 163–171.
59. Shen,H.M., Tanaka,A., Bozek,G., Nicolae,D. and Storb,U. (2006)
Somatic hypermutation and class switch recombination in
Msh6(-/-)Ung(-/-) double-knockout mice. J. Immunol., 177,
5386–5392.
60. Basu,U., Meng,F.L., Keim,C., Grinstein,V., Pefanis,E., Eccleston,J.,
Zhang,T., Myers,D., Wasserman,C.R., Wesemann,D.R. et al. (2011)
The RNA exosome targets the AID cytidine deaminase to both
strands of transcribed duplex DNA substrates. Cell, 144, 353–363.
61. Zarrin,A.A., Del Vecchio,C., Tseng,E., Gleason,M., Zarin,P.,
Tian,M. and Alt,F.W. (2007) Antibody class switching mediated by
yeast endonuclease-generated DNA breaks. Science, 315, 377–381.
62. Flores-Rozas,H. and Kolodner,R.D. (2000) Links between
replication, recombination and genome instability in eukaryotes.
Trends Biochem. Sci., 25, 196–200.
63. Paul,A. and Paul,S. (2014) The breast cancer susceptibility genes
(BRCA) in breast and ovarian cancers. Front. Biosci., 19, 605–618.
64. Robbiani,D.F., Bunting,S., Feldhahn,N., Bothmer,A., Camps,J.,
Deroubaix,S., McBride,K.M., Klein,I.A., Stone,G., Eisenreich,T.R.
et al. (2009) AID produces DNA double-strand breaks in non-Ig
genes and mature B cell lymphomas with reciprocal chromosome
translocations.Mol. Cell, 36, 631–641.
65. Bardelli,A., Cahill,D.P., Lederer,G., Speicher,M.R., Kinzler,K.W.,
Vogelstein,B. and Lengauer,C. (2001) Carcinogen-specific induction




Fig. S1           Bregenhorn, et al. 
Ugi - + - + 







3 distance  58 nt 
Figure S1. DSB induction in the “58” substrate is EXO1-dependent 
The U/G-U/G substrate “58” nicked 5’ from the mispaired Gs was incubated with 
extracts of HEK293 cells pretreated with siRNA targeting EXO1 mRNA and 
supplemented where indicated with Ugi and/or recombinant purified EXO1. As shown, 
no DSBs are formed in the absence of EXO1, even though the nick in the bottom strand 
and the nearest UNG/APE1-cleaved abasic site in the upper strand are only 58 base 




































Figure S2. Graphic representation of  in vivo deletions detected in the U/G-U/G “304” 
substrate nicked 5’ from the mispaired Gs.  
A. Deletion in plasmids recovered from multiple transfections of HEK 293 cells with the listed 
substrates. B. As in A, but the substrates were transfected into HEK 293 cells depleted of MutSα. 
C. As in A, but the substrates were transfected into HEC 59 + chr2 cells (MMR-proficient). D. 
As in A, but the substrates were transfected into HEC 59 cells. Vertical red lines indicate the 
positions of the uracils and the triangle shows the position of the nick. 
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phenomenon	has	not	been	elucidated	to	date.	In	1986,	the	molecular	machinery	involved	in	DNA	demethylation	had	not	been	characterized	yet.	We	 therefore	 wanted	 to	 make	 use	 of	 this	 inducible,	 well-studied	 system	 to	address	 the	 enzymology	 behind	 the	 DNA	 methylation	 and	 demethylation	 in	hormone-dependent	gene	activation	and	the	effects	on	transcription.			Material	and	Methods		
Cell	culture	LMH/2A	cells	were	grown	 in	Williams'	E	medium	(GIBCO)	without	phenol	red,	supplemented	 with	 10%	 FCS,	 streptomycin/penicillin	 (100	 U/ml)	 and	 L-Glutamine	(2.4	mM).	MCF-7	cells	were	grown	in	DMEM	(GIBCO)	with	phenol	red,	supplemented	 with	 10%	 FCS,	 streptomycin/penicillin	 (100	 U/ml)	 and	 insulin	(Sigma-Aldrich,	10	µg/ml).	Cell	lines	were	grown	at	37°C	in	a	6%	CO2	humidified	atmosphere.	Where	 indicated,	 cells	 were	 treated	with	 100	 nM	 β-estradiol	 (E2,	Sigma-Aldrich)	 or	 an	 equivalent	 volume	 of	 ethanol,	 or	 with	 8	 µM	 aphidicolin	(aph,	ready	made	solution,	Sigma-Aldrich)	or	an	equivalent	volume	of	DMSO.	E2	and	aphidicolin	were	added	freshly	every	12	h,	because	of	instability	under	cell	culture	 conditions.	 For	 the	 TET2	 overexpression	 experiments,	 cells	 were	transfected	 with	 the	 mouse	 TET2	 expression	 vector	 (FH-Tet2-pEF	 a	 kind	 gift	from	Anjana	Rao	 (Addgene	 plasmid	#	 41710)(Ko	 et	 al.,	 2010))	 24	 h	 before	 E2	treatment.		





ab36794),	 rabbit	 Anti-TFIIH	 p89	 (Santa	 Cruz,	 sc-293),	 mouse	 Anti-ERα	(ThermoFisher,	 MA5-13065),	 mouse	 Anti-TET2	 (Abiocode,	 M1086-1),	 mouse	Anti-Flag	M2	(Sigma,	F3165),	mouse	Anti-HA	Tag	(GenScript,	A01244).		
Real-time	quantitative	PCR	(RT-qPCR)	Cells	 were	 harvested	 using	 trypsin	 and	 RNA	 was	 extracted	 according	 to	manufacturer's	 instructions	 (RNeasy,	 Qiagen).	 2	 µg	 of	 the	 extracted	 RNA	 was	reverse	 transcribed	 using	 the	 high	 capacity	 cDNA	 reverse	 transcription	 kit	(Applied	 Biosystems)	 according	 to	 manufacturer's	 instructions.	 125	 ng	 of	 the	cDNA	was	used	for	the	PCR	using	the	platinum	SYBR	green	qPCR	superMix-UDG	kit	 (Invitrogen)	 according	 to	 manufacturer's	 instructions,	 except	 that	 the	reaction	was	scaled	down	from	50	µl	to	20	µl.	The	standard	cycling	program	for	ABI	 instruments	was	used	(50°C	 for	2	min,	95°C	 for	2	min,	40x	(95°C	 for	15	s,	60°C	for	30	s)	and	melting	curve	analysis	at	65°C	for	15s,	heating	to	97°C	with	continuous	 acquisition	 per	 5°C,	 40°C	 for	 30	 s).	 The	 RT-qPCR	 was	 run	 on	 a	LightCycler	 480	 (Roche).	 GapDH	 primers	 were	 used	 as	 an	 internal	 control.	Technical	triplicates	were	made	for	every	sample	and	primer.	The	primers	used	are	listed	in	Table	S1	(SI).		





1,	 but	with	 500	mM	NaCl;	wash	 buffer	 3:	 10	mM	Tris,	 pH	 8,	 1	mM	EDTA,	 1%	sodium	deoxycholate,	500	mM	LiCl,	1%	NP-40;	wash	buffer	4:	10	mM	Tris,	pH	8,	1	mM	EDTA).	 One	 additional	wash	with	wash	 buffer	 4	was	 performed,	 during	which	the	beads	were	split	 for	DNA	and	proteins.	For	proteins:	the	beads	were	taken	up	 in	2x	SDS	 loading	dye	(100	mM	Tris,	pH	6.8,	20%	glycerol,	3.2%	SDS,	0.2	mM	DTT,	 0.04%	 bromophenol	 blue),	 the	mixture	was	 vortexed	 vigorously	and	incubated	for	30	min	at	100°C	(denaturing	and	de-cross-linking).	The	beads	were	spun	down	and	the	supernatant	was	loaded	on	an	SDS-PAGE	together	with	inputs.	Gels	were	processed	further	according	to	general	WB	protocol.	For	DNA:	beads	and	inputs	were	taken	up	in	100	µl	crosslink	reversal	buffer	(20	mM	Tris,	pH	8,	 0.5	mM	EDTA,	0.1	M	NaHCO3,	 1%	SDS,	RNase	 at	 10	µg/ml	 (Roche))	 and	incubated	at	65°C	overnight.	The	next	day,	the	DNA	was	purified	using	the	PCR	purification	kit	 from	Qiagen	and	eluted	in	10	µl	of	H2O.	RT-PCR	was	performed	on	 3.5	 µl	 of	 DNA	 using	 the	 platinum	 SYBR	 green	 qPCR	 superMix-UDG	 kit	(Invitrogen)	 according	 to	manufacturer's	 instructions,	 except	 that	 the	 reaction	was	scaled	down	to	20	µl	and	1	mM	of	MgCl2	were	added.	The	following	protocol	was	used	for	amplifications:	50°C	for	2	min,	95°C	for	2	min,	50x	(95°C	for	15	s,	57°C	for	30	s)	and	melting	curve	analysis	at	65°C	for	15	s,	heating	to	97°C	with	continuous	 acquisition	 per	 5°C,	 40°C	 for	 30	 s).	 The	 qPCR	 was	 run	 on	 a	LightCycler	 480	 from	 Roche	 with	 the	 following	 primers:	 fwd	 5'-TAAGCAAAGCTTTGGCTGCATTTTGTATTTGGTTCTGTAGGAAATG-3',	 rev	 5'-TAAGCAGCTAGCCTGCAGGCCAGAGGCTAATCCAGATAAACC-3'.		
Labeling	of	oligos	Fill-in	reaction	(3'-labeling):	2	pmoles	of	ds	5'-overhanged	DNA	were	incubated	for	 15	 min	 at	 RT	 with	 0.2	 µl	 of	 the	 respective	 [α-32P]-dNTP	 (2	 µCi,	 Hartman	Analytic),	1	mM	of	each	of	the	other	three	dNTPs	and	5	U	Klenow	fragment	(3'—>5'	exo-,	NEB)	in	the	corresponding	buffer.	The	enzyme	was	heat-inactivated	for	20	min	 at	 75°C	 and	 slowly	 cooled	 down	 to	 re-anneal	 the	 strands.	 Free	 dNTPs	were	removed	on	a	Sephadex	G-25	column	(GE	Healthcare).		Kinase	reaction	(5'-labeling):	2	pmoles	of	ssDNA	were	phosphorylated	with	0.7	µl	of	[γ-32P]-ATP	(7	µCi,	Hartman	Analytic)	using	T4	polynucleotide	kinase	(10	U,	NEB).	 The	 reaction	was	 supplemented	with	 10	mM	DTT	 and	 incubated	 for	 30	min	 at	 37°C.	 The	 reaction	 was	 heat-inactivated	 for	 5	 min	 at	 95°C	 and	 free	nucleotides	 were	 removed	 on	 a	 Sephadex	 G-25	 column	 (GE	 Healthcare).	 The	oligo	 was	 annealed	 to	 a	 1.5x	 excess	 of	 unlabeled	 complementary	 strand	 by	heating	 for	5	min	 to	80°C	and	slowly	cooled	down	 in	annealing	buffer	 (50	mM	Hepes,	pH	7.5,	100	mM	NaCl).		
Nuclear	extracts	All	 nuclear	 extracts	 were	 prepared	 according	 to	 Dignam	 et	 al.	 (Dignam	 et	 al.,	1983),	with	or	without	pretreatment	of	the	cells	with	E2.		




310)	and	1	µg	 for	10	µg	of	nuclear	 extracts.	 For	 all	EMSAs,	10	 fmol	of	 [α-32P]-dNTP	labeled,	or	[γ-32P]-ATP	phosphorylated	oligos	were	used.	Where	indicated,	an	 excess	 of	 unlabeled	 competitor	 DNA	 or	 100	 nM	 of	 E2	 were	 added.	 For	 the	supershift	 assays,	 200	 ng	 of	 antibody	 (Anti-ERα;	 ThermoFisher	 MA5-13065)	were	added	 together	with	 the	proteins.	Proteins,	 and	 competitor	or	 antibodies	where	 indicated,	 were	 incubated	 for	 20	min	 on	 ice	 in	 binding	 buffer.	 Labeled	DNA	was	added	and	the	mixture	was	left	at	RT	for	another	20	min	before	loading	on	a	5%	polyacrylamide	gel	(Acryl/	Bis	29:1,	Amresco)	eluted	with	1x	TAE	(40	mM	Tris,	20	mM	acetate,	1	mM	EDTA).	The	gels	were	run	at	200	V	for	1	h	in	1x	TAE	and	dried	in	a	gel	dryer	for	1	h.	The	gels	were	exposed	to	phosphor	screens	and	the	autoradiographs	were	developed	in	a	typhoon	FLA	9500	(GE	Healthcare	Life	Sciences).	The	oligonucleotides	used	are	listed	in	Table	S2	(SI).		
SDS-PAGE	of	cross-linked	binding	reactions	EMSAs	were	performed	as	described	and	cross-linked	for	5	min	(~720	mJoules)	in	a	UV	Stratalinker	1800	(Stratagene).	Samples	were	taken	up	in	2x	SDS	loading	buffer	 and	boiled	 for	5	min	before	being	 loaded	on	 a	7.5%	polyacrylamide	 gel	and	run	for	1-2	h	in	10%	SDS-running	buffer	at	130	V.	Gels	were	dried	for	1	h,	exposed	 to	 phophor	 screens	 and	 developed	 in	 a	 typhoon	 FLA	 9500	 (GE	Healthcare	Life	Sciences).		
CpGL	cloning	and	Luciferase	assay	The	 enhancer/promoter	 region	 of	 the	 chicken	 vitellogenin	 gene	 spanning	nucleotides	 -638	 to	 -1	 was	 cloned	 into	 a	 CpG-free	 firefly	 luciferase	 plasmid	(pCpGL-basic,	InvivoGen)	using	HindIII	and	NcoI.	The	enhancer	promoter	region	was	amplified	from	genomic	DNA	of	LMH/2A	cells	using	the	forward	primer	5'-TAAGCAAAGCTTTGGCTGCATTTTGTATTTGGTTCTGTAGGAAATG-3'	 and	 the	reverse	 primer	 5'-ATTCGTCCATGGCGAAGGTGAATAGGGCTCTGCC-3'.	 The	plasmid	 was	 further	 cut	 with	 HindIII	 and	 HpaII	 to	 excise	 the	 intervening	sequence	and	the	annealed	upper	5'-AGCTTAAAAATATTCCTGGTCAGCGTGAC-3'	and	 lower	 5'-CGGTCACGCTGACCAGGAATATTTTTA-3'	 ds-oligo	 was	 ligated	 into	the	plasmid	to	translocate	the	HindIII	site	closer	to	the	ERE	for	further	ligations	of	the	ERE.	On	the	other	side	of	the	ERE	a	KpnI	site	was	created	by	mutagenesis	using	 the	 following	 primers:	 new	 KpnI	 fwd	 5'-CCGGAGCTGAAAGAACACATGGTACCCGTGATTTCAATAAATAC-3';	 new	 KpnI	 rev	5'-GTATTTATTGAAATCACGGGTACCATGTGTTCTTTCAGCTCCGG-3'.	 Another	





Mutagenesis	of	VTG-CpGL	200	ng	of	vector	DNA	were	mixed	with	50pmoles	forward	and	reverse	primers,	250	µM	dNTPs,	2%	DMSO	and	1	U	phusion	high	 fidelty	polymerse	(NEB)	 in	1x	buffer	 provided	 by	 the	 manufacturer.	 Extension	 was	 performed	 in	 50	 µl	according	to	the	following	protocol:	95	°C,	2	min;	30x	(95	°C,	1	min,	55	°C,	1	min,	63	°C,	30	min);	68	°C,	20	min;	15	°C	hold.	Extension	reaction	was	digested	twice	with	20	U	DpnI	for	1	h	at	37°C	followed	by	heat	inactivation	of	the	enzyme	for	20	min	at	80°C.	The	reaction	mix	was	then	transformed	into	electro-competent	Pir1	bacteria	(R6K	gamma	ORI,	Invitrogen)	after	being	desalted	by	incubating	for	15	min	on	a	0.025	µm	Millipore	nitrocellulose	filter	on	H2O.	Bacteria	were	shaken	at	37°C	 for	 40	 min	 and	 plated	 onto	 Zeocin	 (25	 µg/ml,	 InvivoGen)	 agar	 plates.	Clones	were	picked	the	next	day,	grown	in	liquid	culture	overnight	and	plasmids	were	extracted	using	the	NucleoSpin	Plasmid	Kit	(Macherey-Nagel)	according	to	manufacturer's	 instructions.	 Plasmids	 were	 sequenced	 at	 Microsynth	 to	 check	for	 successful	mutagenesis.	The	primers	 for	mutagenesis	are	 listed	 in	Table	S3	(SI).	 For	 sequencing,	 the	 following	 primers	were	 used:	 VTG	 enhan	 seq	 fwd	 5'-GCAATCAATATTGAAAACCAC-3';	 CpGL	 seq	 luc1	 fwd	 5'-CGTGAAGAGAATTTATGATTGC-3';	 CpGL	 seq	 luc2	 fwd	 5'-CCCTGACACTGCCATCCTG-3'.		








	The	 resulting	mix	was	concentrated	by	EtOH	precipitation	and	 the	 supercoiled	form	 of	 the	 plasmid	 was	 extracted	 on	 a	 CsCl	 gradient	 and	 purified	 further	 as	described	(Baerenfaller	et	al.,	2006).	
	
In	vitro	methylation	1	µg	of	plasmid	DNA	was	 incubated	in	1x	NEB	buffer	2,	160	µM	freshly	diluted	SAM	 (NEB)	 and	 4	 U	 of	 SssI	 (NEB)	 for	 1	 h	 at	 37°C.	 Reaction	 was	 stopped	 by	heating	to	65°C	for	20	min.		
EdU	incorporation	and	Click-iT	Reaction	Cells	were	grown	on	coverslips	and	treated	with	8	µM	aphidicolin	or	DMSO,	100	nM	E2	or	ethanol	and	10	µM	of	5-ethynyl-2'-deoxyuridine	(EdU,	 Invitrogen)	 for	24h.	Medium	was	removed,	cells	were	washed	once	with	PBS	and	1	ml	of	3.7%	formaldehyde	in	PBS	was	added.	Cells	were	fixed	for	15	min	at	RT	before	being	washed	twice	with	1	ml	of	3%	BSA	in	PBS.	1	ml	of	0.5%	Triton	X-100	in	PBS	was	added	and	cells	were	 incubated	 for	20	min	at	RT.	Click-iT	 reaction	master	mix	was	 prepared	 (for	 5	 slides):	 129	 µl	 1x	 Click-iT	 reaction	 buffer	 (freshly	 diluted	1:10	in	H2O),	6	µl	CuSO4,	0.36	µl	Alexa	Fluor	azide,	15	µl	reaction	buffer	additive	(freshly	 diluted	 1:10	 in	 H2O).	 Permeabilization	 buffer	 was	 removed	 and	 cells	were	washed	twice	with	1	ml	3%	BSA	in	PBS.	30	µl	of	Click-iT	reaction	mix	were	pipetted	onto	Parafilm	and	the	coverslips	were	put	cells-down	onto	the	mix	and	incubated	for	30	min	at	RT,	protected	from	light.	Coverslips	were	washed	once	with	1	ml	of	3%	BSA	in	PBS	and	then	washed	well	with	1x	PBS	to	remove	BSA.	After	one	final	wash	with	H2O,	cells	were	fixed	with	mounting	media	containing	4',6-diamidino-2-phenylindole	 (DAPI,	 VectaShield).	 Slides	were	 analyzed	 on	 an	Olympus	IX81	fluorescence	microscope.	
	





Polymerase	chain	reaction	on	bisulfite	converted	DNA	100	ng	of	bisulfite-converted	DNA	was	used	as	 template	 for	 the	PCR	using	 the	ZymoTaq	DNA	polymerase	(Zymo	Research).	The	reaction	was	carried	out	 in	a	total	 volume	 of	 40	 µl	 in	 the	 reaction	 buffer	 provided	 by	 the	 manufacturer	supplemented	with	of	1	mM	dNTPs,	1.5	mM	MgCl2,	500	mM	each	primer	and	2	U	of	polymerase.	The	cycling	protocol	was	as	follows:	10	min	95°C;	5x	(30	s	94°C;	30	s	52°C;	90	s	72°C);	5x	(30	s	94°C;	30	s	52°C;	90	s	72°C);	35x	(30	s	94°C;	30	s	55°C;	90	s	72°C);	7	min	72°C.	The	primers	used	were:	Upper	strand	forward	5'-TAAGCAAAGCTTTTTGTTTATTTAAAAATATTTTTGGTTAG-3';	 Upper	 strand	reverse	 5'-TAAGCAGCTAGCCCTCAACTTTAATTTATAACCATTC-3';	 Lower	 strand	forward	 5'-TAAGCAAAGCTTAGTTTTGGTTTATGGTTATTTTTGTA-3';	 Lower	strand	 reverse	 5'-TAAGCAGCTAGCCAAAATACTTATAAAACCTTTATTCATTTA-3'.	The	 forward	 primers	 were	 only	 added	 after	 the	 first	 5	 cycles	 to	 reduce	 the	formation	of	primer	dimers.	The	PCR	fragments	were	purified	using	a	BluePippin	(Sage	 Science)	 on	 a	 2%	 agarose	 gel	 according	 to	 manufacturer's	 instructions,	before	being	bar-coded	for	PacBio	sequencing.		
PacBio	sequencing	and	analysis	Pacific	 Biosciences	 developed	 a	 new	 sequencing	 approach	 that	 uses	 single-molecule	 real-time	 technology	 (SMRT),	 referred	 to	 as	 PacBio	 sequencing.	 The	converted	RSII	sequencers	allow	time-resolved	single-molecule	studies	based	on	custom	experimental	design	(in	manual	operation	mode).	Any	desired	probe	can	be	immobilized	on	the	surface	of	the	SMRT	cell,	which	consists	of	150'000	zero-mode	 waveguide	 (ZMW)	 nanostructures	 allowing	 to	 work	 with	 up	 to	 50'000	single	 molecules	 in	 parallel.	 The	 nanostructures	 allow	 for	 discrimination	between	 single	 molecule	 binding	 events	 and	 fluorescent	 background	 even	 at	high	analyte	concentration.	SMRT	 is	 a	 fluorescence-based	 method.	 For	 each	 of	 the	 150'000	 ZMW	nanostructures,	traces	in	four	wavelength	channels	are	stored.	Software	for	data	evaluation	 was	 created	 by	 informaticians	 at	 the	 Functional	 Genomic	 Center	Zurich	 (FGCZ).	 The	 technology	 is	 able	 to	 produce	 long	 reads	 via	 a	 strand-displacement	mechanism	of	 the	polymerase.	The	resulting	high-quality	circular	consensus	 reads	 faithfully	 correct	 the	 high	 error-rate	 of	 the	 polymerase,	resulting	in	very	accurate	sequencing	results.			Results		
The	 vitellogenin	 enhancer	 is	 methylated	 and	 the	 gene	 silenced	 in	 LMH/2A	 cells	
prior	 to	 exposure	 to	 β-estradiol	 and	 is	 induced	 upon	 hormone	 treatment,	






























Fig 1: VTG mRNA expression is induced upon `<estradiol (E2) treatment in LMH/2A cells, independently of DNA 
synthesis. A Sequence of the enhancer/promoter region of the chicken VTG gene. The ERE binding site (violet), the 
CpGs (green) and the translation start site (yellow) are highlighted. The  four CpGs (a-d) analyzed in Saluz et al. are 
indicated . B Bisulfite sequencing results of the four CpGs in the VTG enhancer region for the lower and the upper DNA 
strand.  C VTG mRNA levels were measured with qPCR after 6 and 24 hours of 100 nM E2 treatment and with additional 
treatment with 8 µM aphidicolin or DMSO for 24h (D). Data are represented as mean ± SD. Significance was assessed 

























































































































Fig 2: ER_ directly interacts with the VTG enhancer upon E2 treatment. Upper panel: Western Blot 
of chromatin extracts immunoprecipitated with Flag- or ER_antibodies (- and + `<estradiol treatment). 
Lower panel: RT-qPCR of immunoprecipitated DNA. Right panel: Ratio of signal of immunoprecipitated 
DNA and input DNA.


























































Fig 3:  CpGs a-d are not demethylated, but E2 treatment brings about conversion of 5mC to 5hmC.
A Representative bisulfite and oxidated-bisulfite sequencing result of CpG a. The numbers below the 
upper panel indicate the total amount of analyzed reads per condition. The percentage of 5hmC (lower 
panel) was calculated as the difference of converted Cs between the oxidated-bisulfite converted DNA 
and the only-bisulfite converted DNA. B Induction of VTG mRNA with mock treatment or mTET2 overex-
pression measured by qPCR (left panel). Data are represented as mean ± SD. C Western Blot showing 









Binding	 of	 ERα	 to	 the	 ERE	 is	 insensitive	 to	 different	 cytosine	 modifications	 and	




The	binding	of	ERα	could	be	shown	to	be	 insensitive	to	methylation	of	 the	two	CpGs	 within	 the	 ERE	 at	 different	 receptor	 concentrations	 (Fig.	 4	 E).	Hemimethylation	(Supp.	Fig.	3	B	&	C),	as	well	as	hydroxy-	(Supp.	Fig.	3	B	&	D)	and	hemihydroxymethylation	(Supp.	Fig.	3	B	&	E),	of	the	ERE	also	failed	to	affect	ERα	 binding.	 Also	 formylcytosine	 and	 carboxycytosine	 in	 the	 ERE	 had	 no	influence	on	receptor	binding	(Supp.	Fig.	3	B).	To	confirm	the	specificity	of	 the	binding,	another	mutant	missing	all	three	nucleotides	of	the	spacer,	resulting	in	direct	 palindromic	 repeats,	 was	 included	 and	 competition	 assays	 were	performed	on	the	45	bp	oligos	and	additionally	on	shorter,	25	bp	oligos	(Supp.	Fig.	 3	 F	 &	 G).	 The	 methylated	 and	 the	 hydroxymethylated	 oligos	 successfully	competed	with	the	unmethylated	oligos,	whereas	the	mutants	did	not.		
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Fig 4: Binding of recombinant ER_ to the ERE is methylation- and hormone-insensitive. A Oligos used for radioac-
tive EMSAs, showing the ERE (violet) and the CpGs (green). B Upper panel: Representative EMSA with increasing 
concentrations of recombinant ER_ (0, 5, 10, 20, 30, 40, 80 and 200 ng) on unmethylated ERE wt oligo and ΔG oligo in 
the last lanes with 40 ng of ER_- (left panel) /+ (right panel) E2. Quantification of percentage bound oligo on unmeth-
ylated (middle panel) or methylated (lower panel) oligo of three independent experiments. Data are represented as 
mean ± SD. C EMSA with 60 ng recombinant ER_ and unmethylated ERE wt oligo, with or without E2 or competitor. 
D EMSAs showing a supershift with ER_ antibody with unmethylated oligo. E Upper panel: Representative EMSA with 
increasing concentrations of recombinant ER_ (0, 5, 10, 20, 30, 40, 80 and 200 ng) and unmethylated (left panel) or 
methylated (right panel) ERE wt oligo and ΔG oligo in the last lanes with 40 ng of ER_. Lower panel: Quantification of 
percentage bound oligo of three independent experiments. Data are represented as mean ± SD.
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Fig 5: Transcription of a luciferase reporter is inhibited upon methylation of the VTG enhancer/promoter region. 
A Scheme of the CpG-free luciferase reporter under the control of the VTG enhancer/promoter. B Luciferase expression 
of unmethylated and in vitro methylated (SssI) CpG-free plasmid with wt ERE (C/C) and a single nucleotide deletion in 
the spacer of the ERE (ΔG). C As B, additionally with a plasmid methylated with HpaII, only present in one CpG in the 
ERE. D Luciferase expression from the plasmid with different cytosine modifications only in the two CpGs in the ERE.  















Fig 6: A methylation-sensitive shift on ERE wt and ΔG that is not mediated by ER_A EMSA with LMH/2A nuclear 
extracts (NEs) pretreated for 24 h with EtOH (LMH/2A-) or 100 nM E2 (LMH/2A+) and recombinant ER_ (last lane). Where 
indicated, reaction mixtures were supplemented with EtOH (-), 100 nM E2 (+) or 100 x excess of specific (spec) or unspe-
cific (unspec) competitor. B EMSA comparing binding of LMH/2A and MCF-7 NEs on unmethylated and methylated ERE 
oligo, -/+ E2. C EMSA comparing  recombinant protein with LMH/2A NEs on shorter oligos (ERE short) unmethylated 
(C/C) and methylated (mC/mC) and a shorter ΔG oligo (ΔG short). D Upper panel: EMSA with LMH/2A NE with titration 
of indicated amounts of recombinant ER_on different oligos. Lower panel: Quantification of ratio of bound oligo by 
ER_ and factor X of three independent experiments. Data are represented as mean ± SD. Significance was assessed 
using the Holm-Sidak test. For A and B oligos from Fig 4 A were used. For C and D oligos depicted in C were used. 
E-H UV-crosslinked binding reaction using 60 µg of LMH/2A or MCF-7 (H) NE and recombinant ER_ and short oligos 
containing BrdU (E, lower panel). Where indicated, 100 nM E2, recombinant ER_ or competitor was added to the 
reaction mix. Crosslinked complexes were resolved on an 8% polyacrylamide gel and visualized on phosphor screens.














































































































































on	the	different	sequences.	The	methylation	sensitivity	on	the	ERE	has	been	seen	before	and	also	on	CpG1	there	was	an	influence	of	methylation,	but	not	on	CpG2.	The	strongest	effect	of	methylation	however,	could	be	seen	on	CpG7.	The	same	behavior	was	visible	in	MCF-7	(Supp.	Fig.	4	E)	and	in	HeLa	extracts	(Supp.	Fig.	4	F).	 SDS	 gels	 with	 cross-linked	 binding	 reactions	 showed	 a	 band	 with	 similar	mobility	on	CpG7	as	on	the	ERE	and	an	additional	band	migrating	slightly	slower	in	LMH/2A	(Fig.	7	B)	and	in	HeLa	NE	(Fig.	7	C).			










































Fig 7: CpG 7 shows strong methylation-sensitivity of a complex migrating at the same height as on the ERE. 
A Left panel: EMSA with LMH/2A nuclear extracts on four different CpG-containing regions bearing different cyto-
sine combinations. Right panel: Quantification of percentage bound oligo of three independent experiments. Data 
are represented as mean ± SD. Significance was assessed using the Tukey test for multiple comparisons. 
B & C UV-crosslinked binding reaction using 60 µg of LMH/2A (B) or HeLa (C) NE and recombinant ER_ (first lanes) 
and short oligos containing BrdU (Fig. 6 E, lower panel). Oligo Δ3 misses the 3nt of the spacer region in the ERE. 











































































CpG7	 plays	 an	 important	 role	 in	 the	 methylation-sensitivity	 of	 the	 expression	 of	





SssI.	To	check	whether	the	mutation	in	CpG7	directly	affects	factor	X	binding,	we	performed	an	EMSA	on	the	mutant	oligo	and	saw	reduced	binding	as	compared	to	the	wt	unmethylated	oligo	bearing	CpG7,	but	still	stronger	binding	than	with	wt	methylated	CpG7	(Fig.	8	D).	This	translated	directly	to	luciferase	expression,	where	 the	 mutant	 CpG7	 showed	 intermediate	 expression	 between	 wt	unmethylated	and	wt	methylated,	hinting	towards	an	important	role	of	factor	X	binding	in	transcriptional	activation.	The	expression	in	all	the	other	mutants	was	still	 inhibited	 when	 methylated	 with	 SssI,	 showing	 that	 these	 individual	 sites,	when	unmethylated,	had	no	influence	on	transcription	(Fig.	8	E	&	Supp.	Fig.	5	D).				
A B
C
Fig 8: CpG7 is responsible for the methylation-sensitivity of the VTG enhancer/promoter. A Scheme of experimental 
setup. B Luciferase assay of different mutants. One representative experiment is shown. Data are represented as mean of 
technical triplicates ± SD. C Luciferase assay of wt unmethylated plasmid (wt), C to T mutations in the ERE (mut ERE) and 
mutation of CpG7 (C594T). Data are represented as mean of three independent experiments ± SD. D EMSA showing bind-
ing of factor X to unmethylated (7), methylated (7 mC) and mutant CpG7 (C594T) in LMH/2A and HeLa nuclear extracts. E 
Same as B but mutants are methylated with SSSI. F Luciferase assay of wt CpGL, of the CpGL with all CpGs mutated except 
for the ERE, CpG7 and CpG8 (ERE/7/8 wt) and the CpGL with all mutated except for the ERE and CpG7(ERE/7 wt), unmethyl-












































































































































Since	CpG7	seems	to	play	an	important	role	in	the	control	of	VTG	transcription,	but	we	could	not	analyze	the	mutant,	we	had	to	use	a	different	approach.	We	set	out	to	mutate	all	CpGs	together,	except	for	CpG	c	and	d	in	the	ERE	and	CpG7.	We	tested	the	combined	mutants	successively	to	exclude	that	 interactions	between	different	sites	had	any	additional	 influence	on	transcription,	which	was	not	the	case.	All	combinations	tested	were	still	active	when	unmethylated	and	inhibited	when	 methylated	 (Supp.	 Fig.	 5	 E).	 Analysis	 of	 the	 final	 plasmid	 (ERE/7	 wt)	unmethylated	and	methylated	confirmed	that	methylation	of	CpG7	and	possibly	the	 combination	with	methylated	 ERE	 (even	 though	methylation	 of	 ERE	 alone	had	no	effect,	Fig.	5	D),	was	conferring	the	inhibition	(Fig.	8	F).	This	prompted	us	to	 conclude	 that	 proteins	 binding	 to	 CpG7	 were	 key	 to	 the	 regulation	 of	expression	 of	 VTG	 and	 that	 their	 binding	 was	 methylation-sensitive.	 Figure	 9	shows	 a	 summary	 of	 the	 results	 obtained	 with	 the	 luciferase	 experiments,	highlighting	again	the	importance	of	CpG7	(arrows).			
Fig 9: CpG7 is responsible for the 
methylation-sensitivity of the VTG 
enhancer/promoter. Summary scheme of 
luciferase assays with the different CpGLs. 
White circles represent unmethylated, black 
circles methylated and blue circles hydroxym-
ethylated CpGs. Ticks indicate induction of 
expression, crosses indicate inhibited expres-
sion. The first five lines show plasmids prepared 
with ligation of short oligos bearing the ERE 
with different cytosine modifications. The 
others were in vitro methylated using SssI, the 




with	 an	 assigned	 role	 in	 demethylation,	 namely	 the	 TETs	 and	 thymine	 DNA	glycosylase	(TDG),	and	that	are	present	in	chicken	embryonic	and	adult	liver,	are	also	 present	 in	 the	 cell	 line.	 The	 involvement	 of	 yet	 unknown	 factors	 in	 the	demethylation	event	at	the	VTG	enhancer	is,	however,	conceivable.	The	finding	that	5hmC	is	enriched	at	the	CpGs	upon	hormone	treatment	and	the	increase	 in	 VTG	 expression	 when	 TET2	 is	 overexpressed,	 points	 towards	 a	functional	 role	 of	 the	 oxidized	 base	 in	 transcription.	 The	 levels	 of	 5hmC	 are,	however,	low	and	there	is	the	possibility	that	TET2	influences	gene	expression	in	a	way	other	than	oxidation	of	5mC.	Another	intriguing	point	is	that	no	oxidation	beyond	 5hmC	 was	 detected.	 5fC	 or	 5caC	 would	 have	 led	 to	 the	 bisulfite-dependent	 conversion,	which	was	 not	 detectable.	 The	 question	 arises	whether	this	 is	 a	 situation	where	 the	TET-mediated	oxidation	cascade	 specifically	 stops	after	 a	 single	 step.	 Another	 possible	 explanation	would	 be	 that	 excision	 of	 5fC	and	 5caC	 and	 re-methylation	 of	 the	 replaced	 cytosine	 are	 extremely	 fast	 and	efficient	 processes.	 Such	 cyclical	 DNA	 methylation	 and	 demethylation	 events	have	been	observed	in	the	pS2	promoter	upon	hormone	treatment	(Kangaspeska	et	al.,	2008;	Metivier	et	al.,	2008).	Even	 though	we	did	not	detect	demethylation	of	 the	enhancer,	 the	observation	that	 we	 can	 shut	 down	 expression	 with	 in	 vitro	 methylation	 of	 the	 gene	regulatory	 region	 points	 towards	 an	 important	 role	 of	 CpG	methylation	 in	 the	regulation	 of	 VTG.	 It	 indicates	 that	 methylation	 in	 this	 system	 is	 more	 than	 a	mere	basal	state,	resulting	as	a	consequence	of	gene	inactivity	before	encounter	with	β-estradiol.	The	fact	that	we	do	not	see	differential	binding	of	the	estrogen	receptor	α	when	the	ERE	is	methylated	or	hydroxymethylated	puzzled	us	at	first,	considering	the	reported	 importance	of	methylation	 at	 this	 locus	 and	our	observations	with	 in	





within	 the	VTG	 enhancer	has	been	described	 (Feavers	et	 al.,	 1987).	We	 indeed	detected	a	methylation-sensitive	mobility	shift	(factor	X)	on	the	ERE	in	nuclear	extracts	 (NEs)	 that	 was	 not	 cell	 type-specific.	 We	 doubt,	 however,	 that	 this	protein	 is	similar	 to	 the	NHPs	published,	due	 to	different	molecular	weights	as	assessed	by	denaturing	SDS	gels.	Additional	evidence	arguing	against	the	NHPs	are	the	strongest	contact	sites	of	NHP1	that	were	found	to	be	the	AGCG,	lying	in	the	spacer	 region	between	 the	palindromic	half	 sites	 (Hughes	et	al.,	1989).	We	see	a	stronger	binding	of	factor	X	on	the	ΔG	substrate	that	misses	the	middle	G	of	this	 sequence.	 Another	 observation	 made,	 concerning	 factor	 X	 binding	 to	 the	ERE,	was	 that	 this	was	 the	 only	 shift	 we	 saw	 in	 NEs.	We	 do	 not	 see	 any	 ERα	binding,	despite	the	presence	of	ERα	in	the	NEs,	arguing	for	a	competition	for	the	ERE	binding	site.		The	second	explanation	for	the	different	methylation	sensitivities	in	the	reporter	and	the	EMSA	could	lie	in	the	regulatory	sequence	downstream	of	the	ERE.	There	are	 six	 additional	 CpGs	 in	 the	 control	 region	 of	 VTG,	 besides	 the	 four	 CpGs	published.	The	inhibitory	effect	of	methylation	was	most	likely	mediated	by	one	or	several	of	these	CpGs.	We	were	able	to	pin	down	the	inhibitory	effect	of	the	in	
























































































Supplementary Fig. 1: A Upper panel: mRNA levels were measured with qPCR after the indicated lenght of 
treatment with 100 nM E2 . One representative experiment is shown in technical triplicates. Data are repre-
sented as mean ± SD. Lower panel: Western Blot showing VTG protein levels and TFIIH as an internal loading 
control. B Relative ER_ mRNA levels measured by qPCR after 6 and 72 h of E2 treatment. One representative 
experiment is shown in technical triplicates. Data are represented as mean ± SD. C Immunofluorescence of 
EdU incorporation without (left panels) or with 8 µM aphidicolin treatment (right panels) without (upper 
panels) and 24h (lower panels) of E2 treatment.
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Supplementary Fig. 2: Bisulfite and oxidised-bisulfite sequencing result of the CpGs b (A), c (B) and d 
(C). The left panels show the results of the transcribed strand, the right panels show the non-
transcribed strand. The numbers under the upper panels indicate the total amount of analyzed reads 
for every condition. The percentage of 5hmC (lower panels) was calculated as the difference of 
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Supplementary Fig. 3: A EMSA showing binding of ER_ to ERE and ΔG substrates of different methylation status, -/+ 
E2 treatment. B EMSA with different cytosine modifications in the ERE, including formylcytosine (fC) and carboxycyto-
sine (caC). C-E EMSA with increasing concentrations of recombinant ER_ (0, 5, 10, 20, 30, 40, 80 and 200 ng) and 
indicated cytosine modifications in ERE wt and ΔG substrates in the last lanes with 40 ng of ER_. Additionally in E right 
panel: Quantification of percentage bound oligo of three independent experiments of fully hemi- and fully-
hydroxymethylated oligos.  Data are represented as mean ± SD.  F & G EMSA on unmethylated ERE with competition 








































- + - + 200ng AB
Supplementary Fig. 4: A EMSA with LMH/2A nuclear extracts and different combinations of modified oligos, -/+ E2. 
B EMSAs with addition of ER_ antibody with unmethylated (left panel) and methylated (right panel) oligo in LMH/2A 
NEs. C EMSA in LMH/2A with increasing concentrations of a RARE consensus competitor or ΔG competitor on 
unmethylated (C/C) or methlyated (mC/mC) ERE. D EMSAs in LMH/2A NEs on ERE and CpG3 with combinations of 
different cytosine modifications showing complexes with distinct mobilities. E EMSA on CpG4, CpG5_6, CpG7 and 
CpG8 in LMH/2A (left panel) and MCF-7 (right panel) NEs, unmethylated and methylated. F EMSAs in HeLa (left 






































































































































Supplementary Fig. 5: A Luciferase assays of different mutants, unmethylated. Data are represented as mean of techni-
cal triplicates ± SD. B Luciferase assay of wt unmethylated plasmid (wt), C to T mutations in CpG7 (C594T) and in CpG8 
(C655T). Data are represented as mean of three independent experiments ± SD. C Fold luciferase induction upon E2 
treatment of different mutants. Data are represented as mean of three independent experiments ± SD. D Luciferase 
assays of different mutants, methylated with SssI. Data are represented as mean of technical triplicates ± SD. E Luciferase 
assays of combined mutants, unmethylated and methylated with SssI. Data are represented as mean of technical tripli-
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Supplementary Fig. 6: EMSA on unmethylated ERE wt of proteins from affinity purification with the ERE wt or ΔG 
from HeLa (A) or LMH/2A (B) nuclear extracts. As a control, beads only eluents were used.
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TET1	 and	 TET2	 could	 be	 detected	 in	 the	 chicken	 hepatoma	 cell	 line	 LMH	 (Fig	 R1	 A)	 and	 in	






Figure R 1: Detection of TETs and cytosine species in LMH/2A and embryonic and adult 
chicken liver. A Western Blots of TET2 (upper panel) and TET1 (lower panel) in different cell 
lines. B Dot Blot of genomic DNA from LMH cells. C As in A, using whole cell extracts (WCE) 
from embryonic (E) and adult (A) chicken liver. TFIIH was used as the loading control. D As in 




We	 investigated	 the	 site-specific	 and	 inducible	 demethylation	 of	 the	 vitellogenin	 enhancer	 in	






































of	embryonic	development.	 Interestingly,	while	CpGs	a,	c	and	d	were	~90%	methylated	 in	 the	
basal	state,	CpG	b	showed	reduced	methylation	levels	of	70-80%	(Fig	R2	B).	This	phenomenon	is	
comparable	to	the	adult	rooster,	where	one	strand	of	CpG	b	was	unmethylated	already	prior	to	
hormone	 treatment	 and	 the	 other	 strand	 50%	 methylated,	 in	 contrast	 to	 90%	 symmetrical	
methylation	of	the	other	CpGs	[332].	Also,	in	LMH/2A	cells,	CpG	b	was	a	special	case,	being	50%	





Figure R 2: Manipulations of chicken embryos in ovo. A Eggs were 'windowed' to enable access 
for manipulations. B Basal methylation states of the four CpGs described by Saluz et al., assessed 







an	 approach	 that	 combined	 affinity-enrichment	 and	mass	 spectrometry	 (MS).	 To	 improve	 the	







































































spectrometric	 analysis	 of	 the	 proteins	 bound	 to	 these	 substrates	 upon	 incubation	 with	 HeLa	
extracts	identified	several	proteins	binding	the	ERE	that	were	absent	in	the	control	(Table	1).	A	
candidate	 that	 caught	 our	 attention	 was	 Max-like	 protein	 X	 (MLX).	 MLX	 is	 a	 helix-loop-helix	
transcription	 factor,	 known	 to	bind	 the	E-box	 sequence	CTCGAG.	The	deletion	of	 the	G	 in	 the	
ERE	spacer	in	DG	generates	an	E-box	motif	and	CpG7,	shown	to	bind	the	same	protein	complex	
in	NEs,	is	located	in	an	E-box	(Results	II).	
Table 1: Proteins enriched from HeLa NE. Proteins of the MAX network are marked in green. 
	
We	 performed	 the	 same	 pull-down/	 MS	 experiment	 also	 with	 LMH/2A	 NEs	 and	 could	 also	
retrieve	MLX,	specifically	in	the	affinity	purification	with	ERE	wt	and	DG,	but	not	in	the	control	




Spectrum ΔG Spectrum beads Probability if 
detected 
MLXPL 93 19  >95% 
MLX 33 13  >95% 
NR2F6 43 11  >95% 
MSH6 153 18 4 >95% 
NR2C2 65 20  >95% 
RXRB 57 10  >95% 
MSH2 105 12 6 >95% 
UBP1 60 15  >95% 
MPG 33 12  >95% 
MLXIP 101 19  >95% 
ESRRA 46 9  >95% 
ZBTB9 51 9  >95% 
ZBED1 78 10  >95% 
RFX5 65 8  >95% 
NR2C1 67 9  >95% 
MGA 332 7  >95% 
MAX 18 4  >95% 	
																																																																																																																																																																																								RESULTS		
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Table 2: Proteins enriched from LMH/2A NE. Proteins of the MAX network are marked in 
green. 
	
To	verify	 that	MLX	 is	 involved	 in	 the	 complex,	 causing	 the	mobility	 shift	with	ERE	wt,	DG	and	







Spectrum ERE Spectrum ΔG Spectrum beads Probability if 
detected 
Gga 147 64 63  >95% 
SALL4 118 56 58  >95% 
RXRG 51 40 35 2 >95% 
CHD4 219 35 31  >95% 
KIA1958 79 20 20  >95% 
ESR1 67 16 11  >95% 
HNF1A 69 13 8  >95% 
CREBBP 265 13 13  >95% 
RARG 49 8 11  >95% 
NR2C1 62 9 8  >95% 
MPG 30 5 6  >95% 
NR2F1 46 6 7  >95% 
MSH2 95 6   >95% 
TBX3 78 4 4  >95% 
HNF4A 51 5 5  >95% 
CTBP1 47 5 7  >95% 
MSH6 142 6 4  >95% 
TDG 45 4 6  >95% 
LXRA 47 3 4  >95% 
NR2C2 65 5 4  >95% 
MLXIP 89  6  >95% 
ZBTB17 89 3 5  >95% 
MLX 28  4  >95% 




Figure R 3: Supershift experiments show evidence for the role of MLX in factor X shift. 200ng of 
the indicated antibodies were added to the EMSA reaction with LMH/2A NE. The mobility 




We	 checked	 the	 localization	 of	 human	 TET1	 and	 mouse	 TET2	 full-length	 proteins	 upon	
expression	in	HEK293	cells.	Both	proteins	were	expressed	in	the	cells	24	h	after	transfection,	as	
assessed	 by	 immunofluorescence	 against	 their	 Flag	 tag	 (Fig	 R4	 A).	 They	 were	 successfully	
targeted	 to	 the	 nucleus	 and	 colocalized	 with	 DAPI	 staining.	 We	 also	 analyzed	 the	 DNA	 of	
transfected	 cells	 to	 assess	whether	 the	 amount	of	 the	oxidized	base	 5hmC	was	 increased.	 To	
this	 end,	 we	 performed	 an	 adapted	 fibre	 assay,	 where	we	 stained	 DNA	 fibres	with	 5mC	 and	
5hmC	 antibodies,	 followed	 by	 staining	 with	 fluorescent	 secondary	 antibodies.	 5hmC	was	 not	




Figure R 4: A Immunofluorescence using DAPI and Anti-Flag antibody in HEK293 cells 
transfected with full-length human TET1 or mouse TET2. B DNA fibres stained with Anti-
ΔG CpG7
BSA TR2TR4Sin3a Mlx200ng AB BSA TR2TR4Sin3a Mlx
mTET2	
hTET1	




5mC and Alexa Fluor 488 and Anti-5hmC and Alexa Fluor 568 antibodies from DNA of mock 







was	 obtained	 in	 high	 purity.	 The	 faster-migrating	 bands	 on	 the	 gel	 most	 likely	 represent	
degradation	products	and	the	bands	that	migrated	slower	might	be	oxidized	TET1-CD	products,	
as	observed	by	others	 [28].	Activity	of	the	purified	protein	was	assessed	by	carrying	out	a	TET	
reaction	 on	 5mC	 bearing	 substrates,	 as	 described	 in	 'Materials	 and	 Methods	 of	 Additional	
observations'.	The	small-scale-	(26.8.15)	and	the	large-scale	(02.10.15)	purifications	from	100	15	
cm	 dishes	 were	 active	 on	 a	 5mC-containing	 plasmid,	 as	 assessed	 by	 Dot	 blot	 using	 a	 5hmC	
specific	antibody	(Fig	R5	B).	
	
Figure R 5: A Coomassie blue-stained SDS-PAGE of purified TET1-CD small-scale (26.08.15) 
and large-scale (02.10.15) preparations. Input (IN), flow-through (FT), elution 1 (E1) and 
elution 2 (E2) of the large scale and E1 of the small scale were loaded onto a 6% gel. B Activity 
test of purified proteins on 5mC-containing plasmid DNA. Product DNA was loaded onto a Dot 
blot and stained with Anti-5hmC antibody. Lanes marked "+" represent control 5hmC-




purified	 TET1-CD	 and	 oligonucleotide	 substrates.	 A	 Dot	 blot	 assay	 revealed	 that	 5mC	 was	
converted	more	efficiently	to	5hmC	at	pH	6.5	(Fig	R6	A).	5hmC-containing	oligonucleotides	were	
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Figure R 6: TET reactions using the TET1-CD from the large-scale purification in Fig R5 at 
different pH. A Starting from 5mC-bearing oligonucleotides, reaction products were visualized 
with Anti-5hmC antibodies and HRP-coupled secondary antibodies. 5hmC-containing oligos 
were used as positive controls (hmC CNTR). B Starting from 5mC (mC), 5hmC (hmC) or 5fC 
(fC) oligos, product formation was assessed by staining with an Anti-5caC antibody. 5caC-




average	 product	 formation	 of	 the	 TET	 proteins,	 either	 in	 vivo	 in	 genome-wide	 studies	 or	
biochemically.	No	information	concerning	single	oxidation	steps	at	defined	loci	can	be	retrieved	
from	 these	 studies.	 We	 established	 an	 approach	 on	 covalently-closed	 oligonucleotide	
substrates,	 sequenced	 with	 the	 PacBio	 technology	 that	 provides	 information	 on	 single	
molecules.	This	enables	us	to	assess	whether	the	TET	reaction	yields	asynchronous	oxidations	or	
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Figure R 7: Schematic representation of the work-flow for the biochemical characterization of 




the	 purification	 steps	 was	 however	 big	 and	 the	 procedure	 needs	 further	 improvement.	 In	






Name	 Origin	 Provider	 Dilution	
Anti-TFIIH	 rabbit	 Santa	Cruz	 1:1000	
Anti-TET1	 rabbit	 Abcam	 1:1000	
Anti-TET2	 mouse	 Abiocode	 1:1000	
Anti-5mC	 mouse	 Serotec	 1:500	
Anti-5hmC	 rabbit	 Active	motif	 1:10'000	
Anti-5fC	 rabbit	 Active	motif	 1:2000	
Anti-5caC	 rabbit	 Active	motif	 1:2000	
Anti-rabbit	Alexa	568	 goat	 Molecular	Probes	 1:300	
!
  CATTTAAAAATATTCCTGGTCAG?GTGAC?GGAGCTGAAAGA 
 AGTAAATTTTTATAAGGACCAGTCG?ACTGG?CTCGACTTTC 
!!
   TATTTAAAAATATTTTTGGTTAG?GTGAT?GGAGTTGAAAGA 
 
 
    







Anti-mouse	Alexa	488	 goat	 Molecular	Probes	 1:300	
Anti-flag	 mouse	 Sigma	 1:1000	
Anti-MLX	 mouse	 Santa	Cruz	 1:1000	
Anti-Sin3a	 mouse	 Santa	Cruz	 1:1000	
Anti-TR2	 mouse	 Santa	Cruz	 1:1000	
Anti-TR4	 mouse	 Santa	Cruz	 1:1000	
Anti-rabbit	IgG	HRP	 goat	 GE	Healthcare	UK	 1:5000	








Samples	were	heated	 for	10	min	at	100°C	 in	a	 total	volume	of	250	µl	 in	0.4	M	NaOH,	10	mM	
EDTA	 and	 transferred	 quickly	 to	 ice	 to	 avoid	 re-annealing.	 An	 equal	 volume	 of	 2	 M	 ice-cold	
ammonium	 acetate	 was	 added.	 After	 pre-soaking	 in	 1	 M	 ammonium	 acetate,	 the	 nylon	
membrane	was	 inserted	 into	 the	Dot	Blot	apparatus	according	 to	manufacturer's	 instructions.	
Wells	were	rinsed	with	water	before	applying	the	samples.	The	vacuum	was	kept	 low	to	avoid	
deforming	 the	membrane.	After	 samples	were	blotted,	 the	wells	were	washed	once	with	1	M	
ammonium	 acetate,	 the	 membrane	 was	 removed	 and	 soaked	 for	 5	 min	 in	 5x	 saline-sodium	




20)	 for	 1	 h.	 Incubation	 with	 the	 primary	 antibody	 was	 performed	 overnight	 at	 4°C.	 The	
membrane	was	washed	3x	for	5	min	in	TBS-T,	incubated	with	the	secondary	antibody	for	1	h	at	
RT	 and	 washed	 again,	 before	 being	 developed	 in	 a	 Fusion	 Solo	 (Vilber	 Lourmat)	 using	
WesternBright	Chemiluminescent	Detection	Reagent.	

















pEF,	 a	 gift	 from	 Anjana	 Rao	 (Addgene	 plasmid	 #	 41710)[446]	 and	 3x	 Flag	 hTet1-ORF using	
Lipofectamine	 2000	 according	 to	 manufacturer's	 instructions.	 Coverslips	 were	 washed	 in	





4°C	 overnight.	 The	 coverslips	 were	 washed	 3x	 in	 PBS	 and	 incubated	 with	 the	 secondary,	
fluorescent	antibody	in	3%	milk/PBS	at	37°C	for	1	h,	shielded	from	light.	After	3	washing	steps	in	





106	 cells/ml,	 were	 pipetted	 onto	 a	 glass	 slide	 (Super	 Frost	 Plus,	 Menzel-Glaser).	 7	 µl	 of	 lysis	
buffer	(200	mM	Tris-HCl	pH	7.4,	50	mM	EDTA,	0.5%	SDS)	were	added,	cells	were	mixed	with	a	
pipette	tip	and	incubated	for	2	min	at	RT	before	glass	slides	were	slightly	tilted	to	let	the	drops	
run	down.	Once	 slides	were	dry,	DNA	was	 fixed	 in	methanol/acetic	acid	3:1	 for	10	min	at	RT.	
Before	staining,	slides	were	washed	twice	in	PBS	and	DNA	was	denatured	in	2.5	M	HCl	for	1	h.	
Slides	were	washed	5x	in	PBS	for	3	min	each	and	blocked	in	2%	bovine	serum	albumin	(BSA)	and	










100	mM	 NaCl)	 to	 10	 µM	 (ERE	 wt	 upper	 5'-TTAATATTCCTGGTCAGCGTGACCGGAGC-3';	 ERE	 wt	
lower	 5'-TTAAGCTCCGGTCACGCTGACCAGGAATA-3';	 ERE	 ΔG	 upper	 5'-










30	 µl	 of	 Dynabeads	 M-280	 Streptavidin	 (ThermoFisher)	 per	 oligo	 were	 washed	 with	 1	 ml	 of	
washing	buffer	(5	mM	Tris,	pH	7.5,	0.5	mM	EDTA,	1	M	NaCl).	The	beads	were	taken	up	in	30	µl	
of	washing	buffer.	The	ligated	oligos	from	above	were	added	and	allowed	to	bind	to	the	beads,	
until	 the	beads	were	saturated,	assessed	by	 the	 lack	of	 radioactive	signal	 in	 the	 flow-through.	
The	beads	were	washed	once	and	taken	up	in	2x	EMSA	binding	buffer	without	BSA	(10	mM	Tris-
HCl,	pH	7.6,	50	mM	NaCl,	1	mM	DTT,	5%	glycerol).	1.5	mg	of	nuclear	extract	were	pre-incubated	
with	 30	 µg	 of	 poly(dI.dC),	 before	 an	 equal	 volume	 was	 added	 to	 the	 beads	 (split	 into	 three	
tubes).	 The	 mixture	 was	 incubated	 for	 15	 min	 with	 gentle	 shaking	 at	 4°C.	 Supernatant	 was	






The	 protein	 mixture	 was	 digested	 with	 trypsin	 into	 peptides.	 After	 cleaning	 up,	 the	 peptide	
mixture	 was	 applied	 to	 a	 reversed-phase	 high-performance	 liquid	 chromatography	 (HPLC)	
column	and	separated	prior	 to	 ionization	and	analysis	by	 the	mass	 spectrometer.	The	peptide	
ions,	selected	by	the	instrument,	were	fragmented	and	the	resulting	fragment	ion	spectrum	was	








pTO-pAIO-FRT-3x	 Flag	 Tet1CD	WT	 (from	 aa	 1418-2136)	 containing	 hygromycin	 resistance	 and	
1.5	µg	of	pOG44	Flp-Recombinase	expression	vector	(ThermoFisher).	When	confluent,	cells	were	
plated	 in	 selection	 medium	 containing	 Hygromycin	 (250µg/ml,	 InvivoGen)	 and	 Blasticidin	
(10µg/ml	 ,	 InvivoGen).	 Once	 visible	 colonies	 formed,	 they	 were	 trypsinized	 and	 re-seeded	 as	
bulk	culture.	














by	 spinning	 for	2	min	at	500	x	g.	Proteins	were	eluted	 in	 two	 rounds	 (E1	and	E2)	with	500	µl	















1	 µg	 of	 ds	 oligonucleotides	 were	 mixed	 with	 1	 µl	 of	 20	 µM	 overhang	 adapter	 (Pacific	
Biosciences).	Provided	template	preparation	buffer	was	added	and	supplemented	with	1.5	µl	of	
1	mM	ATP.	30	units	of	provided	ligase	(Pacific	Biosciences)	was	added,	reaction	was	made	up	to	
30	 µl	 and	 incubated	 for	 2	 h	 at	 25°C.	 After	 heat	 inactivation	 at	 65°C	 for	 10	min,	 reaction	was	
treated	with	 exonucleases	 III	 (50	U)	 and	VII	 (5	U)	 to	 get	 rid	 of	 unligated	 oligos	 and	 adapters.	















The	 experimental	 set-up	 developed	 in	 our	 lab,	 using	 defined,	 lesion-containing	 plasmid	
substrates	and	nuclear	 cell	extracts,	 represents	a	very	nice	 system	to	 study	 the	DSB-induction	
step	 in	 class-switch	 recombination.	 The	 plasmids	 do	 not	 replicate,	mimicking	 the	 situation	 in	
germinal	center	B-cells	 that	are	 in	 the	G1-phase	of	 the	cell	 cycle.	The	defined	 locations	of	 the	
lesions	 enable	 us	 to	 draw	 conclusions	 about	 the	 mechanism	 of	 action	 of	 the	 cellular	 repair	
enzymes	acting	on	them.	
Based	 on	 our	 in	 vitro	 and	 in	 vivo	 experiments	 (Results	 I,	 [517]),	 we	 propose	 a	model	 for	 the	
combined	action	of	BER	and	MMR	in	enabling	efficient	CSR	(Results	I	and	Fig	D1).	U/G	mispairs	
are	 substrates	 for	 both	 BER	 and	MMR.	 This	 leads	 to	 a	 competition	 of	 the	 pathways	 for	 the	
lesions,	whose	outcome	depends	on	lesion-density,	sequence	context	and	cell	cycle	phase.	We	
propose	that	DSBs	occur	 through	a	collision	of	 repair	 intermediates	of	BER	and	MMR,	ss	nicks	
and	ss	degradation	tracts,	which	individually	would	not	form	DSBs,	but	-	when	combined	-	very	
efficiently	do	so.	
We	see	an	 important	 contribution	of	MMR,	namely	MutSα,	 in	 the	 induction	of	DSBs	 in	our	 in	
vitro	 and	 in	 vivo	 systems,	 and	 in	 the	 generation	 of	mutations	 in	 vivo.	 The	 break	 formation	 is	
completely	dependent	on	 the	BER	enzyme	UNG,	on	 the	other	hand.	An	explanation	 for	 these	
differences	might	be	that	MMR	alone	lacks	a	strand-discrimination	signal,	necessary	for	efficient	
repair.	 Is	 has	 already	 been	 shown	 that	MMR	 can	make	 use	 of	 sites	 of	 ongoing	 base	 excision	
repair	 [118]	 and	 sites	 of	 ribonucleotide	 excision	 [129]	 to	 start	 EXO1-mediated	 degradation	 of	
one	strand.	It	is	therefore	conceivable	that	CSR	is	highly	dependent	on	these	UNG-created	nicks.	
This	 phenomenon	 has	 also	 been	 observed	 in	 Ung-/-	 mice	 [64].	 The	 milder	 effect	 on	 DSB	
formation	we	see	in	the	absence	of	MMR	is	also	consistent	with	genetic	studies	[137,	139,	245].	




them.	 A	 stretch	 of	 50	 bp	 between	 the	 uracils	 is	 enough	 to	 keep	 the	 DNA	 stably	 linked.	 It	 is	
imaginable	that	the	sequence	context	in	certain	parts	of	the	S	regions	provides	many	AID	target	
sites	that	could	be	processed	into	MMR-independent	DSB,	whereas	other	regions	might	depend	





Figure D 1: Model of the interplay of BER and MMR in the processing of uracil lesions in 
DNA. In the case when the MMR system is faster than BER in recognizing and binding a uracil, 
MutSa is activated and recruits MutLa that sets additional nicks into the already-nicked strand. 
EXO1 is loaded at the nicks and starts degrading one strand with its 5' to 3' polarity. In the 
meantime, other uracils generated in the vicinity might have been addressed by the fast UNG 
and APE1, resulting in additional nicks. If the EXO1 degradation tract runs into the BER 
created lesions, DSBs are the consequence. Adapted from [517]. 
	
The	 finding	 that	 the	 absence	 of	MMR	 in	 our	 system	 had	 such	 a	 great	 impact	was	 somewhat	
surprising,	as	the	absence	of	MMR	was	reported	to	result	in	a	less	severe	phenotype	than	BER-
deficiency	in	mice	[64,	137,	139,	245],	as	mentioned	above.	By	providing	a	nick	in	the	substrates,	
we	 do,	 however,	 stress	 the	 involvement	 of	 MMR,	 as	 the	 nick	 can	 be	 used	 as	 a	 strand-
discrimination	 signal	 and	 initiation	 site	 for	 the	 EXO1-mediated	 degradation	 tract.	 A	 more	
physiologically-relevant	substrate	would	contain	uracils	on	both	strands,	instead	of	a	nick	on	one	
strand.	 These	 substrates	were	 extremely	 complex	 to	 prepare	 and	 required	 carefully-designed	
purification	 steps.	 Preliminary	 results	 obtained	with	 those	 plasmids	 gave	 puzzling	 results.	We	
completely	lost	MMR-dependence	in	break	formation	using	this	substrate.	We	did	see	efficient	
break	 formation,	 however,	 dependent	on	UNG	and	on	 catalytically-active	 EXO1.	 These	 results	












































































































to	 draw	 here	 is	 that	 EXO1	 is	 loaded	 at	 the	 nicks	 resulting	 from	 BER	 independently	 of	MMR,	
thereby	 assisting	 in	 break	 formation.	Why	 this	 is	 happening	 only	 in	 the	 substrate	 containing	
uracils	on	both	strands	(Fig	D2)	and	not	 in	the	substrate	with	the	nick	 investigated	 in	Results	 I	






An	 interesting	 question	 concerning	 the	mechanisms	of	 SMH	and	CSR	 is	 how	 the	outcomes	of	
lesion	processing	can	be	so	different,	considering	that	the	initial	steps	are	equal.	Both	pathways	
are	 initiated	 by	 AID-induced	 cytosine	 deaminations,	 creating	 uracils	 in	 DNA.	 In	 SHM,	 these	




our	 CSR	 system,	 highly	 dependent	 on	MMR	 (Results	 I),	 similar	 to	 SHM.	 Although	 cytosines	 in	
WRC	 AID	 targeting	 sites	were	 published	 to	 be	mutational	 hotspots	 [215],	 we	 do	 not	 see	 any	
accumulation	of	mutations	at	our	uracil	 sites	above	 random	 levels.	 It	 is	 therefore	 conceivable	
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that	 the	 same	 non-canonical,	 highly-mutagenic	 MMR	 mechanism	 acting	 in	 SHM	 is	 also	
responsible	for	the	mutations	we	detect	in	our	substrates	[117,	148,	149].	
DSB	formation,	on	the	other	hand,	does	also	occur	during	SHM,	mostly	resulting	in	B-cell	death	
and	 therefore	 not	 easily	measurable.	 Another	 point	 to	 keep	 in	mind	 is	 that	 DSB	 formation	 is	
generally	an	infrequent	even,	not	only	in	SHM,	but	also	in	CSR.	The	power	of	the	process	in	B-
cells	 lies	 in	 the	 efficient	 selection	 and	 elimination	 steps.	 In	 our	 in	 vitro	 system	 that	 was	
optimized	to	assess	DSBs	by	having	a	nick	on	the	opposite	strand	to	the	uracils,	DSB	incidence	
never	exceeded	30%,	reached	by	addition	of	recombinant	proteins.	In	the	in	vivo	system,	we	had	
to	 introduce	 two	 selection	 steps	 in	 order	 to	 be	 able	 to	 detect	 the	DSB	 events.	Moreover,	we	
assume	 that	 many	 DSBs	 escaped	 our	 analysis,	 because	 they	 did	 not	 lead	 to	 efficient	 re-
annealing.	In	B-cells,	these	DSBs,	possibly	also	happening	during	SHM,	would	lead	to	apoptosis.	
Higher	eukaryotes	can	easily	tolerate	high	apoptosis	rates	in	B-cells,	compared	to	other	tissues.	
Nevertheless,	 the	balance	of	DSBs	versus	mutations	 is	 clearly	different	 in	 SHM	versus	CSR.	As	
both	 processes	 occur	 in	 germinal	 center	 B-cells	 and	 therefore	 in	 the	 same	 environments,	 the	
differences	have	 to	come	 from	the	exact	 sequence	contexts	and	 the	 targeting	of	AID	 to	 these	
sites,	as	well	as	 from	the	 re-annealing	step	after	DSB	 induction.	Supporting	 this	notion,	 it	was	








puzzling.	 Under	 normal	 circumstances,	 MMR	 and	 BER	 are	 high	 fidelity	 processes	 that	 are	
important	guardians	of	genomic	integrity.	Why	do	they	develop	a	mutagenic	function	in	CSR	and	
SHM,	and	how	can	this	function	be	restricted	to	B-cells?	
Germinal	 center	B-cells	undergoing	SHM	and	CSR	are	mostly	 in	 the	G1	phase	of	 the	cell	 cycle	
[152].	 Canonical	 MMR	 that	 would	 lead	 to	 faithful	 repair	 of	 mismatches	 can	 therefore	 be	
excluded.	 The	 mutagenic	 properties	 of	 non-canonical	 MMR	 outside	 of	 S-phase	 have	 been	
studied	 [117,	 137,	 142].	 Its	 occurrence	 in	 non-B-cells	 seems	 to	 be	 undesirable	 under	 normal	










mutagenic	 action	 of	MMR	 in	 B-cells	 can	 apply	 here.	 AID	 creates	 an	 unusual	 accumulation	 of	
uracils	 in	 close	 proximity.	 This	 could	 possibly	 lead	 to	 overwhelming	 of	 the	 otherwise	 very	
efficient	BER.		
The	case	of	SHM	and	CSR	constitutes	a	unique	situation,	because	it	involves	an	accumulation	of	
lesions	 that	 can	 be	 addressed	 by	 two	 repair	 pathways	 simultaneously.	 The	 two	 pathways	 are	
normally	 prevented	 from	 encountering	 each	 other,	 as	 MMR	 is	 tightly-coupled	 to	 replication,	
whereas	the	BER	enzyme,	TDG	for	example,	is	specifically	degraded	during	S-phase.		
AID	 is	 the	only	B-cell	 specific	 factor	known	that	 is	 involved	 in	 these	mutagenic	processes.	 It	 is	




induction	 of	 dangerous	 and	 normally-undesirable	 DSBs.	 One	 or	 more	 factors	 of	 the	 repair	
pathways	might	be	absent	or	present	to	a	lesser	extent	in	B-cells.	One	candidate	is	polymerase	
b,	 which	 has	 indeed	 been	 shown	 to	 be	 down-regulated	 in	 activated	 B-cells	 [49].	 B-cells	
completely	lacking	polymerase	b	show	a	slight	increase	in	CSR	to	some	isotypes	[520].	
A	 possible	 explanation	 for	 the	 tolerance	 of	 B-cells	 towards	 DSBs	 came	 from	 the	 Dalla-Favera	
group	 that	 found	 reduced	 p53	 expression	 in	 activated	 B-cells	 [521].	 Limited	 signaling	 of	 the	
important	 tumor	 suppressor	 p53	 in	 an	 environment	 of	 high	 mutagenesis	 and	 frequent	 DNA	





cell	 origin	 [522].	 The	 biggest	 subgroup	 of	 Non-Hodgkin	 lymphomas	 are	 the	 mature	 B-cell	
lymphomas.	 They	 comprise	 among	 others	 the	 groups	 of	 diffuse	 large	 B-cell	 lymphoma	 and	






A	 hallmark	 of	 mature	 B	 cell	 lymphomas	 is	 the	 involvement	 of	 at	 least	 one	 Ig	 gene	 in	 the	
transformation-initiating	 translocation	 [524-528].	 BL	 for	 example	 is	 characterized	 by	 the	
translocation	of	c-Myc	to	an	immunoglobulin	gene	locus,	in	most	cases	IgH	[523].	This	leads	to	
the	 erroneous	 regulation	 of	 c-Myc	 and	 promotes	 tumor	 formation	 through	 its	 effect	 on	
proliferation	[528].	Other	examples	are	the	translocation	of	the	Ig	locus	to	Bcl-1,	a	controller	of	
the	cell	cycle	or	to	Bcl-2,	an	inhibitor	of	apoptosis	[529].	
The	 frequent	 involvement	 of	 the	 Ig	 locus	 suggests	 an	 involvement	 of	 the	 Ig-modifying	
mechanism	V(D)J	recombination	and	the	mature	B-cell	specific	processes	SHM	and	CSR.	Indeed,	
it	 has	 been	 shown	 that	 deregulated	 expression	 of	 the	 SHM-	 and	 CSR-initiating	 enzyme	 AID,	
together	with	a	p53	mutation,	causes	extensive	genome	instability,	resulting	in	the	induction	of	
B	cell	lymphomas	[224].	AID	has	also	been	shown	to	act	on	off-target	sequences	that	share	AID-
target	 sequence	 similarity	 throughout	 the	 genome.	 It	 has	 been	 shown	 for	 example	 that	 AID	
frequently	attacks	the	c-Myc	sequence	when	it	is	transcribed	[530],	explaining	the	involvement	
of	c-Myc	in	many	translocation	events.		





our	 in	 vivo	 system.	 The	 incidence	 of	 translocations	 was	 higher	 in	 MMR-depleted	 cells.	 This	
indicates	 that	 MMR	 normally	 provides	 some	 protection	 against	 non-compatible	 ligations,	
probably	by	resolving	imperfect	microhomology-mediated	joining	of	the	two	ends.	
A	 better	 understanding	 of	 the	mechanism	 leading	 to	 B-cell	 specific	 DNA	 rearrangements	 and	




We	could	 show	 that	 vitellogenin	expression	 is	 induced	upon	β-estradiol	 treatment	 in	 LMH/2A	
cells,	but	that	this	is	happening	independently	of	detectable	changes	in	DNA	methylation	of	the	
four	CpGs	that	were	reported	earlier	to	be	demethylated	upon	hormone	treatment	 [332].	The	
fact	 that	we	 see	 an	 accumulation	of	 the	 TET	oxidation	product	 5hmC	at	 these	CpGs	 confirms	
that	 dynamic	 changes	 at	 the	 level	 of	 chromatin	 are	 taking	 place.	Whether	 the	 appearance	 of	
5hmC	is	a	consequence	of	increased	accessibility	for	different	DNA	binding	proteins	or	actually	
causal	 for	 the	 regulation	 of	 expression	 remains	 to	 be	 determined.	 TET2	 overexpression	
experiments	point	 towards	a	role	 for	 the	dioxygenase	 in	 the	transcriptional	 regulation	of	VTG,	
but	 they	 need	 confirmation	 from	 knockdown	 experiments.	 We	 have	 not	 yet	 succeeded	 in	
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efficiently	 downregulating	 the	 TETs	 at	 the	protein	 level	 using	 specific	 siRNAs,	 despite	 the	 fact	
that	mRNA	levels	were	significantly	reduced.	
The	 observation	 that	 we	 could	 induce	 VTG	 transcription	 without	 affecting	 DNA	 methylation	
puzzled	us	at	first.	One	limitation	to	keep	in	mind	is	the	involvement	of	a	PCR	step	that	can	lead	
to	 distortion	 of	 the	 sequencing	 results.	 Moreover,	 there	 is	 the	 possibility	 that	 the	 VTG	
transcripts	 originated	 from	only	 a	 few	 cells	 that	 underwent	 demethylation;	 the	unmethylated	
sites	of	these	genomes	would	have	escaped	detection	in	sequencing	of	the	entire	cellular	pool.	
Alternatively,	 the	 signal	 could	 have	 arisen	 from	 the	 cells	 that	 acquired	 5hmC.	 The	 question	
remains	why	we	 do	 not	 see	 at	 least	 the	 same	 low	 levels	 of	 demethylation	 as	we	 see	 5hmC-
signal.	If	5hmC	was	just	an	intermediate	step	in	demethylation,	we	should	see	oxidation	events	




Since	 this	 is	 the	 first	 time	 that	methylation	 dynamics	 of	 the	VTG	 enhancer	were	 analyzed	 by	
bisulfite	 sequencing,	 we	 cannot	 rule	 out	 the	 possibility	 that	 another	 (yet	 uncharacterized)	





treatment,	whereas	 transcription	 started	 as	 soon	 as	 4	 h	 after	 hormone	 administration.	 These	
studies,	however,	ignored	the	fact	that	hemi-methylated	DNA	was,	similarly	to	fully-	methylated,	
refractory	 to	 cleavage	 by	 HpaII.	 But,	 hemi-methylation	 of	 DNA	 could	 display	 distinct	
characteristics	 when	 it	 comes	 to	 transcription	 factor	 binding	 or	 chromatin	 remodeling.	 The	
method	established	by	Maxam	and	Gilbert,	and	Church	and	Gilbert	to	chemically	sequence	DNA	
[507,	508],	re-opened	the	discussion	about	the	temporal	sequence	of	transcription	initiation	and	
DNA	 demethylation.	 An	 observation	 made	 when	 different	 tissues	 were	 analyzed	 for	 their	
inducibility	 and	 methylation	 dynamics,	 strongly	 suggests	 a	 causal	 function	 of	 DNA	
demethylation.	 Erythrocytes	 did	 not	 express	 VTG	 when	 treated	 with	 E2	 and	 there	 was	 no	
demethylation	of	the	enhancer.	This	was	not	surprising,	since	erythrocytes	also	do	not	express	
ERs.	 Cells	 of	 the	 oviduct,	 however,	 do	 express	 ERα,	 but	 VTG	 is	 not	 inducible.	 Still,	 the	
demethylation	 event	 was	 observed	 in	 these	 cells.	 This	 indicates	 that	 general	 estrogen-
responsiveness	is	the	key	prerequisite	for	the	demethylation	and	not	transcription	per	se	[332,	












fully-methylated	 in	 a	 population	 of	 cells.	 The	 factor	 or	 circumstance	 that	 protects	 the	 hemi-
methylated	state	in	rooster	liver	thus	seems	to	be	absent	in	the	cell	line.	The	methylation	state	
at	 CpG	b	 does	 not	 seem	 to	 confer	 any	 advantage	 to	 the	 cell,	 causing	 one	 cell	 population	 to	
outgrow	the	other.		
The	binding	of	 ERα	 to	 its	 response	element	 is	 insensitive	 to	methylation	of	 the	 two	CpG	sites	
present	 in	 the	VTG	 ERE.	Another	 factor	 (X)	 that	 reconises	 the	ERE,	however,	binds	with	 lower	
affinity	 if	 the	 site	 is	methylated.	 The	 reporter	 assay	 revealed	 no	 significant	 influence	 of	 ERE-
methylation	 though,	 arguing	 against	 an	 important	 role	 of	 factor	 X	 binding	 at	 the	 ERE.	
Interestingly,	 we	 detected	 a	 shift	 with	 a	 similar	 mobility	 on	 other	 CpG	 sites	 in	 the	 VTG	










The	 binding	 of	 the	 same	 factor	 to	 several	 CpG-containing	 sequences	 of	 the	 VTG	
enhancer/promoter	 attracted	 our	 interest,	 because	 the	 factor	 displayed	 the	 strongest	 affinity	
for	CpG7	and	ΔG	substrates,	both	of	which	contain	an	E-box	consensus	sequence.	E-box	binding	
proteins	 form	 a	 large	 superfamily	 of	 basic	 helix-loop-helix	 (bHLH)	 factors.	 bHLH	 proteins	 are	
small,	 dimeric	 transcription	 factors	 reported	 to	 be	 important	 regulators	 of	 embryonic	
development.	They	consist	of	an	N-terminal	basic	α-helix,	responsible	for	the	binding	to	the	E-
box	 motif.	 The	 C-terminus	 forms	 the	 HLH	 structure	 that	 facilitates	 interactions	 with	 other	
members	 of	 the	 family	 [533].	 bHLH	 proteins	 are	 known	 for	 their	 versatility,	 due	 to	 many	
different	 combinations	 of	 homo-	 and	 heterodimers	 that	 can	 be	 formed	 depending	 on	 the	









leucine	 residues	 in	 the	hydrophobic	 core	of	 the	helix.	Members	of	 this	 group	of	bHLH	 factors	
include	 the	 different	 MYCs,	 MAD	 and	 MLX.	 This	 family	 received	 a	 great	 deal	 of	 attention,	
because	the	MYC	genes	are	very	frequently	mutated	in	cancer	[359],	as	discussed	above	on	the	
example	 of	 B-cell	 lymphomas.	 Depending	 on	 their	 dimerization	 partners,	 MYC	 transcription	
factors	can	promote	transcription	or	inhibit	it.	Methylation-sensitive	DNA	binding	of	c-MYC	has	
been	 reported	 in	 combination	 with	 certain	 bHLH	 proteins,	 but	 plays	 no	 role	 in	 other	
combinations	[535,	536].	
When	we	examined	the	proteins	binding	the	ERE	in	our	nuclear	extracts	on	denaturing	SDS	gels,	
we	 detected	 several	 bands,	 corresponding	 to	 proteins	 of	molecular	 size	 of	 20-50	 kDa.	 This	 is	
consistent	with	the	size	of	most	HLH	proteins	and	considerably	smaller	than	the	NHPs	published	
to	 bind	 to	 the	 ERE	 of	 chicken	 VTG	 [509].	 Even	 more	 evidence	 for	 the	 involvement	 of	 HLH	
proteins	came	from	the	mass	spectrometric	analysis	of	the	proteins	binding	the	wt	and	the	ΔG	
ERE	in	LMH/2A-	,	as	well	as	in	HeLa	NEs.	We	could	identify	several	helix-loop-helix	transcription	
factors	 from	 both	 cell	 lines;	 MLX,	 MLXIP	 and	 MAX,	 in	 HeLa	 NEs	 additionally	 MLXIPL.	 The	





Depletion	 or	 knockout	 of	 TETs	 in	 genome-wide	 studies	 provided	 plausible	 evidence	 for	 an	
important	 role	 of	 the	 dioxygenases	 in	 DNA	 demethylation	 during	 development.	 There	 are,	
however,	 still	 a	number	of	open	questions	 concerning	 their	 role	 in	 somatic	 cells,	 their	precise	
targeting	and	-	last	but	not	least	-	their	exact	mechanism	of	action.	Considering	that	5mC	occurs	
almost	 exclusively	 in	 the	 symmetrical	 CpG	 context,	 a	 global	wave	 of	 demethylation,	 involving	
BER,	seems	to	be	a	very	risky	task.	Each	methylated	CpG	site	could	potentially	be	converted	into	
a	 DSB.	 We	 showed	 in	 our	 study	 (Results	 I,	 [517])	 the	 danger	 of	 an	 accumulation	 of	 BER	
intermediates.	During	CSR,	 closely-spaced	uracils	 processed	by	BER	and	MMR	can	give	 rise	 to	
DSBs.	The	situation	in	the	CpG	context	 is	even	more	acute,	as	the	lesions	are	directly	opposite	
each	other	if	processed	simultaneously.	The	involvement	of	several	oxidation	steps	is	a	genuine	
way	 of	 temporally	 spacing	 the	 base	 excision	 events.	 It	 has,	 however,	 not	 been	 shown	 yet,	
whether	 the	 TET	 enzymes	 act	 symmetrically	 on	 CpGs	 and	 whether	 they	 carry	 out	 the	 three	
oxidation	 steps	 in	 a	 processive	manner,	 from	 5mC	 to	 5caC	 and	 excision,	 without	 leaving	 the	




present	 evidence	 for	 higher	 turnover	when	 substrates	 are	 oxidized	 processively	 from	 5mC	 to	
5caC	[432-434,	437].	However,	the	relatively	high	levels	of	5hmC	in	cells,	compared	to	5fC	and	
5caC,	 argue	 against	 this.	 Another	 study	 that	 set	 out	 to	 investigate	 if	 TET-mediated	 oxidation	
steps	 occur	 symmetrically	made	 use	 of	 the	 chemical	 reactivity	 of	 the	 formyl	 group	 of	 5fC	 to	
selectively	 attach	 a	 fluorescent	 pyrene	 group.	 The	 authors	 observed	 predominantly	 pyrene	
modification	 of	 both	 strands,	 prompting	 them	 to	 conclude	 not	 only	 that	 the	 oxidation	 is	
symmetrical,	 but	 also	 that	 the	 oxidation	 steps	 are	 non-processive,	 due	 to	 the	 detectable	
presence	of	5fC	[537].	These	studies	were	followed	by	investigations	of	the	mechanism	of	action	
of	the	TETs	using	high	performance	liquid	chromatography	(HPLC)	and	mass	spectrometry	(MS).	
While	 one	 group	 came	 to	 the	 conclusion	 that	 TET2	 carries	 out	 iterative	 oxidations	 to	 5caC	
without	releasing	the	DNA	in	between	[538],	another	group	objected,	postulating	that	TETs	act	
in	a	distributive	manner	[539].	If	symmetrical	5fC	or	5caC	generation	does	indeed	occur	in	DNA,	
it	 is	 	 not	 certain	 that	 their	 processing	 would	 lead	 to	 the	 formation	 of	 a	 DSB,	 as	 there	 is	 an	
additional	 level	of	control	at	 the	BER	step.	The	analysis	of	 symmetrical	5caC	substrates	with	a	
recombinant	 TDG-BER	machinery	 resulted	 in	HpaII	 cleavable	 sites,	 but	 only	marginal	 levels	 of	
DSB,	 indicating	 an	 efficient	 processing	 of	 the	 sites	 without	 critically	 damaging	 the	 DNA.	 The	
group	 concluded	 that	 TDG	 interacts	 tightly	 with	 AP-sites,	 thereby	 inhibiting	 simultaneous	
processing	of	both	strands.	This	finding	 indicates	that	there	 is	an	additional	 level	of	protection	









Also,	 the	specific	 targeting	of	 the	demethylation	machinery	 requires	 further	 investigation.	 It	 is	
important	during	 the	global	waves	of	demethylation,	 for	example	 to	protect	 imprinted	genes,	
but	even	more	so	in	somatic	cells,	when	single	CpGs	are	addressed.	Another	layer	of	complexity	
concerns	 the	 finding	 that	 the	 oxidation	machinery	 fails	 to	 proceed	 beyond	 the	 generation	 of	










gene	 in	 myelodysplastic	 syndromes	 (MDS),	 with	 up	 to	 30%	 penetrance.	 TET2	 mutations	 are	
found	 in	 the	majority	of	 cells	 in	 the	bone	marrow	of	patients,	 indicating	 that	 these	mutations	
occur	 early	 in	 disease	 development	 [447].	 However,	 no	 reliable	 prognostic	 value	 could	 be	
derived	from	high-throughput	sequencing	of	patients’	DNA	[448].	Also,	the	mechanism	by	which	
TET2	acts	as	a	tumor	suppressor	remains	enigmatic.	
Several	 groups	 studied	 knockout	 mouse	 models	 to	 assess	 the	 role	 of	 TETs	 in	 malignant	
transformation.	 It	 was	 found	 that	 loss	 of	 TET2	 in	 hematopoietic	 cells	 lead	 to	 extensive	




altered	 towards	 monocytic/granulocytic	 lineages	 [449].	 The	 importance	 of	 TETs	 as	 tumour	
suppressors	 was	 further	 strengthened	 by	 the	 finding	 that	 mutations	 in	 isocitrate	
dehydrogenases	(IDH1/2),	enzymes	that	convert	 isocitrate	to	the	TET	substrate	2-oxoglutarate,	
were	found	to	cause	similar	cancers	as	TET	mutations,	which	were	characterized	by	global	DNA	
hypermethylation.	 IDH1/2	 mutations	 were	 additionally	 shown	 to	 be	 mutually	 exclusive	 with	
TET2	mutations	in	cancer	[544].		








The	 involvement	of	 several	 repair	pathways	 in	antibody	diversification	and	 regulation	of	 gene	
expression	 and	 chromatin	 dynamics	 shows	 their	 great	 importance,	 much	 beyond	 repair	 of	
damage	arising	through	endogenous	or	exogenous	agents.	 Instead	of	only	reacting	to	damage,	
they	actively	modulate	cellular	processes,	thereby	enabling	higher	forms	of	life.	The	term	'repair	
pathways'	 clearly	 undervalues	 these	 versatile	 and	 highly	 complex	mechanisms;	 a	 better	 term	
might	be	DNA	modulating	pathways.	
The	 usage	 of	 DNA	 substrates	 containing	 nicks	 and	 uracils	 to	 investigate	 the	 process	 of	 CSR	
enabled	us	 to	gain	 insights	 into	the	exact	way	of	processing	of	 the	 lesions.	By	dispensing	with	
AID,	we	reduced	the	complexity	of	the	events	by	knowing	exactly	where	the	lesions	we	started	
with	 were	 located.	 The	 puzzling	 results	 obtained	 with	 the	 more	 physiological	 substrates	
containing	uracils	on	both	strands	merit	further	attention,	as	they	imply	that	simple	nicks	may	
not	be	identical	to	 intermediates	arising	during	processing	of	damaged	bases.	Thus,	substrates	




Another	 issue	 worth	 addressing	 in	 the	 future	 is	 the	 reason	 for	 the	 unusually	 inefficient	 BER	
during	antibody	diversification.	The	above-mentioned	 saturation	of	 the	 repair	pathway	by	 the	
creation	 of	 a	 high	 density	 of	 targets	 in	 close	 proximity	 is	 a	 conceivable	 explanation,	 it	 	 has,	
however,	 never	 been	 experimentally	 addressed.	 Downregulation	 or	 modification	 of	 key	
enzymes	of	the	pathway	in	germinal	center	B-cells	is	also	under	discussion.		
There	is	still	a	great	deal	to	learn	about	CSR	and	the	enzymes	and	pathways	involved.	It	is	a	very	
unique	 and	 fascinating	 process	 and	 a	 valuable	 model	 system	 to	 investigate	 the	 interplay	 of	
several	DNA	metabolic	pathways.	The	finding	that	CSR	is	frequently	involved	in	the	formation	of	
malignancies	makes	its	detailed	understanding	particularly	relevant.	
In	 addition	 to	 bona	 fide	 DNA	 repair	 and	 antibody	 diversification,	 BER	 appears	 to	 have	 an	
important	role	in	DNA	demethylation	and	the	control	of	gene	expression.	Epigenetic	processes	
are	extremely	challenging	to	decipher	 in	cells,	as	they	are	complex	and	 involve	many	different	
players	 and	 consecutive	 modifications	 of	 chromatin.	 The	 order	 of	 events	 leading	 to	 the	
activation	or	 shut-down	of	 a	 specific	 gene	 is	 difficult	 to	 address	 and	might	 vary	 from	gene	 to	












pose	 to	 cells	 and	 multicellular	 organisms.	 The	 flexibility	 of	 DNA	 modifications	 and	
rearrangements,	 enabling	 an	 efficient	 immune	 protection	 and	 differential	 gene	 expression	 in	
higher	eukaryotes,	goes	at	the	expense	of	an	 increased	risk	for	DNA	damage	and	uncontrolled	
proliferation,	potentially	leading	to	tumor	formation.	A	deep	understanding	of	the	mechanisms	
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Xenopus laevis egg extracts
a  b  s  t  r a  c t
The cytotoxicity  of SN1-type alkylating  agents such  as  N-methyl-N′-nitrosourea  (MNU),  N-methyl-N′-
nitro-N-nitrosoguanidine  (MNNG),  or  the  cancer chemotherapeutics  temozolomide,  dacarbazine  and
streptozotocin  has  been  ascribed  to the  persistence  of O6-methylguanine  (meG) in genomic  DNA. One
hypothesis  posits  that meG  toxicity is  caused  by  futile  attempts of the  mismatch  repair (MMR)  system to
process meG/C or meG/T  mispairs arising during  replication,  while  an  alternative proposal  suggests that
the  latter  lesions  activate  DNA  damage  signaling,  cell  cycle  arrest and  apoptosis  directly. Attempts  to
elucidate  the  molecular  mechanism  of meG-induced cell killing  in  vivo  have  been hampered  by  the  fact
that  the  above  reagents  induce several types of modiﬁcations  in genomic  DNA,  which  are  processed  by
different repair pathways.  In  contrast,  deﬁned substrates studied  in vitro  did not undergo  replication.
We set out  to  re-examine  this  phenomenon  in replication-competent  Xenopus  laevis  egg extracts,  using
either phagemid  substrates  containing  a single meG  residue,  or  methylated sperm chromatin.  Our  ﬁndings
provide  further  support  for  the  futile  cycling hypothesis.
©  2015  Elsevier B.V.  All  rights  reserved.
1. Introduction
The postreplicative mismatch repair (MMR)  system improves
replication ﬁdelity by up to three orders of magnitude through
excising nucleotides misincorporated into the nascent strand by
DNA polymerases [1,2]. This task is  carried out predominantly by
the mismatch recognition protein MutS (a heterodimer of MSH2
and MSH6), the endonuclease MutL (MLH1/PMS2 heterodimer)
and EXO1 exonuclease, together with accessory replication factors
PCNA, RPA, RFC, polymerase- and DNA ligase I  [3,4].
In contrast to its key role as an antimutator [5],  MMR can perturb
genomic stability by attempting to  process DNA damage induced
by, for example, SN1-type methylating agents such as N-methyl-
N′-nitrosourea (MNU), N-methyl-N′-nitro-N-nitrosoguanidine
(MNNG) or temozolomide [6,7].  The toxicity of this class of
chemicals, some of which (e.g. temozolomide, dacarbazine,
∗ Corresponding author at: Institute of Molecular Cancer Research, University of
Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland.
Tel.: +41 044 6353450.
E-mail address: jiricny@imcr.uzh.ch (J. Jiricny).
streptozotocin) are used in  the therapy of various types of  cancer,
is linked to  their ability to generate O6-methylguanine (meG) in
DNA. This simple modiﬁcation can be  efﬁciently detoxiﬁed by O6-
methylguanine DNA-methyltransferase (MGMT), which transfers
the methyl group from the guanine onto a cysteine residue in its
active site [8]. Because MGMT  is  inactivated by this transaction,
and because some cells express only low amounts of this protein,
meG can persist in  genomic DNA after treatment with these chem-
icals and cause cytotoxicity. More than three decades ago, Karran
and Marinus showed that meG toxicity in  E. coli was dependent
on functional MMR  [9]. Like MMR-deﬁcient bacteria, mammalian
cells lacking MMR are also highly resistant to  killing by  SN1-type
methylating agents [7,10–12], but the molecular events leading
to cell death have been the subject of extensive discussion. One
hypothesis, referred to  as “futile cycling” [7],  posits that replicating
polymerases will incorporate a  C or a  T  opposite the meG.  As meG/C
and meG/T are not  Watson-Crick base pairs, they will activate MMR.
However, because MMR is directed to the nascent strand, EXO1
will catalyze degradation of the strand containing the mispaired
C or T. As the meG residue will remain in  the template strand,
repair synthesis will regenerate the meG/C or meG/T mispairs that
will trigger further, “futile” rounds of MMR-directed excision and
http://dx.doi.org/10.1016/j.dnarep.2015.01.014
1568-7864/© 2015 Elsevier B.V. All  rights reserved.
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resynthesis, which were suggested to  activate cell cycle arrest
and apoptosis. Support for this hypothesis comes from several
directions; iterative cycles of MMR-dependent excision and repair
synthesis were seen in in vitro assays [13],  and cell cycle arrest
induced by  treatment with SN1-type methylating agents was
shown to require two rounds of replication [14–16].  In an attempt
to  explain the latter ﬁnding, we  suggested that the MMR  machinery
might abandon its futile attempts at repair of the meG/C or meG/T
mispairs and that DNA synthesis might re-initiate downstream.
This would leave single-stranded gaps opposite meG, the collision
of which with replication forks in the subsequent S phase would
give rise to  double-strand breaks that would activate the ATR and
ATM checkpoint machineries and cause a  cell cycle arrest in  the
second G2/M [16].  In our later work, we succeeded in identifying
persistent gaps in  nascent DNA of cells treated with low MNNG
doses [14],  which provided further support for the above pathway.
Although the “futile cycling” hypothesis [7] has met  with broad
acceptance, work from the Hsieh laboratory suggested that MutS
may act as a  damage sensor that recruits and activates ATR directly
[17], and support for this hypothesis was provided by evidence
of interactions between MMR  proteins and the ATR checkpoint
machinery [18,19].  Although this “direct signaling” model fails to
explain why recognition of the meG-containing mismatches should
activate cell cycle arrest only in  the second S phase, there is  no rea-
son why the two scenarios should not co-exist, each addressing a
subset of lesions.
The experimental evidence described above has been obtained
either from in vitro MMR  assays [13,17],  or from cell culture experi-
ments [14–16]. The former system deploys heteroduplex substrates
that do not undergo replication in the human cell extracts, while
the latter is not amenable to manipulation. We therefore decided
to analyze the processing of meG-containing substrates in Xenopus
laevis egg extracts (XEE), an experimental system that permits the
study of DNA damage signaling, DNA replication and DNA repair
either in plasmid substrates or in  chromatin, under conditions that
can be altered at will [20,21]. We  show here that replication of
meG-containing DNA in XEE did indeed give rise to persistent single-
stranded gaps opposite meG. Furthermore, recruitment of MMR
proteins to the meG-containing DNA occurred throughout repli-
cation and persisted thereafter, which is  likely to be indicative
of repeated attempts to  repair the gaps. Importantly, recruitment
of MMR  proteins to alkylation-damaged chromatin did not  coin-
cide with that of the ATR  checkpoint machinery, and we detected
no evidence of checkpoint activation after the single replication
round. Our data thus provide further support for the “futile cycling”
hypothesis.
2. Materials and methods
Detailed information regarding antibodies, primers, DNA sub-
strates, X. laevis egg extract preparation, chromatin isolation and
MSH6 immunodepletion, as well as band-shift-, dot blot- and MMR
assays in  X. laevis extracts (xMMR) can be found in  Supplementary
Information.
2.1. X. laevis egg extracts and chromatin isolation
Lysolecithin-permeabilised X. laevis sperm nuclei (“sperm chro-
matin”) were prepared as described [22]. S  phase extract capable of
performing a  single round of replication was prepared as previously
described [23]. Brieﬂy, eggs were dejellied, activated with calcium
ionophore (Sigma), rinsed with S  buffer (50 mM  Hepes-KOH pH
7.5, 50 mM KCl, 2.5 mM MgCl2 and 250 mM sucrose), transferred to
2 ml  Eppendorf tubes and crushed by  centrifugation for 12 min  at
13′200 rpm. The cytoplasmic layer was removed and, after addition
of CytB (Sigma), cleared by centrifugation for 25 min  at 70′000 rpm
(Beckman TL199 ultracentrifuge, TL55 swing-bucket rotor). The
extract was supplemented with 250 g/l cycloheximide, 25 mM
phosphocreatine and 10 g/ml creatine phosphokinase before use.
Where indicated, sperm chromatin was exposed to  varying
doses of MNU, MNNG or  1%  MMS  (all from Sigma) for 30 min  at
RT.
HSS and NPE were prepared as described previously [24].  To
make NPE, unfractionated egg  extract (crude S  phase extract)
was supplemented with nocodazole (3.3 g/ml), cycloheximide
(50 g/ml), DTT (1 mM),  aprotinin/leupeptin (10 g/ml each) and
cytochalasin B (5 g/ml), and centrifuged at 10′000 rpm for 15 min
in  a Sorvall HB-6 rotor at 4 ◦C. The dark brown layer at the top of
the tube was  removed by aspiration and the extract was decanted
into a  fresh Falcon tube, supplemented with an ATP regeneration
system and demembranated sperm chromatin to a  concentration
of 4000 n/l.  The mixture was  incubated at room temperature for
75–90 min. To collect the nuclei, the reaction was centrifuged for
2 min  at 10,000 rpm at 4 ◦C in a Sorvall HB-6 rotor. The clear ∼4 mm
layer of nuclei was  removed from the top of the tube and trans-
ferred to 5 × 20 mm  ultracentrifuge tubes. It was then centrifuged
for 30 min  at 55,000 rpm in a  Beckmann TL55 rotor. After centrifu-
gation, lipids at the top of the sample were aspirated and the clear
nucleoplasm was  harvested.
2.2. Isolation of nuclear and chromatin fractions
To isolate sperm chromatin, sperm nuclei (4000 n/l)  were
added to S  phase extract for the indicated times. For Western blot-
ting, samples were diluted in ten volumes of EB  buffer (100 mM
KCl, 2.5 mM MgCl2 and 50 mM Hepes-KOH pH 7.5) containing
0.25% Nonidet P-40 and centrifuged through a 30% sucrose layer
at 10,000 rpm for 5 min  at 4 ◦C using a Sorvall HB-6 rotor, washed
twice with 500 l EB buffer and centrifuged at 10′000 rpm for 1 min.
The pellet was  resuspended in Laemmli loading buffer, the proteins
were resolved by either 4–15%, 7.5% or 10% SDS-PAGE and analyzed
by Western blotting with speciﬁc antibodies as indicated. Unless
otherwise indicated, Precision plus protein dual color standard
(Biorad) was used as a  size reference. Nuclei were isolated by the
same procedure, except that the EB buffer contained no detergent.
2.3. DNA replication
Replication of sperm chromatin in  S phase extract (4000 n/l)
was measured by monitoring the incorporation of [32P]dCMP for
120 min  at 23 ◦C as previously described [25].  Treatments are
indicated in the ﬁgure legends. 5 l  aliquots were removed and
combined with 15 l  of STOP mix (6 mM  EDTA, 0.13% phosphoric
acid, 10% Ficoll, 5% SDS, 0.2% bromophenol blue and 80 mM  Tris–HCl
pH 8). Proteinase K  (Roche) was then added to  a  ﬁnal concentra-
tion of 2 g/l  for 1 h at 37 ◦C. The samples were separated on
0.8% agarose/TAE gels, and the dried gels were exposed to  Phos-
phoImager screens. The images were quantitated with ImageQuant
software (GE Healthcare).
For plasmid replication, plasmid DNA pRichi2850t was initially
incubated in  6 l HSS for 30 min  at 23 ◦C, followed by  addition of a
2-fold volume of NPE. DNA replication was assayed by [-32P]dCMP
(32P) incorporation as described [24].  For substrate recovery, 40 l
STOP solution (5% SDS, 80 mM Tris–HCl pH 8 and 5 mg/ml RNase)
were added for 30 min at 37 ◦C. The reaction was then incubated
with Proteinase K (1 mg/ml) overnight at 37 ◦C.  Samples were puri-
ﬁed on MiniElute columns (Qiagen) and subjected to  restriction
digests in  the presence of RNase (0.5 mg/ml, 5prime). The digested
DNA was  cleaned up again and resolved on 1% TAE agarose gels
stained with GelRed.
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Fig. 1.  Replication-dependent and -independent MMR  activity in X. laevis egg extracts. (A) Schematic representation of the phagemid substrate and the fragments generated
by  HindIII/DraI  digestion. The HindIII site lies 12 bp from the SalI site that contains the mismatch (triangle). Nt.BstNBI generates a single nick in the 3197 bp substrate (not
depicted), either 363 nucleotides 5′ from the C, T or meG residue in the top (complementary) strand, or 376 nucleotides 3′ from the mispaired G, C or T in the bottom (viral)
strand. The  MMR  excision/resynthesis machinery is directed to the nicked strand. (B and C) MMR  assays in Patrin-2-pretreated HSS extracts with top- (B) or bottom- (C)
nicked  C/G, T/G, meG/C and meG/T substrates. The phagemids recovered from the reaction were digested with HindIII/DraI, and the restriction fragments were separated on
1%  agarose/TAE gels stained with GelRed. The  dried gels were then autoradiographed (32P).  Bar graphs represent data from three independent experiments, with error bars
showing standard deviation from the mean. (D) As in (B), but the meG/C or meG/T substrate was  incubated with Patrin-2-pretreated HSS extract, either mock- or Msh6-depleted.
The  MMR defect in the Msh6-depleted extracts could be rescued by the addition of recombinant human MutS. Bottom: Western blot showing Msh6 depletion efﬁciency in
the  extract. (E) Kinetic analysis of phagemid replication (supercoiled product, sc) in Patrin-2-pretreated X. laevis extract. The indicated substrates were incubated in HSS for
30  min  to allow the formation of a pre-replication complex, followed by  addition of NPE that initiates replication (see Supplemental Information for details). Aliquots were
withdrawn at  the indicated time points, cleaned up and loaded on  0.8% agarose/TAE gels. The  dried gels were then autoradiographed (32P). Middle panel: dot blot analysis
of  the replicated substrates with an anti-meG antibody. Bottom panel: bar graph depicting data quantiﬁcation from the top panel.
All replication reactions were carried out in the presence of
Patrin-2 [O6-(4-bromoethynyl)guanine; 100–150 M],  unless oth-
erwise indicated.
3. Results and discussion
We ﬁrst set out to examine MMR  activity in X. laevis egg  extracts,
using circular heteroduplex substrates (Fig. 1A) containing either a
single T/G, meG/C or meG/T mismatch. The substrates, as well as the
control C/G homoduplex, were generated by primer extension on
single-stranded phagemid DNA, using synthetic oligonucleotides as
primers. The mispairs were situated within the unique SalI restric-
tion site (Fig. S1A), which makes the DNA refractory to cleavage by
this enzyme.
Chemical synthesis of oligonucleotides requires the presence of
an isopropyl protecting group on the N2 position of guanines, which
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Fig. 2. Replication of meG-containing DNA in X. laevis egg extracts gives rise to gaps that escape checkpoint monitoring but hinder further replication. (A) Analysis of checkpoint
activation after replication of the indicated substrates in Patrin-2-pretreated HSS + NPE. Aliquots removed at  the 120 min  time point were resolved by 7.5% SDS-PAGE and
probed  for phospho-Chk1 (S345, p-Chk1) and total Chk1. (B) Scheme of post-replicative gap-ﬁlling assays. (C) Schematic representation of the substrate digested with DrdI (left
panel)  and gap-ﬁlling reactions of the C/G and meG/C substrates (top right panel). Substrates were replicated in Patrin-2-pretreated extract without addition of radioactive
nucleotide (control sample was  spiked with [-32P]dCTP). Aphidicolin (7.5 M)  was added for 5 min  after the replication was complete, the substrate was  isolated and the
gap-ﬁlling  reaction with Klenow polymerase was  performed in the presence of [-32P]dCTP. The substrates were then digested with DrdI  (Dr) and the samples were separated
on  1% agarose/TAE gels stained with GelRed. The dried gels were subsequently autoradiographed (32P). Bottom panel: dot blot of the  replicated substrates with an anti-meG
antibody.  (D) Replication of the gapped meG/C and the control closed-circular C/G substrates in HSS +  NPE supplemented with [-32P]dCTP. Aliquots removed at the indicated
times  were divided in two, one portion was used to  extract the DNA, the other was  used for protein analysis. Top panel: autoradiograph of DNA molecules recovered from the
replication reactions and separated on 0.8% agarose/TAE gels. oc – open circular, sc  – supercoiled. Asterisk denotes supercoiled dimer C/G molecules. These are not visible in
the  gapped substrate reactions due to the substantially lower yield of supercoiled plasmids. Bar graph represents data from three independent experiments, with error bars
showing  standard deviation from  the mean. Bottom panel: Western blot of extract proteins resolved by 7.5% SDS-PAGE and probed for phoshpo-Chk1 (p-Chk1) and total
Chk1.
is removed in  the ﬁnal deprotection step by ammonia treatment.
The latter step cannot be used on oligonucleotides containing O6-
methylguanine, because ammonia would remove the 6-methoxy
group. An alternative deprotection is therefore used, but this is
often incomplete. In order to ensure that our oligonucleotides
indeed contained fully deprotected meG,  we annealed them to their
complementary sequences to  generate 31-mer duplexes contain-
ing meG/C or meG/T mispairs, and carried out gel-shift experiments
with puriﬁed human MutS. Neither oligonucleotide was bound
efﬁciently, but, upon treatment with recombinant X. laevis Mgmt
(Fig. S1B), a  strong gel-shift was observed with the meG/T oligonu-
cleotide, which is indicative of its efﬁcient conversion to G/T (Fig.
S1C).
We next  had to inhibit the Mgmt  activity in the extracts. Human
MGMT  is routinely inhibited by  O6-benzylguanine (BG), and this
was the case also for the X. laevis enzyme. As shown in  Fig S1D (left
panel), the meG/C substrate incubated with the high speed super-
natant (HSS) in the presence of 10 M BG was readily converted
to G/C, as shown by SalI  cleavage of the plasmid into fragments a
and b. Higher concentrations inhibited the cleavage, which showed
that the meG/C mismatch was intact. However, the high BG concen-
trations necessary to inhibit Mgmt  in the extracts inhibited also
the MMR  efﬁciency (data not shown). For this reason, we made
use of Patrin-2 [O6-(4-bromoethynyl)guanine; a  kind gift of Geoff
Margison], which inhibits Mgmt  with similar efﬁciency to BG (Fig.
S1D, right panel), but without the deleterious effect on MMR.
In  earlier studies, meG in DNA was  shown to be addressed by
MMR in  E. coli [26], S. cerevisiae [27] and human cells [13,28],
and we  set out to extend these ﬁndings to the X. laevis sys-
tem. Although the meG/C or meG/T oligonucleotide duplexes were
not efﬁciently bound by puriﬁed MutS in the extracts (Fig.
S1C), the circular phagemids containing a meG/C or meG/T mis-
pair and a  single nick in  either the complementary (Fig. 1B) or
the viral strand (Fig. 1C) activated excision and repair synthe-
sis, as shown by incorporation of [32P]dCMP predominantly into
fragments a and b of the phagemid DNA. This process was depend-
ent on MutS, as shown by immunodepletion of this factor from
the extracts with a X. laevis anti-Msh6 antibody (Fig. S1E–G)
and subsequent rescue with puriﬁed recombinant human MutS
(Fig. 1D).
We next set out to ask whether the presence of meG in DNA
affects replication. As shown in  Fig. 1E, the covalently closed
T/G, meG/C, meG/T and the C/G control phagemids were replicated
efﬁciently in a mixture of high speed supernatant (HSS) and nucleo-
plasmic extracts (NPE) of X. laevis eggs, with the meG-containing
substrates showing only a  slight decrease in [32P]dCMP incorpo-
ration (5–13%). Importantly, meG could be shown to  persist in
the meG/C and meG/T substrates after replication was  completed
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Fig. 3. Recruitment of X. laevis MMR  proteins to MNU-treated sperm chromatin. (A) Schematic representation of the chromatin association assay. (B) Western blot of
recruitment  of replication- and MMR  proteins to sperm chromatin treated with 1.5 mM MNU. (C) Western blot of recruitment of MMR  proteins to  undamaged or MNU-
treated (1.5 mM)  sperm chromatin, incubated for 90 min  with extracts pretreated with DMSO (control) or Patrin-2 (150 M).  (D)  Efﬁciency of replication of MNU-treated sperm
chromatin in S phase extracts, monitored by supplementing the extracts with [-32P]dCTP (32P) and incubation for 120 min  (sc-supercoiled DNA). Top  panel: autoradiograph
of  a 0.8% agarose/TAE gel (32P).  Bottom panel: column graph of data from three independent experiments, with error bars representing standard deviation from the mean.
(E)  Western blot showing recruitment of MMR-  and checkpoint proteins to  sperm chromatin treated with increasing concentrations of MNU. Extracts were pretreated with
Patrin-2. MMS  (1%) treatment was used as a positive control of checkpoint activation and Orc2 was used as a loading control. (F) Phosphorylation of Chk1 (S345)  in Patrin-2-
pretreated S  phase extracts in response to MNU. Nuclei were isolated after 120 min  and probed for p-Chk1 and total Chk1. (G) MMR-independent phosphorylation of Chk1
in  S phase extracts in response to high MNU concentrations. Nuclei were isolated after 120 min  and probed for p-Chk1 and total Chk1. (H) Re-replication of MNU-treated
sperm chromatin. As shown in the scheme, the chromatin was  ﬁrst replicated in Patrin-2 pretreated extracts, isolated, and incubated with fresh extracts that were either
pretreated with Patrin-2 or only with DMSO. The extracted DNA was  separated on  0.8% agarose/TAE gels and autoradiographed (32P). ExoIII-pre-treated chromatin was used
as  positive control; this  treatment generates single-stranded gaps from random strand breaks in the DNA.
(120 min), as conﬁrmed in the dot blot assay using a  speciﬁc anti-
body against meG (a kind gift of Jürgen Thomale).
To test whether replication of meG-containing substrates
induced DNA damage signaling in the extracts, we incubated the
heteroduplexes with HSS and NPE as above. The control, C/G
phagemid, either untreated or treated with MMS  (commonly used
to trigger DNA damage signaling in X. laevis extracts), was used as
a  control. As shown in Fig. 2A, only the MMS-treated C/G substrate
gave rise to signiﬁcant ATR activation upon replication completion
(120 min), as seen by phosphorylation of the ATR downstream tar-
get Chk1. Closer analysis of this signaling indicated that replication
of the meG/C substrate also activated ATR at the 30 min. time point,
but the phospho-Chk1 signal did not persist until replication was
completed (Fig. S2A). It is possible that this transient activation
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reﬂected an interaction of MMR  with the checkpoint machinery as
observed previously both in vitro [17,18] and in vivo [19,29].
As mentioned above, DNA damage signaling induced by SN1
type methylating agents in human cells is activated after the ﬁrst
S phase, but cell cycle arrest occurs in  the second G2/M phase
[10,16], believed to be triggered by single-stranded gaps resulting
from replication re-initiation behind the unrepaired meG residues
[14]. We  therefore searched for the presence of such gaps in our
in vitro-replicated substrates. We  designed an experimental pro-
tocol shown schematically in Fig. 2B,  in which we incubated the
C/G and meG/C phagemids with HSS and NPE, isolated the repli-
cated DNA, incubated it with Klenow polymerase in  the presence of
aphidicolin, dATP, dGTP, dTTP and [-32P]dCTP, and then digested
it with DrdI. As shown in Fig. 2C, only the meG/C substrate incorpo-
rated substantial amounts of [32P]dCMP into fragment a. Because
this fragment contains the meG residue, it is most likely that the
radionucleotide was incorporated into gaps remaining opposite
this modiﬁed base after replication. This ﬁnding was  comple-
mented by  the fact that the non-denatured phagemid isolated from
the replication mixture reacted with an anti-meG antibody in  a dot
blot assay (Fig. 2C, lowest panel).
The futile cycling hypothesis [7] posits that the single-stranded
gaps opposite meG would be effectively irreparable, because
polymerases attempting gap-ﬁlling would be aborted by  MMR acti-
vation [13]. We therefore set out to test this prediction in  X. laevis
egg extracts. We  anticipated that replication of the control C/G
plasmid would give rise predominantly to supercoiled molecules,
whereas replication of the meG/C plasmid in which a  gap had been
generated opposite the methylated guanine (Fig. S2B–D) would
give rise to open-circular molecules that  should be  converted to
supercoiled DNA with only low efﬁciency. However, pretreatment
of the latter gapped plasmid with Mgmt,  which will have con-
vertedmeG to  G, should give rise to proportionally more supercoiled
plasmid DNA. This was indeed the case, as shown in  Fig. 2D. Inter-
estingly, the gapped meG/C phagemid did give rise to  supercoiled
molecules at the later time points, which indicates that the gaps
were eventually repaired. This would happen if a  DNA polymerase
succeeded in  ﬁlling the gap completely such that the 3′ terminus of
the resynthesized strand could be ligated to  the 5′ terminus of the
downstream nascent DNA strand generated by replication reini-
tiation. In this scenario, the meG would still be in the DNA, but
the duplex would be largely refractory to MMR,  as there would
be no strand discontinuity in  the vicinity. We also detected ATR
activation, as shown by phosphorylation of Chk1 that appeared
already prior to replication, as seen previously with gapped sub-
strates [30,31]. Importantly, in  the case of the gapped meG plasmid,
the signal persisted throughout the 120 min  time course of the
assay, but not when the same plasmid was pre-treated with Mgmt
(Fig. 2D, bottom panel).
In order to gain more information about the interplay between
replication and MMR-dependent DNA damage signaling in a  more
physiologically relevant setting, we studied the recruitment of
the respective proteins to  X. laevis sperm chromatin, as shown
schematically in  Fig. 3A. Using in-house-generated rabbit poly-
clonal antibodies against frog polypeptides (Fig. S1E–G), as well
as other antibodies generously provided by others (see  M&M),
we ﬁrst monitored protein recruitment to  undamaged chromatin
in S phase extracts. As shown in Fig. 3B,  Msh2, Msh6, Mlh1 and
Exo1 were recruited with kinetics similar to those of the three
replicative polymerases and several other replication factors,
which conﬁrms that MMR  and replication are closely associated
[32,33]. When we repeated the experiment with chromatin treated
with 1.5 mM MNU (Fig. 3A and C), MMR  protein recruitment was
signiﬁcantly increased when the chromatin was incubated with
extracts pre-treated with the Mgmt  inhibitor Patrin-2, which
ensured that meG persisted in  the DNA. Treatment with different
doses of the methylating agent showed that replication was dele-
teriously affected only at MNU  concentrations exceeding 80 mM
(Fig. 3D); the observed protein recruitment was thus not the
result of blocked replication. Similar experiments carried out with
MNNG-treated chromatin (Fig. S3A and B)  conﬁrmed that, at doses
that do not affect DNA replication, MMR proteins are recruited
to methylated chromatin together with replication factors, and
persist because of the presence of meG in  the DNA.
In in vitro assays, MMR  proteins were shown to  directly interact
with the checkpoint machinery upon meG recognition [17,18].  In
contrast, our in vivo data indicated that activation of DNA damage
signaling required replication. In order to  gain more insight into this
phenomenon, we  examined the recruitment and activation of  DNA
damage signaling factors to MNU-treated sperm chromatin during
a single round of replication in  the naturally synchronous Patrin-2
pre-treated XEE. As control we used either untreated chromatin,
or chromatin treated with MMS,  which is  known to  elicit a  potent
checkpoint response in the extract [34]. As shown in Fig. 3E, treat-
ment with 1% (110 mM)  MMS  resulted in  the ready recruitment
of DNA damage signaling machinery. In  contrast, no comparable
recruitment could be seen to chromatin treated with MNU, even at a
dose of 80 mM,  which led to MMR protein recruitment comparable
to that seen with 1% MMS and which would have generated similar
amount of methylation damage other thanmeG (predominantly N7-
methylguanine and N3-methyladenine). At this dose, replication
efﬁciency was  beginning to  decrease (Fig. 3D), while phosphoryla-
tion of Chk1, a downstream target of ATR became detectable and
continued to increase up to  500 mM  MNU  (Fig. 3F and G), a  concen-
tration that severely inhibited replication (Fig. 3D).  Moreover, Chk1
phosphorylation became Mgmt/Patrin-2 independent (Fig. 3G) and
therefore independent of MMR-mediated processing of meG. Simi-
lar results were obtained with MNNG (Fig. S3C).
To test whether the presence of meG-containing gaps impairs
replication in  genomic DNA, we carried out a re-replication reaction
with untreated- or MNU-treated sperm chromatin. The chromatin
was ﬁrst allowed to replicate in  Patrin-2 pretreated extracts, iso-
lated, and incubated with fresh extracts that were either pretreated
with Patrin-2 or  only with DMSO. As shown in  Fig. 3H, re-replication
of themeG-containing chromatin in  the Patrin-2 pretreated extracts
was severely impaired, but was unaffected in  mock (DMSO) treated
ones.
4. Conclusions
X. laevis egg  extracts represent an in vitro experimental system
that permits the dissection of biological processes that can other-
wise be studied only in vivo. In this study, we set out to deploy
this system to help us identify key processes and intermediates
that bring about the cytotoxicity of meG residues generated by  SN1-
type methylating agents. We  demonstrate here that the presence
of meG in DNA does not hinder replication, but that both meG/C
and meG/T mispairs activate MMR.  In contrast to a  previous report
[35],  we show that, analogously to human cell extracts, the MMR
process is nick-directed. We  also show that meG in the template
strand is not removed by MMR-mediated excision, but that its
processing results in the generation of single-stranded gaps oppo-
site the meG residues. The sluggish repair of these gaps is suggestive
of iterative MMR-dependent resection/resynthesis. Unexpectedly,
the checkpoint machinery activation was  only weak, which sug-
gested that the gaps were possibly shielded from signaling and
thus unlikely to trigger a  cell cycle arrest during the ﬁrst repli-
cation round. However, the structures remaining in  the DNA
following one round of replication inhibited the subsequent repli-
cation round. This is  consistent with the ﬁnding that the cell
cycle arrest induced by SN1-type methylating agents in vivo is
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activated only after the second S phase, possibly through collision
of the gaps with replication forks, which would give rise to  double
strand breaks that would activate the ATR-dependent G2/M check-
point and subsequently also apoptosis. Taken together, the above
evidence provides further experimental support for the hypothe-
sis that MMR-mediated processing of meG-containing mismatches
arising during DNA replication rather than direct signaling of these
mispairs to the apoptotic machinery is  the underlying cause of the
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DNA substrates and X. laevis MMR assay  
The substrates were generated as described previously (Baerenfaller et al, 
2006). Briefly, the hetero- and homoduplexes were constructed by primer 
extension using the oligonucleotides listed below as primers and the single-
stranded phagemid DNA as template. pRichi2850topSalI (pRichi2850t SalI) 
pRichi2850bottom AclI (pRichi2850b) and pRichi2850top AclI (pRichi2850t) 
that create 5' top-nicked or 3’ bottom-nicked substrates were used as the 
ssDNA templates. A single mutation abrogating an AclI site and creating a 
SalI site was used to generate the pRichi2850top SalI phagemid. After primer 
extension and ligation, the desired supercoiled heteroduplex substrates were 
purified on CsCl gradients. 
Mismatch-provoked excision/resynthesis assays were performed as 
previously described (Varlet et al, 1990) in the presence of 100 ng DNA 
substrate and 26 µl S phase extract in a total volume of 30 µl in a buffer 
containing 15 mM Hepes-KOH pH 7.4, 15 mM potassium glutamate, 8.75 mM 
magnesium acetate, and 2 µCi of [α-32P]dCTP. The extracts were incubated 
at 23°C for 45 min. The reaction was stopped by adding 70 µl STOP solution 
containing 1 mM EDTA, 3% SDS and 5 mg/ml proteinase K (Roche). The 
samples were incubated at 55°C for 30 min, purified on MinElute columns 
(Qiagen) and subjected to restriction digests in the presence of RNase 
(5prime) at 37°C overnight. The digested DNA was cleaned up again and 
resolved on 1% agarose/TAE gels stained with GelRed. 
 
Primers 
All primers were obtained from Microsynth (Balgach, Switzerland). The 
sequences are indicated below. The SalI restriction site (GTCGAC) is 
underlined. The mispaired residue is highlighted in bold.  
C/G-SalI primer:  
5' CCAGACGTCTGTCGACGTTGGGAAGCTTGAG 3’ 
T/G-SalI primer:  
Olivera et al., SI 
5' CCAGACGTCTGTTGACGTTGGGAAGCTTGAG 3’ 
meG/C and meG/T *-SalI primer: 
 5' CCAGACGTCTGTCmeGACGTTGGGAAGCTTGAG 3’ 
* pRichi2850top AclI was used for this substrate to pair a T with meG  
 
Production of recombinant proteins  
Fragments of X. leavis MMR proteins and full-length X. laevis Mgmt were 
PCR-amplified from EST clones obtained from Imagenes using primers 
containing restriction sites for NcoI and XhoI. The PCR products were then 
cloned in a pET28B(+) vector (Novagen). 6xHis-tagged protein fragments 
(Msh2F1: 258-404 aa, Mlh1F1: 615-744aa, Msh6F1: 128-249aa, Exo1F1: 
344-450aa) were expressed in BL21 cells (Invitrogen) and purified on Ni-NTA 
agarose columns (Qiagen) according to the manufacturer’s protocol.  
 
Antibodies 
Rabbit anti-X. laevis Msh2, Msh6, Mlh1 and Exo1 antisera were generated by 
the Institute of Laboratory Animal Science (University of Zurich) against 
recombinant 6xHis-tagged protein fragments described above. Two rabbits 
per fragment were injected. Immunoglobulins specific for the X. laevis MMR 
proteins were affinity-purified using Hitrap NHS-activated HP (GE healthcare) 
according to standard protocols. Only the Msh6 and Exo1 sera were suitable 
for immunodepletions.  
Rabbit polyclonal antibodies against X. laevis TopBP1, Atr, Rad9, Rad1, 
Hus1, Rad17, Orc2, Pol δ and Pol ε were gifts from Masahiro Akiyama (Nara 
Institute of Science and Technology), Julian Blow (Dundee University), 
Karlene Cimprich (Stanford University), William Dunphy (California Institute of 
Technology), Howard Lindsay (Lancaster University) and Shou Waga (Japan 
Women's University).  Antibodies against human PCNA (Santa Cruz), MCM7 
(Sigma), CHK1 (Santa Cruz), polymerase α (Abcam) and RPA32 subunit 
(Abcam), which cross-react with the X. laevis proteins, were obtained 
commercially. The antibody that recognizes phospho-S345 of X. laevis p-Chk1 
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was purchased from Cell Signaling Technology. Anti-meG (EM2-3) antibody 
was a kind gift of Jürgen Thomale (Duisburg-Essen University). 
Western blot procedures were performed using ECL or ECL advanced (GE 
Healthcare). Antibodies for Western blots were used at 1:1000 dilutions, 
unless otherwise specified. 
 
Dot blots 
The dot blot procedure was described previously in “Technologies for 
detection of DNA damage and mutations” (G.P. Pfeifer, 1996 edition). Briefly, 
200 ng of pRichi2850t SalI substrates were heat-denatured at 100°C for 10 
min, 2 M ammonium acetate was added to a final concentration of 1 M and 
the samples were blotted onto pre-wetted nitrocellulose. The membrane was 
rinsed in 5 x SSC (0.75 M sodium chloride and 75 mM trisodium citrate) and 
blocked for 1 h in PBS/0.5% Casein/0.1% deoxycholate for 1 h at RT. Anti-
meG antibody (EM2-3) was used at 1:10 000 dilution for 1 h at RT in the same 
solution. Membranes were washed with PBS/160 mM NaCl/0.1% Triton X-100 
for 3 x 5 min, incubated with a secondary anti-mouse antibody, washed 
further 3 times and developed. 
 
Band-shift assays 
The oligonucleotide heteroduplexes were created by annealing the 5' labeled 
oligonucleotide meG, primer for synthesis of the top (complementary) strand of 
the heteroduplex, with its complementary oligonucleotides containing a C or a 
T opposite the meG. Where indicated, the annealed substrates were pre-
treated with Mgmt. The binding reaction mixtures (50 mM Hepes pH 7.5, 0.5 
mM EDTA, 10% glycerol, 0.5 mM DTT, 0.5 mg/ml BSA and 20 ng poly(dI-C) 
contained 40 fmol duplex meG/C or meG/T and human MSH2/MSH6 (250 ng). 
Protein-bound substrates were separated from the free probes by 
electrophoresis on 6% native polyacrylamide gels eluted with TAE. 
 
Xenopus laevis MSH6 immunodepletion 
To prepare Msh6-depleted extracts, 100 µl of the extract were incubated 3 
times for 30 min with 33 µl protein A-Sepharose beads 4B fast flow (Sigma) 
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coupled to 100 µl of Msh6 antiserum. Mock depletion was performed using 
beads coupled to the pre-immune serum. Coupling to the beads was 
performed overnight at 4°C without dilution. After the coupling reaction, the 
beads were washed extensively with EB buffer. The extract was reconstituted 
with 1 µg hMutSα where indicated.  
 
 
Supplementary Figure Legends 
 
Figure S1. Purification of recombinant X. laevis Mgmt, quality control of 
meG-containing substrates in XEE, Mgmt inhibitor testing and antibody 
generation. A, Sequences of pRichi2850 substrates depicting the position of 
the T/G, meG/C and meG/T mismatches with respect to the restriction sites 
used in this study (GTCGAC, SalI, TTCGAA, HindIII). B, SDS-PAGE of full-
length 6xHis-tagged Mgmt (25kDa, 1 µg/µl). C, Band shift assay with 
hMutSα and meG/C or meG/T substrates. Treatment of the substrates with 
Mgmt prior to incubation with hMutSα converted the oligos to C/G and T/G, 
respectively. D, Efficiency of the Mgmt inhibitors O6-benzylguanine (BG) and 
O6-(4-bromothenyl)guanine (Patrin-2) in XEE. HSS was incubated for 10 min 
with increasing concentrations of either BG or Patrin-2 and then the meG/C 
substrate was added to the mix for a further 30 min. This was followed by SalI 
cleavage of the substrate and analysis on 0.8% agarose/TAE gels to 
determine the most effective dose of the inhibitor. Lack of cleavage indicates 
presence of meG/C in the SalI site. Left panel: GelRed-stained gel of a 
representative assay for BG efficiency. Right: Quantification of experiments 
done with BG and Patrin-2. E, BLAST search showing degree of conservation 
between H. sapiens and X. laevis MMR proteins of interest. F, Coomasie-
stained 6xHis-tagged MMR protein fragments resolved on a 15% SDS-PAGE. 
3 µg of purified fragment F1 was loaded per lane (Msh2F1: 1.5 µg/µl, 
Msh6F1: 1.5 µg/µl, Mlh1F1: 3 µg/µl, Exo1F1: 1.2 µg/µl). M, size marker in 
kDa. G, Western blot analysis of the X. laevis egg extract (NPE, 1µl) with the 
affinity-purified MMR antibodies using the following dilutions (Msh2: 1:5000, 
Msh6: 1:5000, Mlh1: 1:500, Exo1: 1:1000). 
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Figure S2. DNA damage signaling, gapped substrate preparation and 
restriction digest analysis. 
A, Kinetic analysis of checkpoint activation (p-Chk1) during replication of the 
indicated substrates in HSS+NPE. Aliquots removed at the indicated times 
were resolved on a 7.5% SDS-PAGE and probed for p-Chk1 (S345) and total 
Chk1. Time point 0 indicates addition of NPE to the HSS/DNA mix. B, 
GelRed-stained 0.8% agarose/TAE gel showing the following samples (from 
left to right): 1kb DNA ladder, single-stranded phagemid pRichi350 (200 ng), 
supercoiled pRichi350 (300 ng), bottom-nicked pRichi350 (150 ng) and 
gapped pRichi350 substrate (150 ng). The latter was made by incubating 10 
µg of the bottom-nicked meG/C substrate with recombinant human Exo1 (28.5 
nM) for 5 min at 37˚C. When nicked by Nt.BstNB1, the nick occurs at position 
350 in the 3197 bp pRichi350 substrate (308 bp from meG, not depicted). C, 
Top panel: Schematic representation of the restriction sites for NotI (30 bp 
from meG), NdeI (730 bp from meG) and XmnI (1,3 kb from meG) in the 
pRichi350 substrate with regard to the meG (triangle). Bottom panel: GelRed-
stained 0.8% agarose/TAE gel showing restriction digest analysis of the 
gapped pRichi350 substrate (150 ng). The restriction enzymes used are 
indicated above the gel. The result shows that the gaps extended past the 
NotI site but did not reach the NdeI site.  
 
Figure S3. Recruitment of MMR and replication factors to chromatin and 
DNA damage signaling induced by MNNG. A, Kinetic analysis of replication 
of undamaged- and 1.5 mM MNNG-damaged sperm chromatin in the 
absence or presence of the Mgmt inhibitor Patrin-2. Recruitment of Msh2, 
MCM7 and pol-ε to chromatin was monitored by Western blotting. B, meG-
dependent recruitment of MMR proteins to chromatin. Binding of mismatch 
repair proteins Msh2, Msh6 and Mlh1 to undamaged- or MNNG-damaged 
chromatin in the absence or presence of the Mgmt inhibitor Patrin-2. The 
samples were assayed after 120 min. E, extract. C, Checkpoint activation in 
XEE in response to the indicated MNNG concentrations. Undamaged- or 
MNNG-damaged sperm chromatin was replicated in S phase extracts in the 
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absence or presence of Patrin-2. Nuclear proteins were isolated after 120 min 
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